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Abstract
Voltage dependent calcium channels (VDCCs) are heteromultimeric
^  i
membrane proteins which open to allow Ca entry upon depolarisation of the plasma 
membrane. The p subunit of voltage-dependent calcium channels interacts with the 
alpha interaction domain (AID) in the I-II linker of the pore forming a l  subunit and 
regulates trafficking and biophysical properties of these channels.
A surface plasmon resonance binding assay has been developed to measure 
the interaction between the I-II linkers of Cay 1.3, Cay 2.1 and Cay2.2 and CayPlb, 
Cayp2a and CavP3 and the dissociation constants (Kd) for these interactions have 
been calculated and were found to be between 12.1 and 20nM. The assay was then 
extended to measure the interaction between the I-II linkers of Cay 1.3 and Cay 2.2 
and G protein py subunits. The dissociation constant for G Py binding to the I-II 
linker of Cay2.2 was calculated to be 62.2nM whereas no interaction was detected 
between the I-II linker of Cayl.3 and GPy.
The effects of specific mutations within AID on CayP subunit binding and 
calcium channel trafficking were measured using surface plasmon resonance and cell 
surface biotinylation assays. Mutation of tryptophan within AID abolished CayP 
binding and reduced the amount of Cay2.2 channels in the plasma membrane whereas 
mutation of tyrosine reduced the affinity of CayP for AID by 24 fold but had no effect 
on the biophysical properties or trafficking of Cay2.2 expressed in tsA 201 cells.
Activation of phosphoinositide 3-kinase (PI3 kinase) promotes translocation of 
VDCC’s to the plasma membrane, this mechanism involves protein kinase B and is 
specific for calcium channels containing the CayP2a subunit. Co-expression of PI3 
kinase resulted in increased phosphorylation on serine 574 of CayP2a and protein 
kinase B was found to co-precipitate with Cayp2a.
Finally, a proteomic approach was used to identify proteins which may 
interact with CayP subunits. Ca2+/calmodulin dependent kinase II was found to 
interact specifically with the C-terminus of CayPlb.
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Chapter 1: 
General Introduction
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1.1 Intracellular calcium homeostasis
From prokaryotic to eukaryotic organisms, calcium ions are important and 
versatile signalling agents. In mammalian cells, Ca ions are involved in many 
cellular processes including gene transcription, hormone secretion, muscle contraction 
cellular proliferation and neurotransmitter release (Bootman, 2001). Intracellular 
Ca2+ concentrations are usually around lOOnM whilst the concentration in the 
extracellular space can be up to 2mM (Clapham, 1995). Although Ca2+ ions are 
essential for life, high levels of intracellular Ca are extremely toxic and result in cell 
death. It is therefore not surprising that nature has developed specialised mechanisms 
for controlling the levels of intracellular Ca as well as utilising the steep 
concentration gradient for signalling and information transfer.
Intracellular Ca can be derived from two sources. Channels in the 
endoplasmic reticulum such as the inositol trisphosphate (IP3) receptor or the 
ryanodine (RyR) receptor allow release of Ca2+ from internal stores within the 
endoplasmic reticulum into the cytoplasm in response to certain stimuli. Extracellular 
calcium is delivered to the cytoplasm via Ca influx channels in the plasma 
membrane. Several types of influx channel contribute to the elevation of cytosolic
^  I
Ca , these include voltage dependent calcium channels (VDCC) which are activated 
in response to depolarisation of the plasma membrane. Receptor-operated Ca 
channels (ROCs) are activated in response to agonist binding to the extracellular side 
of the plasma membrane. Receptor operated channels include the N-methyl-D- 
aspartate (NMDA) receptor and the nicotinic acetylcholine receptor. Store-operated 
calcium channels (SOC) allow influx of calcium from the extracellular space in
9-4-response to depletion of Ca from intracellular stores. First discovered in non- 
excitable cells (Hoth et al., 1992), and later described in other cell types (Skryma et 
al., 2000; Albert et al., 2002; Hunton et al., 2004; reviewed by Bolotina, 2004). The 
molecular identity of the channels and the mechanism by which store depletion is 
sensed has only recently been discovered. Feske et al, (2006) reported that the genetic 
defect responsible for severe combined immunodeficiency (SCID) in humans is also
9-4-responsible for store operated Ca current. The protein named orail is the product of
9  ,
the ORAI1 gene and expression of orail in SCID T cells restored store operated Ca 
current. Previous studies had identified STIM1 as a calcium sensor which can 
migrate from the ER to the plasma membrane upon Ca2+ depletion (Zhang et al.,
2005) and subsequent studies have shown that orail and stiml functionally interact
17
94*(Peinelt et al., 2006) and reconstitute store operated Ca channels (Soboloff et al.,
2006). Mechanically-activated calcium channels are activated in response to stretch, 
stress or shape change in cells such as tracheal epithelia (Boitano et al., 1992).
As Ca2+ ions can be extremely toxic, rises in cytosolic Ca2+ are rapidly 
buffered such that only 0.25-1% of the ions which enter the cytoplasm remain free 
(Neher, 1995). Calcium buffering is carried out, at least in part, by a large group of 
calcium binding proteins known as the “EF hand” family. The family is named after 
the E and F regions of parvalbumin which contains two a  helices separated by a Ca2+
^  I
binding loop. The Ca binding loop is composed of amino acid residues containing 
side chain oxygen groups such as glutamate (Krestinger, 1980) as between 4 and 12
94 -oxygen atoms are required to coordinate a single Ca ion (Fasman, 1989). Members 
of the EF hand family include calmodulin which is ubiquitous and can change its
9 «
conformation upon Ca binding and can act as a calcium sensor, calbindin, calretinin 
and parvalbumin (Heizmann et al., 1991; Baimbridge et al., 1992; Lewit-Bentley, 
2000). The Ca2+ buffering mechanism means that Ca2+ ions diffuse slowly in the 
cytoplasm relative to unbuffered signalling molecules such as IP3. The range of 
action is therefore very short and the majority of its signalling action takes place at or 
around its site of entry into the cytoplasm.
94 -Mechanisms have also evolved to actively extrude Ca ions from the 
cytoplasm. In the endoplasmic reticulum, the sarco-endoplasmic reticulum calcium 
ATPase (SERCA) pump uses energy in the form of ATP to sequester Ca2+ ions from 
the cytoplasm into the endoplasmic reticulum where they are again buffered by Ca2+ 
binding proteins such as calreticulin and calsequestrin which bind Ca2+ ions with low 
affinity but high capacity (Baksh et al., 1991; Michalak et al., 1998). Plasma 
membrane calcium ATPase (PMCA) pumps perform a similar function but extrude
9  ,
cytosolic Ca ions into the extracellular space (Brandt and Vanaman, 1996).
I ^  I
Operating in parallel to these pumps in most cell types it the Na /Ca exchanger, this
9  i
exchanger can move Ca into or out of the cytoplasm depending upon the 
electrochemical gradient. Under normal physiological conditions, the exchanger
^  I j
effectively extrudes Ca ions from the cytoplasm in exchange for Na ions at a rate of
2 1 j
1 Ca for 3 Na . The direction of exchange can be reversed in response to high 
intracellular Na+ ion concentrations. Finally, mitochondria, as well as being the
9 4 .
cellular power houses may play a role in intracellular Ca homeostasis.
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Figure 1.1
Metabolism
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Muscle contraction
Hormone secretion 
/  Neuronal excitability
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(eg. calmodulin)
Mitochondria
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calbindin)VDCCROC
MOC
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Figure 1.1. Summary of main processes which contribute cytosolic Ca2+ homeostasis. 
VDCC voltage dependent calcium channel; ROC receptor operated calcium channel; 
MOC mechanically operated calcium channel; SOC store operated calcium channel; 
RyR ryanodine receptor; IP3R inositol 1,4,5 trisphosphate receptor;
ER/SR endoplasmic/sarcoplasmic reticulum; SERCA sarco-endoplasmic reticulum 
calcium ATPase; PMCA plasma membrane calcium ATPase. Reproduced from 
Bootman, (2001) with modifications.
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Mitochondria can accumulate Ca2+ up to concentrations of 500pM in the 
mitochondrial matrix, the Ca enters via a Ca uniporter and entry is driven by the 
large electrochemical gradient generated by extrusion of H+ ions from respiration.
The affinity of the Ca uniporter for Ca is low however there is evidence that when 
in close contact with the endoplasmic reticulum, Ca microdomains resulting from 
release of Ca from the ER are formed and mitochondrial Ca uptake is significant 
(Sparanga et al., 1995). There is also evidence that mitochondrial Ca2+ uptake is
^  I
sufficient to contribute to buffering of cytosolic Ca levels in neurons (White et al., 
1997).
20
1.2 Voltage dependent calcium channels
Voltage dependent calcium channels (VDCCs) open to allow Ca2+ entry upon 
depolarisation of the plasma membrane. Voltage dependent calcium channels play 
major roles in normal physiological processes such as muscle contraction, gene 
transcription, electrical signalling and hormone secretion (Catterall, 2000) and in the 
pathological processes of many diseases. They are major routes of Ca2+ entry in 
excitable cells and their presence has been said to define an excitable cell (Hille, 
2001).
Voltage dependent calcium channels are heteromultimeric membrane proteins 
composed of a pore-forming a l  subunit, a cytoplasmic P subunit, an extracellular a2 
subunit linked to a transmembrane 8 subunit by at least one disulphide bond. In some 
cases a transmembrane y subunit is also present. The transmembrane topology of 
VDCCs is shown in figure 1.2. Genes encoding 10 different a l  subunits, 4 different 
P subunits, 4 a25 subunits and 8 putative gamma subunits have been identified and 
cloned. In addition many splice variants for each class of subunit have been 
described.
Voltage dependent calcium channels were first discovered in crustacean 
muscle (Fatt & Katz, 1953), the muscle was found to still generate action potentials 
when sodium was omitted from the bathing solution. Nearly 30 years later, the first 
biochemical analysis was performed on channels purified form solubilised skeletal 
muscle transverse tubules (Curtis & Catterall, 1983). Analysis by SDS PAGE 
revealed an a  subunit, a p subunit, a 8 and a y subunit and showed a l  and p subunits 
to be substrates for cAMP-dependent phosphorylation (Curtis & Catterall, 1985). 
Subsequent biochemical analysis revealed the a  subunit to consist of two proteins a l  
and a28 (Takahashi et al., 1987). a28 was largely extracellular, heavily glycosylated 
and a disulphide linked heterodimer of a2 and 8. The a l  subunit was designated the 
pore-forming subunit as it bound to radiolabelled 1,4 dihydropyridines.
1.2.1 Voltage dependent calcium channel classification
VDCCs were originally classified according to their biophysical and 
pharmacological properties. In skeletal, cardiac and smooth muscle, L-type calcium 
currents were so called because of their long lasting nature, this is due to slow voltage 
dependent inactivation. L-type calcium currents are inhibited by dihydropyridines,
21
Figure 1.2
a2 subunit
_  S
subunitAIDSH3 8 subunit
GK
subunit
C
Figure 1.2. Subunit composition of HVA calcium channels. The pore forming a1 subunit consists of 24 membrane spanning segments, 
transmembrane segm ents marked in red represent the voltage sensor. The a1 subunit is associated with an extracellular a2 subunit which 
is linked to the transmembrane 6 subunit by a disulphide bond. The cytoplasmic Cavp subunit associates with the a1 subunit primarily via 
the highly conserved AID motif located within the cytoplasmic linker between transmembrane domains I and II.
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phenylalkylamines and benzothiazipines (Reuter, 1983). Calcium currents recorded 
from dorsal root ganglion (DRG) neurons (Nowycky et al., 1985) inactivated more 
quickly than L-type current and were insensitive to the organic calcium channel 
antagonists which inhibited L-type current. The N-type current identified in this way 
was so called as it was not L-type and was neuronal. The rapidly inactivating voltage 
dependent calcium current first described in starfish eggs (Haigawara et al., 1975) and 
later in DRG and Purkinje neurons (Carbone & Lux, 1984; Llinas & Yarom, 1981) 
was designated T-type or transient current, also known as low voltage activated 
current for its more negative voltage dependency. High voltage activated calcium 
currents in Purkinje neurons were termed P-type current as they were insensitive to 
dihydropyridines, and also insensitive to the co-conotoxin GVIA used to distinguish 
N-type current (Tsien et al., 1988). P-type current is inhibited by co-agatoxin IVA 
(Mintz et al., 1992). A similar type of current first identified in cerebellar granule 
neurons (Randall & Tsien., 1995) is inhibited with lower affinity by co-agatoxin IVA 
was termed Q-type current, P and Q-type current were subsequently found to be the 
product of a single gene which is alternatively spliced (Bourinet et al., 1999). Other 
high voltage activated calcium currents were identified in cerebellar granule neurons
94-which were resistant to known peptide Ca blockers and organic antagonists (Randall 
& Tsien., 1995) this was named R-type current.
Molecular cloning and heterologous expression of Ca subunits in systems 
such as Xenopus laevis oocytes has revealed the identities of the pore forming a l  
responsible for the different types of current observed in native tissue. As more new 
pore forming a l  subunits were cloned, a unified nomenclature was developed such 
that each subunit received a letter eg. a l  A (Bimbaumer et al., 1994). However this 
nomenclature was considered confusing and was revised (Ertel et al., 2000) such that 
the channels are grouped according to their sequence similarities. The sequence 
similarities between the Cay calcium channel families are shown in Figure 1.3. The 
channels are named using the chemical symbol of the permeating ion eg. Ca followed 
by the physiological regulator which in this case is voltage. The following numerical 
value denotes the family and the order in which the subunit was discovered. The 
subunit composition of VDCC channel types is shown in Table 1.1.
The nomenclature regarding VDCC auxiliary subunits has remained 
unchanged, these are shown in Table 1.2.
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Table 1.1
Ca Current Tissue specificity Selective (Function Reference
channel type blocker
Cavl.l L Skeletal muscle Dihydropyridines E/C coupling 
Ca2+ homeostasis 
Gene expression
Tanabe et al., 
(1987)
Cav 1.2 L Cardiac muscle
Endocrine
CNS
Dihydropyridines E/C coupling 
Hormone 
secretion 
Gene expression
Koch et al., 
(1990)
Cav1.3 L Endocrine
CNS
Dihydropyridines Hormone 
secretion 
Gene expression
Williams et 
al., (1992)
Cav1.4 L Retina Dihydropyridines Tonic
neurotransmitter
release
Strom et al., 
(1998)
Cav2.1 P/Q CNS co-agatoxin IVA Neurotransmitter
release
Mori et al., 
(1991)
Cav2.2 N CNS (D-conotoxin
GVIA
Neurotransmitter
release
Dubel et al., 
(1992)
Cav2.3 R CNS SNX 482 Ca22+ dependent 
action potentials 
Neurotransmitter 
release
Soong et al., 
(1994)
Cav3.1 T Cardiac muscle 
Skeletal muscle 
CNS
Mibefradil Pacemaker
activity
Perez-Reyes 
et al., (1998)
Cav 3.2 T Cardiac muscle 
CNS
Mibeffadil Pacemaker
activity
Cribbs et al., 
(1998)
Cav3.3 T CNS Mibefradil Pacemaker
activity
Lee et al., 
(1999)
Table 1.1. Voltage dependent calcium channels are grouped into one of three families according to 
their sequence similarities. The table shows a list of the pore forming a l  subunits, the type of current 
they mediate, their tissue specificity and their selective pharmacological blocker.
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Table 1.2
Subunit Function Tissue specificity Reference
a28-l Trafficking of Cava l  subunit
Increase in current amplitude 
Hyperpolarise voltage 
dependence of activation 
a 25-2 Increase in current amplitude
a 25-3 Increase in current amplitude
Hyperpolarise voltage 
dependence of activation 
0 2 8 -4  Increase in current amplitude
Brain, Heart, Skeletal muscle
Lung, testis, brain, heart, pancreas, 
prostate, skeletal muscle, spinal cord 
Brain, heart, skeletal muscle
Heart, skeletal muscle, intestine, fetal 
liver, erythroblasts, adrenal gland, 
pituitary
Gumett et al.,1996
Klugbauer et al., 1999 
Klugbauer et al., 1999 
Qin et al., 2002
pi
P2
P3
P4
Trafficking of a l  subunit to 
plasma membrane 
Increases current amplitude 
Activation / inactivation 
kinetics and voltage 
dependence
Trafficking of a l  subunit to 
plasma membrane 
Increases current amplitude 
Activation / inactivation 
kinetics and voltage 
dependence
Trafficking of a l  subunit to 
plasma membrane 
Increases current amplitude 
Activation / inactivation 
kinetics and voltage 
dependence
Trafficking of a l  subunit to 
plasma membrane 
Increases current amplitude 
Activation / inactivation 
kinetics and voltage 
dependence 
Inhibitory effects
Skeletal muscle ((31 a), Brain (other pi 
isoforms)
Heart, lung, trachea, aorta, brain
Bogdanov et al., 2000
Chienetal., 1998
Smooth muscle, trachea, aorta, lung, 
brain
Brain
Brice et al., 1999
Brice et al., 1999
yl
Y 2
y3
y4
y5
y6
y?
y8
>
Inhibitory effects 
Trafficking of AMP A 
receptors
Activation and inactivation 
kinetics
Inactivation kinetics
Activation and inactivation 
kinetics (Cav3.1)
Reduction in current amplitude 
(LVA channels)
Reduction in current amplitude
As y2, y3 and y4
Skeletal muscle 
Brain
Brain
Heart, lung, brain, prostate, spinal cord 
Brain
Heart, skeletal muscle, brain 
Brain, heart, lung, testis 
Brain, testis, spinal cord
Jay et al., \M --------
Letts et al., 1998
Klugbauer et al., 2000 
Klugbauer et al., 2000 
Klugbauer et al., 2000 
Chu et al., 2002 
Moss et al., 2002 
Klugbauer et al., 2000
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Table 1.2. Auxiliary subunits of voltage dependent calcium channels. Adapted from Arikkath & 
Campbell, (2003)
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Figure 1.3
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Figure 1.3. Phylogenetic diagram showing the sequence similarities between the Cav calcium channel 
families. Only the transmembrane and pore forming loop are compared. Within each family, the 
sequence similarity is greater than 80%. Between families the sequence identities are 52% between 
Cav 1 and Cav 2 families and 28% between the Cav 3 family and the Cav 1 2 families. Taken from 
Ertel et al., (2000).
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1.2.2 The pore forming a l  subunit
The VDCC a l  subunit is composed of approximately 2000 amino acid 
residues giving it a molecular weight of about 250 kilo Daltons (kDa). The 
polypeptide chain is arranged into 24 transmembrane helices which in turn are 
arranged into 4 homologous domains connected by cytoplasmic linkers. In addition 
there are a cytoplasmic N- and C-termini (Figure 1.2), this domain architecture is 
similar to the voltage gated sodium channel (Yu & Catterall, 2003). The 4th 
transmembrane segment of each domain contains charged residues and serves as the 
voltage sensor. Under the influence of the electric field, the voltage sensor rotates
th tiloutwards and causes the channel to open. The 5 and 6 transmembrane segments 
form the inner lining of the pore, a membrane associated loop known as the P-loop 
between segments 5 and 6 contains a conserved glutamate residue which enables the 
pore’s selectivity for Ca2+ (Yang et al., 1993). The T-type channel family have two 
aspartate residues and two glutamate residues rather than 4 glutamate residues in the 
selectivity filter, it is this which gives rise to their altered ion permeation 
characteristics (Tavelera et al., 2001).
The I-II linker of all HVA Ca2+ channels contains a highly conserved 18 
amino acid motif known as the alpha interaction domain (AID) (Pragnell et al., 1994). 
The AID is the primary site of interaction with the CavP subunit which binds to AID 
with very high affinity (De Waard et al., 1995). Binding of the CavP subunit has 
substantial effects on the biophysical properties of HVA a l  subunit including 
increased plasma membrane expression and induction of hyperpolarising shifts in the 
voltage dependence of activation, voltage dependence of inactivation and voltage 
dependence of steady state inactivation (Catterall, 2000; Dolphin, 2003). In the Cay2 
family of HVA Ca2+ channels the AID also contains a QQXXR motif which has been 
shown to be involved in interaction with Py subunits of heterotrimeric G proteins (De 
Waard et al., 1997). Although the sites of interaction of CavP and G protein Py 
overlap in Cav2 AID, whether these subunits can bind AID at the same time remains 
controversial (Meir et al., 2000; Sandoz et al., 2004).
Detailed structural information regarding the structure of the ion conducting 
pore and the voltage sensor of voltage gated potassium channels from both 
prokaryotes and eukaryotes has been determined using x-ray crystallographical 
studies (Doyle et al., 1998; Jiang et al., 2003). However, detailed structural
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information about VDCCs is still not available probably due to their large and 
complex nature and difficulties with overexpression and subsequent purification.
Some low resolution data have been obtained from analysis of purified 
dihydropyridine receptor complexes from skeletal and cardiac muscle by electron 
microscopy (Murata et al., 2001; Wang et al., 2002; Wolf et al., 2003; Wang et al., 
2004). These data provide some information about the overall dimensions of the 
dihydropyridine receptor complex and labelling studies revealed the approximate 
positions of some auxiliary subunits (Wolf et al., 2003; Wang et al., 2002). There 
was however substantial variation between the structures presented and there is no 
consensus on whether the channels are monomeric, dimeric or exist as oligomers 
under physiological conditions (Wang et al., 2004). Higher resolution structures and 
clearer labelling studies are necessary to provide more detailed information about the 
pore forming a l  subunit.
1.2.3 The Cavl  family
In humans the Cayl family of calcium channels consists of four members.
All members of this family are high voltage activated, mediate L-type current and are 
sensitive to dihydropyridines. The Cay 1.1 channel is expressed in skeletal muscle and 
is involved in excitation-contraction coupling. Cavl .1 links directly with the 
ryanodine receptors in the sarcoplasmic reticulum acting primarily as a voltage 
sensor, coupling membrane depolarisation to release of Ca from intracellular stores
y I
(Schwartz et al., 1985), influx of Ca through the channel is secondary to its role as a 
voltage sensor.
Expressed in a variety of cells including cardiac muscle, smooth muscle and
9-4-neurons (Perez-Reyes et al., 1990; Mori et al., 1993) Cayl.2 does function as a Ca 
channel. Cayl .2 is involved in cardiac excitation-contraction coupling and is 
modulated by [3-adrenergic agonists acting via cyclic AMP dependent protein kinase 
which enhances calcium current through Cay 1.2 and consequently increases cardiac 
contractility producing a positive inotropic effect (Morad et al., 1981). In neurons, 
Cay 1.2 is involved in coupling membrane depolarisation to regulation of gene 
expression (Weick et al., 2003).
Cay 1.3 is expressed in many of the same tissues as Cayl .2. Cayl .3 is 
responsible for a major fraction of L-type Ca current in neurosecretory and neuronal
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cells (Dolphin, 1999; Hell et al., 1993) and is also expressed in hair cells of the inner 
ear and in cardiac sino atrial nodes where it is involved in pacemaker activity 
(Scholze et a l , 2001; Kollmar et al., 1997).
Originally thought to only be expressed in retinal tissue, Cay 1.4 is also 
expressed in spleen, spinal cord, bone marrow and thymus (McRory et al., 2004). 
Missense mutations in Cay 1.4 have been implicated in the human condition 
incomplete X-linked congenital stationary night blindness. Cayl .4 has only recently 
been functionally characterised (Koschak et al., 2003; McRory et al., 2004) and was 
found, unlike other L-type Ca channels to display very slow voltage dependent 
inactivation and no calcium dependent inactivation (Koschak et al., 2003; McRory et 
a l , 2004).
1.2.4 The Cay2 family
The three members of the Cay 2 family are mainly expressed in neuronal 
tissue. These channels are predominantly localised in the synaptic terminals where 
they control release of neurotransmitters and regulate synaptic communication 
(Catterall, 1999; Seager and Takahashi, 1998). A common feature of the Cay 2 family 
is their susceptibility to modulation by py subunits of heterotrimeric G proteins 
coupled to G protein coupled receptors (GPCRs) (Dolphin, 1986; Ikeda and 
Schofield, 1989). Modulation by G proteins manifests itself as a slowing of current 
activation kinetics and a shift in the current-voltage relationship to more depolarised 
potentials (Bean, 1989), recovery from inactivation is both time and depolarisation 
dependent and can be removed by large depolarising pulses (Ikeda, 1991). Multiple 
structural determinants have been implicated in the modulation of Cay 2 family by G 
proteins. The cytoplasmic linker between domains I and II of all members of the Cay 
2 family has been shown to interact directly with the G protein Py subunit (De Waard 
et al., 1997; Zamponi et al., 1997; Bell et al 2001). Additional binding sites have 
been demonstrated in the C-terminus (Kinoshita et al., 2001; Qin et al., 1997) 
however, other groups have demonstrated full G protein modulation of Cay 2.2 in a 
construct where the C-terminus was removed (Stephens et al., 1998). The N-terminus 
of all channels of the Cay 2 family contains the motif YKQSIAQRART which has 
been shown to be essential for G protein modulation (Canti et al., 1999; Dolphin,
2003). Removal of the Cay 2.2 N-terminus abolishes G protein modulation (Page et
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al; 1998) and replacement of the N-terminus of other classes of channel with that of 
Cay2.2 enabled the chimeric channels to be modulated by G proteins (Canti et al.,
1999). More recently Agler et al. (2005) demonstrated using yeast two hybrid assays 
and mammalian cell flourescence resonance energy transfer (FRET), interactions 
between Gpy, the Cay2.2 N-terminus and the Cay I-II linker and the Cay2.2 N- 
terminus and the Cay I-II linker. A model is proposed in which the N-terminus acts 
as a G-protein Py gated inhibitory module which binds to the I-II linker to inhibit the 
channel.
Cay2.1 is present throughout the brain and central nervous system (Mori et al.,
1991) and is involved in neurotransmitter release. As mentioned previously Cay 2.1 
channels mediated P/Q type current and alternative splicing gives rise to two distinct 
channel types (Bourinet et al., 1999) which are blocked by co-agatoxin IVA with 
different affinities. Cay2.1 channels interact with proteins involved in exocytosis via 
a site on the cytoplasmic II-III linker (Walker and DeWaard,1998; Seager et al.,
1998). Mutations within CACNA1 A, the human gene which codes for Cay2.1 have 
been linked to three autosomal dominant neurological disorders in humans, these are 
episodic ataxia type-2 (EA2), familial hemiplegic migraine (FHM) and 
spinocerebellar ataxia type 6 (SCA6) (Zhuchenco et al., 1997; Ophoff et al., 1996).
The Cay2.2 channal is responsible N-type current, Cay2.2 channels are 
primarily expressed in nerve terminals where they are involved in release of 
neurotransmitters (Dunlap et al., 1995). Cay 2.2 appears to be less involved in 
neurotransmitter release than Cay2.1 channels as Cay2.2 does not couple so 
efficiently with the exocytotic machinery as Cay2.1 (Mintz et al., 1995; Qian et al.,
2000).
The Cay2.3 channels mediate R-type current and are specifically inhibited by 
a 41 amino acid peptide toxin isolated from the African tarantula, Hysterocrates gigas 
(Newcomb et al., 1998). Cay2.3 channels are mainly localised in neuronal cell bodies 
(Yokoyama et al., 1995) but are also present in some nerve terminals (Wu et al.,
1999; Dietrich et al., 2003).
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1.2.5 The Cay3 family
The Cay 3 family of Ca2+ channels is the most recent family to be cloned and 
characterised (Perez-Reyes et al., 1998; Cribbs et al., 1998; Lee et al., 1999). The 
family consists of three members (Perez-Reyes, 1999) all of which mediate T-type 
current. T-type current activates from small depolarisations and at more negative 
membrane potentials than HVA current and inactivates rapidly. Unlike HVA Ca2+ 
channels members of the Cay3 family do not seem to require the presence of any 
known calcium channel auxiliary subunits for normal plasma membrane expression or 
function. Members of the Cay3 family are expressed in many tissue types, especially 
in heart and brain and particularly in tissues which display spontaneous electrical 
activity such as the sinoatrial nodal cells of the heart and thalamic neurons 
(Hugenard., 1996). When expressed in HEK-293 cells, Cay3.1 and Cay3.2 both 
produced large transient currents and are likely to be involved in pacemaker activity 
(Chemin et a/., 2001), this role was confirmed for Cay3.1 when generation of a 
Cay3.1 knockout mouse displayed no burst mode firing of action potentials in 
thalamocortical relay neurons (Kim et al,. 2001). In contrast, Cav 3.3 exhibited a 
degree of facilitation and produced a sustained calcium entry and is capable of 
generating sustained electrical activity associated with pacemaker activity (Chemin et 
al., 2 0 0 1 ).
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1.3 Ca channel auxiliary subunits
1.3.1 The y subunit
The y subunit is the smallest of the VDCC auxiliary subunits with a molecular 
weight of between 25 and 35 kDa. The y subunit was first described as a protein 
which copurified with the dihydropyridine receptor complex from skeletal muscle 
(Campbell et al., 1989). Molecular cloning of this subunit, termed yl, revealed a 
protein containing 4 transmembrane segments and intracellular N-and C-termini.
Some time later, a neuronal y subunit was identified and cloned (Letts et al., 1998), 
this gene is mutated in the mutant mouse stargazer and thus, the gene product is 
known as “stargazin”. More recently six new putative y subunits have been identified 
and cloned (Klugbauer et al., 2000; Burgess et al., 2001; Moss et al., 2002).
0 4 -The function of the y subunit as a Ca channel subunit remains to some extent 
controversial but some functional effects have been described. In mice where yl 
expression is eliminated, dihydropyridine sensitive Ca2+ current in isolated 
myotubules was increased and the voltage dependence of steady state inactivation was 
shifted to more depolarised potentials suggesting that y\ serves to decrease Ca entry 
(Freise et al., 2000). The neuronal y2 subunit has a small but significant effect upon 
P/Q type current in BHK cells (Letts et al., 1998) and y 3, y4 and y5 subunits will 
associate with and exert some effects upon currents mediated by Cay2.1 and Cay2.2 
(Sharp et al., 2001; Klugbauer et al., 2000; Rousset et al., 2001). In addition, there 
are reports of modulatory effects of y subunits upon T-type currents in coexpression 
studies (Klugbauer et al., 2000; Green et al., 2001; Lacinova, 2000). There is also 
evidence that the neuronal y2 subunit is involved in trafficking of alpha-amino-3- 
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors to the plasma 
membrane (Chen et al., 2000) and this is now accepted to be the main role for y2, y3, 
y4 and y8 (Nicoll, Tomita and Bredt, 2006; Tomita et al., 2006; Rouach et al., 2005; 
Tomita et al., 2005).
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1.3.2 The oc25 subunit
The a28 subunit is a highly glycosylated protein which is encoded by a single 
gene. The a28 subunit gene product is highly post-translationally processed and 
cleaved (Jay et al., 1991) to yield an entirely extracellular a l  subunit which is joined 
to the 5 subunit by a disulphide bond. The 8 subunit anchors the a l  subunit to the 
plasma membrane via a single transmembrane segment. Four a28 subunit genes have 
so far been cloned and characterised (Ellis et al., 1998; Klugbauer et al., 1999; Qin et 
al., 2002). a28-l appears to be expressed in most tissue types (Barclay et al., 2001) 
where as a28-2 and a28-3 expression is restricted mostly to the brain (Barclay et al., 
2001; Klugbauer et al., 1999). The a28-4 subunit appears to be localised to 
specialised cell types such as pituitary gland, adrenal gland, colon and liver (Qin et 
al., 2002). In co-expression studies, when expressed with a pore forming a l  and 
CavP subunit, a28 subunits increase the current density and shift the voltage 
dependence of activation to more hyperpolarised potentials (Felix et al., 1997; Hobom 
et al 2000; Klugbauer et al., 1999). There is also an increase in dihydropyridine 
binding sites in the plasma membrane suggesting that the number of channels in the 
membrane is increased and that a28 may have a role in Ca2+ channel trafficking 
(Shistik et al., 1995). A recent study by Canti et al. (2005) showed that the Von 
Willebrand factor-A (VWA) domain which is present in all a28 subunits contains a 
metal ion dependent adhesion site (MIDAS). When mutated so that it can no longer 
bind divalent cations, the mutant a28 subunit no longer enhanced Ca2+ currents 
mediated by Cavl .2 , Cav 2.1 or Cav2 .2 . The authors suggest that it is the interaction 
between the MIDAS motif and the Caval subunit which promotes trafficking to the 
plasma membrane.
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1.3.3 The Cay (3 subunit
Beta subunits of voltage dependent calcium channels are small (55-75 kDa) 
entirely cytoplasmic proteins which have substantial effects upon the trafficking and 
biophysical properties of high voltage activated calcium channels. The CavP subunit 
binds with high affinity to a highly conserved motif within the cytoplasmic linker 
between domains I and II of HVA Ca2+ channels known as the alpha interaction 
domain (AID) (DeWaard et al., 1995).
The p subunit associated with the skeletal muscle dihydropyridine receptor 
was the first to be identified (Takahashi et al., 1987). The gene encoding CavP la  was 
subsequently cloned and characterised (Ruth et al., 1989) and shortly afterwards three 
more CavP subunits were cloned based on their homology with CavPl (Castellano et 
al., 1993; Hullin et al., 1992; Perez-Reyes et al., 1992). Alignments of the four CavP 
subunit gene sequences revealed the presence of five amino acid sequence similarity 
domains (D1-D5) (Bimbaumer et al., 1998) of which two, D2 and D4 are encoded by 
4 and 6 exons respectively and are highly conserved (Figure 1.4). Alternative splicing 
can occur in the variable regions Dl, D3 and D5 giving rise to many splice variants 
for each CavP subunit including one, CavP2a which can be palmitoylated at its N- 
terminus (Chien et al., 1998).
1.33.1 Tissue distribution and subcellular localisation of CavP subunits
All four CavP subunits have been shown to be expressed in the brain (Ludwig 
et al., 1997). Using specific antibodies and riboprobes for Cavotl subunits as well as 
CavP subunits, an expression profile was generated which suggested that whilst 
CavP3 associates predominantly with Cav2.2 and CavP4 associates with Cav2.1, a 
Cavp subunit may associate with any HVA Caval subunit. This was confirmed by 
the findings that L-type channels, Cav2.1 and Cav2.2 immunprecipitated from brain 
were associated with multiple Cavp subunits (Pichler et al., 1997; Scott et al., 1996; 
Liu et al., 1996).
The Cavp la  subunit is expressed in skeletal muscle and appears to be the only 
P subunit expressed in this tissue. Mice in which the CavP 1 gene is deleted die at 
birth from asphyxia and the amount of Cav 1.1 in the myotubes is undetectable,
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Figure 1.4
D1 D2 D3 D4 D5
1 100 161 218 430 597
SH3 GK
Figure 1.4. Linear model of C a ^ l b  produced from alignment of known C a ^  subunit 
sequences. C a ^  subunits contain five amino acid sequence similarity domains (D1-D5), 
two of which (D2 and D4) are highly conserved and form SH3 and GK domains respectively. 
The numbers represent the number of amino acid residues in each domain of C a ^ l  b.
Data are taken from Dolphin, (2003)
highlighting the important role of the CayP in calcium channel trafficking (Gregg et al
1996). The CayPlb subunit is more widely expressed, being present in brain, 
ventricular, spleen and cardiac tissue (Powers et al., 1992; Scott et al., 1996; Hullin et 
a l , 1999; Hullin et a l, 2003).
The Cayp2 subunit was found to be the least highly expressed p subunit in 
rabbit brain (Witcher et al., 1995) however localised areas of high expression have 
been detected in Purkinje cells of the cerebellum, hippocampus and thalamus (Ludwig 
et al., 1997). Cavp2 protein was also detected in heart (Ludwig et al., 1997) and will 
coprecipitate with dihydropyridines receptors from human heart (Hasse et al., 1996). 
However, coexpression of the cardiac Cayl .2 with CayP2a does not produce channels 
with the biophysical properties of endogenous cardiac Ca channels (Wei et al.,
2000). Recently, Colecraft et al. (2002) used 5’ rapid amplification of cDNA ends (5’ 
RACE) PCR to clone a new CayP2 splice variant named Cayp2b. Expression of 
CayP2b in heart cells yielded channels with biophysical properties which closely 
resembled those of native cardiac Ca channels. The authors suggest that it is 
CayP2b rather than Cayp2a which is the major CayP2 variant expressed in cardiac 
tissue and it is for this reason that previous attempts to isolate CavP2a from cardiac 
tissue (Qin et al., 1998) have been unsuccessful. Mice in which the gene coding for 
CayP2 has been inactivated have been generated and this mutation was found to be 
lethal (Ball et a l, 2002). By placing the P2 gene under the control of a myosin heavy 
chain promoter and thereby restricting the expression to the heart, the authors were 
able to rescue the mice and study the effects of CayP in the retina. The CayP2 
deficient mice showed abnormal retinal function and abnormal distribution of the 
retinal calcium channel Cayl .4 suggesting that CayP2 is the primary p subunit 
expressed in retina.
The CayP3 subunit is strongly expressed in the brain where it appears to be 
associated with the majority (56%) of Cay2.2 subunits (Scott et al., 1996) but also 
associates with Cay2.1. CayP3 is also expressed in aorta, lung, trachea and p cells of 
the pancreas and is considered to be the CayP subunit which associates with Cayl .2 in 
smooth muscle (Hullin et al., 1992; Collin et al., 1994; Berggren et al., 2004). Mice 
lacking a Cayp3 subunit have been generated and characterised in detail with regard 
to cardiovascular function and glucose homeostasis. The CayP3 deficient mouse
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showed little phenotype (Murakami et al., 2000), there was no difference in smooth
• j t
muscle contraction or sensitivity of muscle contraction to L-type Ca channel 
blockers compared to wild type mice and the authors concluded that there may be 
some compensation by other Cay(3 subunits such as CavP2a. The CavP3 deficient 
mice did show an increase in blood pressure in response to a high salt diet suggesting 
a possible role for CavP3 in salt sensitivity hypertension (Murakami et al., 2000). 
Whilst there was no difference in smooth muscle contraction, western blotting and
s y t
dihydropyridine binding experiments showed reduced expression of L-type Ca 
channel a l  subunits in the plasma membrane of cells of the aorta,
9 +electrophysiological experiments revealed a 30% reduction in Ca current density 
(Murakami et al., 2003). The impact of Cayp3 disruption on pain processing was also 
investigated. Pain processing was found to be reduced or dampened in Cavp3 
deficient mice which expressed only low levels of Cay2.2 in DRG neurones compared 
to wild type mice and whilst no reduction in expression was observed in Cay2.1 
channels, a depolarising shift in their voltage dependence of activation and a change 
in the voltage dependence of facilitation of compound Ca currents was reported.
The Cayp4 subunit is also strongly expressed in the brain, particularly in the 
cerebellum (Ludwig et al., 1997) and has also been detected in kidney, testis, retina 
and lymphocytes (Escayg et al., 1998). Three splice variants of CavP4 have been 
cloned and characterised, all are expressed in the brain, eye, heart and lung but the 
truncated CavP4c isoform is expressed in cochlea and is the only Cavp4 isoform 
expressed in this tissue (Hibino et al., 2003). The variants Cayp4a and Cavp4b differ 
slightly in their N-terminal regions and this has been shown to have effects on the 
voltage dependence of activation and inactivation of Cay2.1 and Cay2.2 with channels 
containing CavP4a showing a more depolarised voltage dependence of activation and 
inactivation than those with Cayp4b (Helton et al., 2002). The CavP4c isoform is 
truncated within its guanylate kinase like domain and perhaps not surprisingly has
9-4-little effect upon Ca currents. However, this isoform was found to be recruited to 
the nucleus of tSA-201 cells and to attenuate the gene silencing activity of chromobox 
protein 2/heterochromatin protein ly (CHCB2/HPly) (Hibino et al., 2003).
The CavP subunit has no predicted transmembrane regions and is regarded as 
a cytoplasmic protein. However, the N-terminus of the Cayp2a isoform contains two 
cysteines as positions 3 and 4 which can be palmitoylated (Chien et al., 1996). This
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palmitoylation directs CavP2a, when expressed alone, to the plasma membrane 
(Chien et al., 1995; Bogdanov et al., 2000) whereas a palmitoylation deficient mutant 
in which cysteine 3 and 4 are changed to serine shows a more diffuse pattern of 
expression (Leroy et al., 2005). The CavP3 and Cavp4 subunits show a more diffuse 
localisation throughout the cytoplasm when expressed in COS-7 cells with some 
staining observed in the nucleus (Bogdanov et al., 2000). Plasma membrane 
expression has also been observed for Cavp lb when expressed alone In COS-7 cells 
(Brice et al., 1997). The determinant for this localisation was identified as a highly 
acidic 11 amino acid motif in the C-terminus of Cavpl which when deleted reduced 
membrane expression and when transferred to Cavp3, promoted localisation of CavP3 
to the plasma membrane (Bogdanov et al., 2000).
Recently, five splice variants of CavP2 have been cloned (CavP2a-e) and their 
subcellular localisation characterised (Takahashi et al., 2003). Of the five isoforms, 
both the palmitoylatable Cavp2a isoform and the non-palmitoylatable CavP2e isoform 
showed distinct plasma membrane localisation when fused to the fluorescent protein 
GFP and expressed alone in HEK 293 cells. The other three isoforms showed a more 
diffuse cytoplasmic localisation. Interestingly and in agreement with other studies 
(Brice et al; 1997; Bogdanov et al; 2000), the subcellular localisation of the Cavp2 
subunit isoform did not affect its ability to traffic Cayal subunits to the plasma 
membrane nor did the presence of a Cayccl subunit change the subcellular distribution 
of the CavP subunit isoform (Takahashi et al., 2003).
39
1.3.3.2 CayP subunit structure
As previously mentioned, the primary structure of the CavP subunit contains 
five domains, two of which are highly conserved (Bimbaumer, 1998). The first 
insights into the structure of the Cavp subunit came from homology models made by 
Hanlon et al. (1999). Using homology searches and threading algorithms, structural 
predictions were made which assigned the D2 domain as an Src Homology-3 (SH3) 
domain and the D4 domain as being similar to the yeast Guanylate Kinase (GK). This 
domain structure places the CavP subunit in the membrane associated guanylate 
kinase (MAGUK) family of proteins. The N-terminus of CavPlb upon which the 
model was based was predicted to contain a putative Post Synaptic Density protein 95 
(PSD-95), Discs large protein (dig) and Zona occludens-1 (ZO-1) (PDZ) domain. 
However, this N-terminal region is poorly conserved among CavP subunits and is 
subject to alternative splicing and thus this homology is not conserved.
The MAGUK family of proteins always contain a 300 amino acid region with 
homology to yeast GK. This family of proteins are believed to be ubiquitous 
scaffolding molecules and other members include PSD-95, PSD-93, SAP 97 and 
CASK. In the GK domain of MAGUK proteins GK is catalytically inactive, this is 
the case for CavP subunits in which the glycine-rich ATP binding motif is not 
conserved. The MAGUK family of proteins also always contain at least one PDZ 
domain, although probably absent in CavP subunits, PDZ domains are involved in 
protein-protein interactions at sites of cell-cell contact such as synapses, 
neuromuscular junctions and tight junctions (Gamer et al., 2000). Interaction of PDZ 
domains with their protein partners usually occurs via short C-terminal sequences, 
these interactions also occur with a relatively low affinity (low pM range) (Harris and 
Lim, 2001). SH3 domains are also involved in protein-protein interaction and have 
been found to bind to polyproline motifs (P X X P). However, these types of 
interaction are rarely found in MAGUK proteins (Funke, Dakoji & Bredt, 2005). 
Instead, many ligands have been found to interact with the GK domain, these include 
guanylate kinase associate protein (GKAP) (Kim et al., 1997), A kinase anchoring 
protein (AKAP) (Colledge et al., 2000) and guanylate kinase associated kinesin 
(GAKIN) (Hanada et al., 2000). In addition to binding to its many protein partners, 
GK will interact with SH3 in an intramolecular fashion (Shin et al., 2000), this
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intramolecular interaction appears to be essential for some functions of MAGUK 
proteins (McGee et al., 1999; Shin et al., 2000). This certainly appears to be the case 
for Cayp subunits as the SH3 and GK domains have been shown to interact with one 
another (Opatowsky et al., 2003; Takahashi et al 2004). Although some modulatory 
effects were observed using the GK domain alone (Maltez et al., 2005), this 
interaction is required to fully reconstitute the trafficking and modulatory effects 
characteristic of CavP subunits (Takahashi et al, 2004; Maltez et al., 2005; Takahashi 
et al., 2005).
Recently, three groups reported the crystal structures of CavP2, p3 and P4 
core domains (Chen et al., 2004; Van Petegem et al., 2004; Opatowsky et al., 2004). 
By removing the highly variable N and C-termini and either truncating the central 
variable region or using Cavp subunit isoforms in which this was very short, the 
authors were able to generate constructs from which structural data could be obtained, 
in one study, the two conserved domains were expressed as separate entities and 
resulting complex was crystallised. The structures were also presented as complexes 
with AID peptides, revealing the exact nature of the CavP/Caval interaction.
The structure of CavP3 core complexed with AID peptide is shown in Figure 
1.5. The structure shows that the CavP subunit core does indeed contains two 
interacting domains, the SH3 domain consists of four p strands and two long a  helices 
which extend away from the SH3. The second a  helix (a2, Figure 1.4) joins to the 
non-conserved central variable region, the C-terminal residues of which form the fifth 
P strand of SH3 (P5, Figure 1.4). The central P strands of the SH3 are arranged in a 
similar fashion to those of other MAGUK proteins such as PSD-95 whose structure 
was also recently solved (McGee et al., 2001). However unlike other MAGUK 
proteins, CavP has a long a  helix at its N-terminus (a l Figure 1.4), this structure 
seems to be in place of a PDZ domain which would be N-terminal to the SH3 in other 
MAGUK proteins. There are also differences in the orientation of the SH3 relative to 
the GK domain, the orientation of SH3 in CavP is shifted by approximately 90° 
compared to PSD-95.
The main revelation of the structure concerns the nature of AID peptide 
binding. All three structure clearly show the AID peptide tightly embedded in a deep
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Figure 1.5
SH3 GK
Figure 1.5. The structure of C a ^ a  core in complex with the Ca^/M AID peptide is 
shown as a ribbon diagram with the SH3 domain marked in blue, the GK domain is 
marked in red and the AID peptide in yellow. The SH3 and GK domains are closely 
associated and the AID peptide fits into a deep groove on the reverse side of the GK 
domain termed the aid binding pocket (ABP). The central variable region of the Cayp 
subunit is not shown but would occur between helix a2 and p strand p5. The structural 
elements are numbered according to Chen et al., (2004).
Taken from Richards, Butcher and Dolphin, (2004)
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groove in the GK domain now termed the AID binding pocket (ABP) (Van Petegem 
et al., 2004). Comparison of Cavp structures with and without AID present show 
small movement of three backbone a  helices in GK and a larger movement of their 
side chains making way for the AID to bind, this movement does not however 
constitute any sort of structural rearrangement or conformational change (Chen et al.,
2004). It is now clear that residues which were previously believed to make up the 
beta interaction domain (BID) (De waard et al., 1994; De waard et al., 1996) and be 
essential for AID binding are in fact critical for Cavp core structural integrity and for 
maintaining SH3/GK association.
The structure of AID interacting with the ABP showed the many contacts 
formed between the conserved amino acid residues in AID and the ABP particularly 
the aromatic rings of the tryptophan and tyrosine residues of AID which are stacked 
together forming a hairpin in the AID binding pocket (Opatowsky et al., 2004).
These residues have previously been shown to be essential for AID/Cavp interaction 
(Pragnell et al., 1994; Witcher et al 1995; De Waard et al., 1995) and more recently 
the conserved tryptophan was shown to be essential for binding and modulation of 
Cav2.2 (Leroy et al., 2005) whilst the conserved tyrosine is necessary only for 
maintenance of the high affinity interaction between AID and the ABP (Butcher et al., 
2006).
Recently, the structure of the N-terminus of Cavp4a was solved by nuclear 
magnetic resonance (NMR) spectroscopy (Vendel et al., 2006). This region 
represents the highly variable D1 domain (Figure 1.3) and was previously believed 
not to contain significant secondary structure as it is so poorly conserved across the 
CavP subunit family. The structure of the Cavp4a N-terminus was shown to contain 
two antiparallel p sheets and two a  helices which form an independent protein 
module separate from that of the Cavp subunit core. The authors speculate that this 
module may participate in protein-protein interactions either within the Cavp subunit 
or with other proteins and contribute to CavP subunit function.
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1.3.3.3 CavP subunit function
Cayp subunits have substantial effects on the plasma membrane localisation 
and biophysical properties of the HVA a l  subunit with which they are expressed. In
t
systems where HVA Ca channel a l  subunits are expressed without CavP subunits 
or when the amounts of Cavp subunits are depleted in native tissue, the result is a 
reduction in macroscopic Ca current, reduced trafficking to the plasma membrane 
and slowed activation kinetics (Singer et al., 1991; Berrow et al., 1995; Brice et al., 
1997). Coexpression of CavP subunits has since been shown to increase functional 
expression of Caval at the plasma membrane (Brice et al., 1997; Bichet et al., 2000) 
and a recent study in which mutations were introduced into Cav2.2 such that it could 
no longer bind to CavP resulted in substantially reduced levels of Cav2 .2  in the 
plasma membrane along with reduced current density (Leroy et al., 2005). The 
mechanism by which CavP mediated its trafficking effects is unclear but it has been 
suggested that an endoplasmic reticulum (ER) retention signal present in the I-II 
linker of HVA Ca channels is masked by CavP subunit binding (Bichet et al., 2000) 
causing the Caval to be released from the ER to proceed to the plasma membrane. 
However, the AID does not contain any known ER retention signal (Dolphin, 2003) 
and interestingly, recent work in which part of the I-II linker of Cav2.2 including AID 
was transferred to Cav3.1 which does not require Cavp subunits for efficient 
trafficking did not result in decreased plasma membrane expression of the chimeric 
channels (Arias et al., 2005). These results suggest that the signal for ER retention 
may lie elsewhere or be masked by regions of the CavP subunit other than the ABP.
In addition to increasing the number of functional channels at the plasma 
membrane, CavP subunits also hyperpolarise the voltage-dependence of activation 
and steady-state inactivation (Dolphin, 2003). In other words, the channels with 
which they are associated require smaller membrane depolarisations to activate or 
open, this would manifest itself as a leftward shift in the current-voltage relationship 
on a plot where the normalised current traces are plotted against the test potential.
There is little difference in the effects of any CavP subunit on the voltage 
dependence of activation (Dolphin, 2003) but there are differences in steady-state 
inactivation, which are due to determinants in both Caval and CavP subunits. For
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example, the voltage-dependence of steady state-inactivation of Cay2.2 and Cay2.3 
were shown by Canti et al. (2000) to be hyperpolarised by all CayP subunits except 
CavP2 a which shifted the steady-state inactivation process in the depolarising 
direction by approximately +10 mV. This effect had previously been shown for 
Cayal.2, Cay2.1 and Cay2.3 by other groups (De Waard and Campbell, 1995; Cens 
et al., 1998). The determinant for the unique behaviour of CayP2a was shown to be 
its ability to be palmitoylated which when removed caused Cayp2a to behave like 
other Cayp subunits with regard to steady-state inactivation (Canti et al., 2000).
All HVA Cayal subunits have the intrinsic ability to inactivate without the 
need for accessory subunits (Stotz and Zamponi, 2001). The determinants involved in 
voltage-dependent inactivation have been investigated in detail and several regions of 
the channel have been shown to be important. By using chimeric channels of Cay2.1 
and Cay2.3, Zhang et al. (1994) reported that the differences in inactivation kinetics 
were due to determinants within the sixth transmembrane segment of domain I and a 
short sequence within the I-II linker. Subsequent studies have implicated all four 
transmembrane domains as determinants in voltage dependent inactivation with 
domains II and III being particularly important (Spaetgens et al., 1999). Other 
determinants have been reported in the cytoplasmic C-terminus of Cay 1.2 and the I-II 
linker of Cay2.1 (Soldatov et al., 1998; Herlitz et al., 1997) and a single amino acid 
change in Cay2.1 is known to change the properties of Cay2.1 from Q-type to non­
inactivating P-type (Bourinet et al., 1999). Despite this intrinsic ability of the 
Cayal subunit, Cayp subunits have substantial effects upon the kinetics of voltage- 
dependent inactivation (Stotz & Zamponi., 2001). Coexpression of either Caypi or 
Cayp3 causes a substantial increase in inactivation rates whereas Cayp2a dramatically 
slows inactivation kinetics and Cayp4 produces a moderate slowing. The ability of 
CayP2 a to slow inactivation kinetics has again been shown to be due to its 
palmitoylation (Qin et al., 1998) as prevention or removal of palmitoylation reduces 
the effect of slowed inactivation kinetics induced by CayP2a (Stephens et al., 2000). 
On the basis of results regarding the properties of Cayp2a and the I-II linker in 
voltage dependent inactivation, a model is proposed whereby the I-II linker acts as an 
inactivation gate (Restituto et al., 2000; Stotz et al., 2000). This is consistent with 
evidence that CayP subunits bind to the I-II linker and exert substantial effects upon
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voltage-dependent inactivation and also with data regarding Cay(32a which whilst 
tethered to the plasma membrane due to its palmitoylation, restricts the movement of 
the I-II linker and thus slows inactivation (Restituto et al., 2000).
1.3.3.4 Role of CayP subunits in modulation by G proteins and facilitation
9-4-As described previously, the Cay2 family of HVA Ca channels can be 
modulated by Py subunits of heterotrimeric G proteins (Dolphin., 2003). Although 
important determinants of G protein modulation have been identified in the I-II linker 
(De Waard et al., 1997), the N-terminus (Canti et al., 1999) and in some channels the 
C-terminus (Qin et al., 1997), the CayP subunit also plays an important role in G 
protein modulation.
Canti et al. (2000) demonstrated by coexpression studies in Xenpus laevis 
oocytes that all CavP subunits antagonised G protein mediated inhibition of Cay2.2, 
this result had previously been reported by other groups who had reported substantial 
increases in G protein mediated inhibition in the absence of CayP subunits (Bourinet 
et al., 1996) and interpreted the results as simply a competition between Cayp and 
GPy for sites on the Cayal subunit. However, Canti et al, (2000) noted that the 
effects were voltage-dependent and activation of G proteins antagonises the Cayp 
mediated hyperpolarisation of Cay2.2. Furthermore, the presence of CavP increases 
the rate of dissociation of GPy from Cay2.2 during a depolarising prepulse and the 
authors therefore concluded that both CayP and GPy bind to the channel at the same 
time. Unbinding of Gpy from the channel is measured as facilitation and manifests 
itself as an increase in current following a large depolarising prepulse. It is believed 
that the prepulse removes bound GPy, thus, the amount of facilitation observed 
represents the amount of GPy bound to the channel. The idea that both Cayp and 
GPy can occupy the channel together is still controversial. Displacement of G py was 
demonstrated using fluorescence resonance energy transfer (FRET) by Sandoz et al.
(2004), the authors suggested that displacement of CayP from the I-II linker is a key 
step in G protein regulation of Cay2.1 calcium channels. However, this contradicts 
findings of Hummer et al. (2003) who found, again using FRET that CayP and G 
protein p can bind to the I-II linker at the same time. A recent study by Leroy et al.,
(2005) showed using a Cay2.2 channel in which the conserved tryptophan in the I-II
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linker is mutated to alanine thus preventing Cayp binding that the channel was still 
inhibited by GPy. However, the inhibition was not voltage-dependent, but 
coexpression of CayP2a which is targeted to the plasma membrane by its 
palmitoylation restored all elements of G protein modulation. The authors conclude 
that Cayp subunits are essential for removal of inhibition by Gpy and that in this 
system the effects mediated by CayP are probably via low affinity interactions with 
Cay2.2 at sites other than the AID.
1.3.3.5 Novel functions of CavP subunits
' j .
In addition to the well established role of CayP subunits in Ca channel 
trafficking and modulation, some recent studies have highlighted novel functions 
which seem to involve CayP subunits. Some of these functions do result in regulation 
of VDCC a l  subunits but others involve different protein partners and are not directly 
related to Cayal function. Beguin et al. (2001) identified by yeast two hybrid and 
immunoprecipitation a small GTP binding protein known as GEM which interacted 
with CayP3. Further experiments showed that the interaction was not restricted to 
Cayp3 but GEM could also bind CavPl and Cayp2. The outcome of the interaction 
which was to prevent channel trafficking to the plasma membrane was also not 
restricted to any particular class of channel as it occurred for both L and non L-type 
channels but not T-type channels (Finlin et al, 2003). Another novel protein partner 
was reported by Viard et al. (2004). The authors showed that Protein kinase B/Akt, a 
protein kinase downstream of PI3 kinase co-precipitated with CayP2a and can 
phosphorylate CayP2a in its C-terminus. The result is increased trafficking of CayP2a 
containing Ca2+ channel complexes to the plasma membrane. Hibino et al. (2003) 
isolated a short splice variant of CayP4 from cochlea and showed that in yeast 2 
hybrid assays this variant interacted with a nuclear protein involved in gene silencing. 
Subsequent experiments showed that this splice variant is preferentially targeted to 
the nucleus and could regulate the gene silencing activity of chromobox protein 2 
(CHCB2). Finally, the CayP3 knockout mouse studied by Berggren et al. (2004) 
showed a more efficient glucose homeostasis compared to wildtype mice. The 
authors showed that Cayp was able to negatively modulate the formation of inositol
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1,4,5-trisphosphate (I11SP3) and so negatively modulate the release of Ca2+ ions from 
intracellular stores However, the mechanism by which this occurs is as yet unknown.
1.4 Aims of this work
The initial aim of this work was to develop a surface plasmon resonance 
(SPR) binding assay to study the interaction of Cavp subunits with the highly
^  I
conserved AID motif located within the I-II linker if HVA Ca channels. Surface 
plasmon resonance has advantages over other biochemical binding assays as there is 
no requirement for fluorescent or radio-labelling and the assay allows on- and off- 
rates to be measured and a dissociation constant (K d) for the interaction to be 
calculated. This involves production of I-II linker fusion proteins containing the 
entire I-II linker of L-type (Cay 1.3) and non L-type (Cay2.1 and Cay2.2) channels and 
the production of purified CavP subunits. The assay was then extended to examine 
the interaction of purified G protein Py subunits with the purified I-II linkers. The 
assay was then extended further to examine the effects of mutating the conserved 
tryptophan and tyrosine residues in the I-II linker on CavP subunit binding. These 
residues have previously been shown to disrupt CavP subunit binding (Pragnell et al., 
1994; Witcher et al 1995; De Waard et al., 1995). Next, the effects of introducing 
these mutations into the I-II linker of full length Cay2.2 were investigated with regard 
to the ability of CavP subunits to traffic the mutated channels to the plasma 
membrane. This was studied by western blotting with anti Cay2.2 antibodies and cell 
surface biotinylation assays.
The second part of this work focuses specifically on the CavP2a subunit. It 
was recently reported that activation of phosphoinositide 3-kinase (PI3 kinase) 
promotes translocation of VDCC’s to the plasma membrane (Viard et al., 2004). This 
mechanism was shown to involve protein kinase B and to be specific for channels 
containing the CavP2a subunit. Biochemical assays were developed to investigate the 
interaction between Cayp2a and protein kinase B, these include metabolic labelling of 
transfected cells with ‘P, western blotting with phospho-specific antibodies, in vitro 
phosphorylation and immunoprecipitation.
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Finally, in view of recent findings that the CavP subunit may have functions 
other than trafficking and modulation of Cayal subunits (Beguin et al., 2001; Finlin 
et al., 2003, Hibino et al, 2003; Viard et al., 2004), it was highly desirable to identify 
other proteins which may interact with the Cavp subunit. To this end, a proteomic 
approach was used to identify unknown proteins which coprecipitate with CavP 
subunits from immunoprecipitation and pull down experiments.
49
Chapter 2: 
Materials and methods
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2.1 Molecular Biology
2.1.1 Suppliers
All reagents used in these experiments were purchased from Sigma Aldrich 
Company LTD and were of the highest purity available.
2.1.2 Water
The water used for both molecular biology and tissue culture was prepared 
using a Milli-Q Ultrapure Water Purification System (Millipore). The water quality 
was 18MQ/cm and was filtered through a 0.22pm membrane prior to use.
2.1.3 Deoxyribonucleic Acid
The following cDNA’s were used in these experiments. Cay2.2 from rabbit 
(D14157) (Fujita et al., 1993). CavPlb from rat (X61394) (Pragnell et al., 1991). 
CavP2a from rat (M80545) (Perez-Reyes et al., 1992). CavP3 from rat (M88751) 
(Castellano et al., 1993). a282 from mouse (Barclay et al., 2001). Cay2.1 from 
rabbit (X57689) (Mori et al., 1991). Cayl.3 from human (M76558) (Williams et al.,
1992). PI3 kinase regulatory subunit PlOly from pig (Y10742) (Stephens et al.,
1997). PI3 kinase catalytic subunit PI 10y from Human (X83368) (Stoyanov et al., 
1995). Akt 1/PKBa from mouse was purchased from Upstate Cell Signalling 
Solutions (Charlottesville, VA) (Franke et al., 1995). Green fluorescent protein (GFP- 
mut3b) (U73901) (Cormack et a l , 1997).
2.1.4 Expression vectors
2.1.4.1 Eukaryotic expression vectors
The expression vector pMT2 (Swick et al., 1992) was used for expression of 
proteins in eukaryotic cell lines. This vector contains the SV40 origin of replication 
and so can replicate in cells expressing the SV40 large T antigen. Originally 
developed as a Xenopus laevis oocyte expression vector, pMT2 expresses well in both 
COS-7 and tsA 201 cells. pMT2 has been modified in our laboratory to contain 
additional restriction endonuclease sites in its multiple cloning site (MCS) this 
increases its versatility and facilitates the subcloning of large cDNA fragments. In 
these experiments, pMT2 was used for the expression of all cDNA constructs in
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mammalian cells with the exception of PI3 kinase regulatory subunit PlOly which 
was in pcDNA3.
2.1.4.2 Prokaryotic expression vectors
Prokaryotic expression vectors enable foreign proteins to be expressed in 
bacterial cells, the host cells are usually E.coli. In these experiments, three 
prokaryotic expression vectors were used all of which were used because they 
provided high level protein expression under the control of the isopropyl-1-thio-P-D- 
galactopyranoside (IPTG) inducible lac operon.
The lac operon consists of three contiguous genes which encode p- 
galactosidase, lacYlac permease lacZ and lac transacetylase lac A. A fourth gene lacl 
is situated upstream. Lacl encodes a repressor protein which under conditions of no 
lactose binds to the promoter region of the operon, upstream from the three 
contiguous genes known as the lac operator. When lactose or its non-metabolisable 
analogue IPTG are present, the lac repressor protein preferentially binds this and the 
promoter region becomes available for RNA polymerase to begin transcription. In 
inducible expression vectors, the lac promoter is replaced with the T7 promoter and 
the three genes involved in lactose metabolism replaced with a cloning site into which 
foreign genes can be inserted.
The three prokaryotic expression vectors used in these studies were pET28, 
pETM6Tl and pGEX-2T. The pET28 vector contains a versatile multiple cloning site 
under the control of the T7 promoter and genes of interest can be expressed with 
either N-terminal or C-terminal His(6) tags. The pETM6 Tl vector was a generous gift 
of Dr Andrei Okorokov, (Wolfson Institute for Biomedical Research, University 
College London) and is a modified version of pET44b. This vector contains an N- 
terminal His(6) tag followed by the 495 amino acid NusA solubility tag. The gene of 
interest is inserted between the NusA and an optional C-terminal His(6) tag, this vector 
is also under the control of the T7 promoter. The pGEX-2T vector was used to 
generate GST fusion proteins. pGEX-2T contains an N-terminal Glutathione-s- 
transferase fusion tag, expression is IPTG inducible and under the control of a hybrid 
tac promoter (a hybrid of the E. coli trp and lac promoters) (De Boer et al., 1983).
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2.1.5 Polymerase chain reaction (PCR)
Polymerase chain reaction (PCR) was used to amplify DNA sequences of 
interest from cDNA templates. PCR was used to introduce point mutations, to 
engineer epitope tags into genes of interest or to introduce restriction endonuclease 
sites to facilitate subcloning. In all cases two oligonucleotide primers were used 
which flanked the region of interest in the 3’ and 5’ direction and the primers 
contained at least 18 base pairs which were complimentary to the target sequence. All 
primers were obtained from Invitrogen and were purified by polyacrylamide gel 
electrophoresis (PAGE) if they exceeded 25 base pairs in length. The Pyrococcus 
furiosus (Pfu) DNA polymerase was used in all PCR reactions and was purchased 
from Stratagene. The Pfu DNA polymerase possesses 3' to 5’ exonuclease 
proofreading activity that enables the polymerase to correct nucleotide- 
misincorporation errors. This means that Pfu DNA polymerase-generated PCR 
fragments will have fewer errors than Jia^-generated PCR inserts. All PCR reactions 
contained 5% dimethyl sulfoxide (DMSO), as addition of DMSO can promote DNA 
“melting” in GC rich DNA sequences. PCR reactions were set up as follows in a 
reaction volume of lOOpl.
Components Concentration
10 x Pfu reaction buffer 1 OjLll
Deoxynucleotide triphosphate 0.5mM each
Forward primer 40pmol
Reverse primer 40pmol
Pfu DNA polymerase 5 units
Template DNA 0.5pg
DMSO 5 pi
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The reaction mixture was split into two 200pl PCR tubes and subjected to the 
following conditions using a thermal cycler.
Time Temperature °C Step Cycles
3 min 98 Initial melt 1
20  sec 98 Melting 25
2 0  sec 55 Annealing 25
As required 72 Extension 25
5 min 72 Final extension 1
For all primer combinations tested, an annealing temperature of 55°C was used and 
was found not to give rise to significant non-specific priming. The resulting PCR 
products were purified using a rapid PCR purification kit (Marligen Bioscience Inc, 
2502 Urbana Pike Ijamsville, USA) according to the manufacturer’s protocol and 
were eluted in ultra pure water.
2.1.6 Agarose gel electrophoresis
DNA fragments were separated by electrophoresis on 0.7 -  2% agarose 
minigels. The electrophoresis buffer was Tris-acetate EDTA (TAE) and contained 
lOmM Tris acetate pH 7.4 and ImM ethylenediaminetetraacetic acid (EDTA). 
Staining was performed after electrophoresis using a solution of 1 pg/ml Ethidium 
bromide dissolved in TAE. Stained gels were viewed using a UV transilluminator.
2.1.7 DNA extraction from agarose gels
DNA fragments of interest were extracted from agarose gels using a Rapid Gel 
Extraction kit (Marligen Bioscience Inc, 2502 Urbana Pike Ijamsville, USA) 
according to the manufacturer’s protocol and were eluted in ultra pure water.
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2.1.8 DNA modifying enzymes
Restriction endonucleases were used to cleave double stranded DNA in 
specific positions. All restriction endonucleases were purchased from Invitrogen 
LTD (3, Fountain Drive, Inchinnan Business Park, Paisley, UK) and were used 
according to manufacturer’s instructions. DNA ligation was performed using T4 
DNA ligase purchased from Invitrogen LTD. Ligation reactions contained 1 unit of 
T4 DNA ligase in lOpl reaction volume, ligation reactions were performed at 16°C 
overnight.
2.1.9 Bacterial cultures
For routine subcloning and propagation of expression vectors, One Shot 
TOP 10 chemically competent E.coli were used (Invitrogen LTD), cells were 
transformed according to manufacturer’s instructions. Mini cultures were set up in 
5ml Lysogeny broth (LB) (Bertani, 1951) containing appropriate antibiotics. Cultures 
were grown at 37°C overnight in a shaking incubator. For propagation of plasmids, 
50pg/ml Ampicillin or 30pg/ml Kanamycin were used.
2.1.10 DNA purification
Plasmid DNA was purified from E.coli minicultures using a Rapid plasmid 
purification kit (Marligen Bioscience Inc) according to manufacturer’s instructions, 
plasmid DNA was eluted in 50pl Tris-EDTA (TE) and stored at -20°C. Large scale 
plasmid DNA was purified from 200ml cultures using High Purity Plasmid 
Purification kits (Marligen Bioscience Inc) according to manufacturer’s instructions. 
Purified DNA was adjusted to 1 pg/pl and stored at -20°C.
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2.1.11 Generation of epitope tagged constructs and fusion proteins
2.1.11.1 GST fusion proteins
The cytoplasmic linker between domains I and II of Cayl.3, Cay2.1 and 
Cay2.2 were amplified by PCR using primers which introduced BamHl and EcoRl 
restriction sites into the 5’ and 3’ ends respectively. The resulting PCR products were 
ligated into BamHl and EcoRI cut pGEX-2T to create GST Cayl-II linker fusion 
proteins. The resulting constructs were verified by DNA sequencing.
2.1.11.2 NusA fusion proteins
The cytoplasmic linker between domains I and II of Cay2.2 was amplified by 
PCR using primers which introduced EcoRl restriction sites into the 5’ and 3’ends. 
The resulting PCR product was inserted into pETM 6T1 which had been made linear 
by digestion with EcoKL to create NusA Cay2.2 I-II linker fusion protein. Mutations 
within the I-II linker fusion protein which changed tryptophan 391 to alanine, tyrosine 
388 to serine and tyrosine 388 to phenylalanine were made by site directed 
mutagenesis.
2.1.11.3 HA tagged constructs
Wildtype Cayp2a and Cayp2a S574A were amplified by PCR using primers 
which introduced EcoRl restriction sites into the 5’ and 3’ ends and in addition, 
modified the N-terminus of Cayf2a to remove the first methionine, introduce an HA 
tag and to change cysteine 3 and 4 to serine. The N-terminus of HA tagged Cayp2a 
and Cavp2aS574A now reads MYPYDVPDYAQSSGLVH.
Wildtype protein kinase B in expression vector pUSEamp was amplified by 
PCR using primers which introduced EcoBl restriction sites into the 5’ and 3’ ends 
and also introduced an HA tag to the N-terminus of the protein. The resulting PCR 
products were ligated into pMT2 which had been made linear with EcoBl. All HA 
tagged constructs were verified by DNA sequencing.
2.1.11.4 HiS(6> tagged constructs
As described previously, the prokaryotic expression vector pET28 was used to 
generate all His(6) tagged constructs used in these experiments. His(6) tagged Caypib 
(H6 Cplb) was made by amplifying Caypib by PCR using primers which removed
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the existing stop codon, replacing it with a His(6) tag followed by a new stop, the 
forward and reverse primers also contained Ncol and EcoRI restriction sites 
respectively to facilitate subcloning into pET28. His(6) tagged CavP3 (H6CP3) was 
made by two rounds of PCR, the first amplified the 5’ end of Cavp3 removing an 
internal Afllll restriction site. The second round used the product from the first round 
of PCR as forward primer and a reverse primer which included a His(6) tag and an 
EcoRI restriction site. H6CP3 was subcloned into pET28 using Ncol and EcoRI 
restriction sites. HiS(6) tagged CavP2a was amplified by PCR using primers which 
introduced EcoRI restriction sites into both the 5’ and 3’ ends. The resulting PCR 
product was subcloned into pET28 in frame with the N-terminal His(6) tag encoded by 
the vector.
2.1.11.5 CavP C-terminus and AC-terminus constructs
The His(6) tagged C-terminus of Cavp lb was generated by digesting CavPlb 
in pET28 with Ncol, this removed the majority of Cavp coding region. The resulting 
construct contained 166 residues of Cavp lb C-terminus fused to a C-terminal His(6) 
tag. CavPlb without a C-terminus (H6 Cplb AC-terminus) was generated by PCR 
using a reverse primer which truncated Cavp lb at the end of the GK like domain 
introducing a C-terminal His(6) tag followed by a stop codon.
The C-termini of CavP2a and CavP2aS574A were amplified by PCR using 
primers which introduced EcoRI into the 3’ and 5’ ends. The resulting PCR products 
were subcloned into pET28 using EcoRI, the resulting constructs contained an N- 
terminal His(6> encoded by the vector.
2.1.11.6 Site Directed Mutagenesis
Site directed mutagenesis was used to create point mutations in His(6) tagged 
Cavp2a to create Cavp2aS574A and also to change tryptophan 391 to alanine and 
tyrosine 388 to serine or phenylalanine in Cav2.2 NusA I-II linker fusion constructs. 
Point mutations were made using the QuickChange Site Directed Mutagenesis kit 
(Stratagene). The technique is PCR based and involves the use of a pair of 
complimentary DNA primers both of which harbour the intended mutation. PCR 
followed by Dpril digestion of methylated template DNA results in mutated plasmids
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consisting of “nicked” circular strands. The mutated plasmid is introduced without 
the need for ligation into XL1 blue E.coli which repair and propagate the plasmid.
All constructs generated this way were verified by DNA sequencing
2.1.12 DNA sequencing
DNA sequencing was performed using a PCR based method. The reaction 
mixture contains a mix of standard deoxynucleotide triphosphates and fluorescent 
dideoxyribonucleotide triphosphates. The polymerase and fluorescent nucleotide mix 
used was BigDye version 3.1 (Applied Biosystems). DNA sequencing reactions were 
set up in the following way.
Component Concentration
Template DNA 0.5pg
Primer 4pmol
BigDye Version 3.1 4 pi
Water To lOpl
The reaction mixture was subjected to the following reaction conditions using 
a thermal cycler.
Time Temperature (°C) Step Cycles
2  min 98 Initial melt 1
2 0  sec 98 Melt 25
20  sec 50 Annealing 25
4 min 60 Extension 25
4 min 60 Final extension 1
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The resulting products were precipitated using sodium acetate and ethanol and 
finally washed with 70% ethanol to remove traces of salt. The DNA sequences were 
analysed using an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems) 
according to the manufacturer’s instructions. The resulting sequence data was 
inspected using Chromas version 1.45 software and sequence alignments against the 
corresponding sequence obtained from GenBank were made using Omiga software.
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2.2 Protein Chemistry
2.2.1 Bacterial strains and cultures
E.coli BL21-CodonPlus-RIL (Stratagene) bacteria were used as the host strain 
for large scale protein production. BL21-CodonPlus-RIL E.coli contain extra copies 
of the argU, ileY and leuW  transfer RNA genes. This enables this strain to recognise 
arginine codons AGA and AGG, the isoleucine codon AUA and the leucine codon 
CUA. These codons can restrict translation of heterologous proteins from certain 
organisms causing expression of truncated protein products or no expression at all.
For protein expression, single colonies of E.coli BL21-CodonPlus-RIL 
containing the plasmid of interest were picked and cultured overnight in LB pH7.4 in 
a shaking incubator at 37°C. The following day, the saturated cultures were diluted 
1:10 in LB pH5.5 containing the appropriate antibiotics and l%w/v glucose. The 
cultures were grown at 37°C until the optical density at 560nm was between 0.5 and 
0.6. Cultures were then cooled to 22°C and protein production was induced by 
addition of IPTG to a final concentration of 0.5mM for CavP subunit constructs and 
0.1 mM for all other constructs. Protein expression was allowed to proceed for 4 
hours before cultures were harvested by centrifugation at 10,000 x g for 5 min. 
Pelleted cultures were stored at -80°C until required.
2.2.2 Ni-NTA chromatography
Ni-NTA chromatography was used to purify expressed proteins carrying 
hexahistidine tags from bacterial lysates. Metal ions can be divided into three groups 
based on their preferential reactivity towards nucleophiles (Pearson, 1973) Iron, 
Calcium and Aluminium are known as hard metal ions and react preferentially with 
oxygen. Intermediate metal ions include copper, nickel, zinc and cobalt coordinate 
oxygen, nitrogen and sulphur. As there are limited numbers of cysteines exposed on 
the surface of proteins, histidines are a major target for intermediate metal ions 
(Chaga, 2001). The use of engineered affinity tags and immobilised metal affinity 
chromatography (IMAC) was first demonstrated by Hochuli et al. (1988), the 
technique is now widely used in the purification of recombinant proteins. In these 
experiments, nickel complexed with nitrilotriacetic acid (NI-NTA) (Qiagen) was used
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as this forms stronger complexes with the metal ion than some other adsorbents 
leading to less metal ion leaching during use.
For purification of all CavP subunit constructs, frozen E.coli pellets were 
thawed on ice and resuspended in 10ml of buffer containing 20mM Tris pH 8.0, 
150mM NaCl, ImM dithiothreitol (DTT) and 20mM imidazole. Complete EDTA 
free protease inhibitor cocktail (Roche Diagnostics) was present in all buffers at a 
concentration of 1 tablet per 50ml buffer. The cells were lysed by sonication for two 
pulses of two min, the cells were rested on ice between pulses. The lysates were 
cleared by centrifugation for 20 min at 20,000 x g at 4°C. The cleared lysate was 
loaded onto a 1ml NI-NTA column which had been pre-equilibrated with buffer 
containing 20mM Tris pH 8.0, 150mM NaCl, ImM DTT, 20mM Imidazole. The 
column was washed with 25 volumes of equilibration buffer before elution with 5 
volumes of equilibration buffer containing 400mM imidazole. The eluate from the 
column was collected in 1ml aliquots and stored at 4°C until required.
For purification of NusA fusion constructs, the initial cell lysis was performed 
as for CavP subunit constructs. After centrifugation the resulting pellet was washed 
once in 10ml lysis buffer and resuspended in 10ml buffer containing 20mM (N-(2- 
Hydroxyethyl)piperazine-N'-(2-ethanesulfonic acid) (HEPES) pH 8.0, 150mM NaCl, 
ImM DTT, 20mM imdazole and 1.5% 3-[(3-Cholamidopropyl)dimethylammonio]-l- 
propanesulfonate (CHAPS), and was incubated fori hour at 4°C on a rolling platform. 
After centrifugation at 20,000 x g for 20 min, the resulting supernatant was diluted 1:1 
with lysis buffer and loaded onto a 1ml Ni-NTA column which had been pre­
equilibrated with lysis buffer containing 0.5% CHAPS. The column was washed with 
25 volumes of lysis buffer containing 0.5% CHAPS before proteins were eluted in 4 
volumes of lysis buffer containing 0.5% CHAPS and 400mM imidazole. The column 
eluates were collected in 1ml aliquots and stored at 4°C until required.
2.2.3 Glutathione Sepharose chromatography
Glutathione-s-transferase (GST) fusion proteins were purified using 
glutathione sepharose 4b beads. This type of separation is known as affinity
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chromatography and is based on the high affinity of GST for its substrate peptide 
glutathione. Glutathione is a tripeptide of glutamate, cysteine and glycine, its 
physiological role is as an antioxidant protecting cells from toxins such as free 
radicals. Glutathoine-s-transferase catalyses the conjugation of toxins with 
glutathione via the sulphydril group on the peptide, thus aiding cellular detoxification 
(Douglas, 1987; Martinez-lara et al., 2002).
Frozen E.coli pellets were thawed on ice and resuspended in 10ml of buffer 
containing 20mM Tris pH 7.4, 150mM NaCl, ImM DTT, ImM EDTA, 1% n-lauryl 
sarcosine. Cells were lysed by sonication for two pulses of two min followed by 
incubation on a rolling platform for 10 min at 4°C. Triton X-100 was added to a final 
concentration of 1% and the cell lysates was re-sonicated for 2 min. The lysate was 
cleared by centrifugation at 20,000 x g for 20 min at 4°C. The resulting supernatant 
was loaded on to a 1ml glutathione sepharose column which had been pre-equilibrated 
with buffer containing 20mM Tris pH 7.4, 150mM NaCl 1mm DTT, ImM EDTA 
0.1% tritonX-100. The column was washed with 25 volumes of equilibration buffer 
and eluted in 4 volumes of buffer containing 20mM tris pH8.0, 150mM NaCl, ImM 
DTT, ImM EDTA, 0.1% tritionX-100, 5mM reduced glutathione. The eluate was 
collected in 1ml aliquots and stored at 4°C until required. The purified GST fusion 
proteins remained soluble in elution buffer, addition of 1% n-lauryl sarcosine and 1% 
Triton X-100 was not necessary to keep proteins soluble for subsequent experiments
2.2.4 Polyacrylamide gel electrophoresis -  SDS PAGE
SDS polyacrylamide gel electrophoresis (PAGE) was performed on NuPAGE 
Bis-Tris gels 10 well mini gels (Invitrogen) with a running buffer of NuPAGE MOPS 
or NuPAGE MES depending upon the required resolution. The NuPAGE system is 
based on the system described by Laemmli. (1970) with some modifications. The 
Laemmli system used Tris-Glycine polyacrylamide gels cast at a pH of 8.7 which 
increased to 9.5 during electrophoresis. In addition, the Laemmli sample buffer was 
at pH 6.8  where disulphide bonds are poorly reduced leading to reduced resolution. 
NuPAGE Bis-Tris gels are cast at a lower pH and the pH of the gel during 
electrophoresis is around neutral. The change in buffer composition and pH gives
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greater resolution of protein bands and means that higher concentrations of protein 
can be separated without loss of resolution. For resolution of large proteins, NuPAGE 
MOPS was used, the working concentration contained 50mM 3(N-morpholino) 
propane sulphonic acid (MOPS), 50mM Tris, 3.4mM SDS, ImM EDTA pH 7.4. For 
smaller proteins, NuPAGE MES running buffer was used the working concentration 
contained 50mM 2-(morpholino) ethane sulphonic acid (MES), 50m Tris, 3.4mM 
SDS, ImM EDTA pH 7.3. Protein samples were prepared by addition of the 
appropriate volume of 4 x NuPAGE LDS sample buffer followed by NuPAGE 
reducing agent, samples were heated to 80°C for 5 min prior to loading. Gels were 
run at a constant voltage of 200 V.
After electrophoresis, protein bands were visualised by staining with 
coomassie blue. This was done using SimplyBlue safe stain (Invitrogen) according to 
manufacturer’s instructions.
2.2.5 Western blotting
For western blotting, proteins were transferred from polyacrylamide gels to 
polyvinyldeneflouride (PVDF) membrane. This was used in preference to 
nitrocellulose membrane as it has a higher binding capacity for protein. The transfer 
was made using a semi dry blotting apparatus (Biorad) with NuPAGE transfer buffer 
(Invitrogen). Working concentrations of transfer buffer contained 25mM Bicine, 
25mM Bis-Tris, ImM EDTA, 10% methanol and 0.001% SDS.
For transfer of one gel, 3 pieces of Whatman filter paper (8.5 cm by 7.5cm) 
were soaked in transfer buffer and placed on the platinum anode. A sheet of PVDF 
membrane cut to the same size and pre-soaked in methanol before being placed on the 
filter paper. The gel was pre-soaked in transfer buffer for 5min prior to being placed 
on the membrane and a further 3 pieces of soaked filter paper were placed on the gel. 
The circuit was completed by addition of the stainless steel cathode to the gel 
sandwich. The apparatus was run at a constant current of 5mA/h per cm of gel with 
the voltage limited to 25 V.
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The membrane was removed from the transfer apparatus and blocked for 1 
hour in a buffer containing 20mM Tris pH 7.4, 500mM NaCl, 5% bovine serum 
albumin (BSA) and 0.05% Tween-20. The blocked membrane was placed in a 50 ml 
tube and primary antibodies were diluted 1:1000  in antibody diluent which consisted 
of 20mM Tris pH7.4, 500mM NaCl, 5% BSA, 10% goat serum, and 0.5% nonioinic 
detergent Igepal. The primary antibodies used in these experiments are listed in Table
2.1. The membrane was incubated with primary antibody overnight at room 
temperature on a rolling platform. The membrane was washed 3 times for 15 minutes 
with wash buffer (20mM Tris pH 7.4, 500mM NaCl) and secondary antibody was 
diluted 1 :1000  in antibody diluent and incubated with the membrane for 1 hour at 
room temperature on a rolling platform. The membrane was then washed again 3 
times for 15 min. The secondary antibodies used were goat anti rabbit conjugated to 
horse radish peroxidase (HRP) or goat anti mouse conjugated to HRP depending on 
the origin of the primary antibody.
Immunoreactive bands were revealed using ECL plus western blotting 
detection reagent (GE Healthcare) according to the manufacturers instructions. ECL 
plus is primarily a very sensitive chemiluminescent detection reagent, that is, the 
peroxidase coupled to the secondary antibody catalyses a reaction involving peroxide 
and luminol which emits light which can then be detected using photographic film. 
The ECL plus chemical reaction however also has a fluorescent component. The 
fluorescent component of the reaction was imaged directly using a Typhoon 9210 
variable mode phosphorimager.
2.2.6 Autoradiography and Densitometry
For analysis of proteins containing incorporated 'P, protein samples were
'>'1
separated by SDS PAGE as described above. As ‘P emits a weak radioactive signal, 
even a thin layer of polyacrylamide can interfere with the detection of labelled 
proteins. To avoid this, the proteins were transferred to PVDF membrane as 
described above. Labelled proteins were detected by exposing the membranes to a 
storage phosphor screen (Molecular Dynamics, Amersham Biosciences) overnight. 
The radioactive bands were revealed by scanning the storage phosphor screen using a 
Typhoon 9210 variable mode phosphorimager.
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For analysis of 32'P labelled proteins, it was not necessary to transfer the 
proteins to a PVF membrane. The SDS PAGE gels were placed on a square of 
Whatman filter paper, covered in a plastic membrane and dried. The dried gels were 
exposed to a storage phosphor screen overnight and the screens were scanned with a 
Typhoon 9210 variable mode phosphorimager to reveal the radioactive bands.
Images of western blots and storage phosphor screens were inspected and 
quantified using ImageQuant 5.2 software (Molecular Dynamics, Amersham 
Bioeciences). Band intensities were compared after subtraction of the background 
signal which was measured at the same point on the gel as the protein of interest but 
in a lane where the protein of interest is not present.
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Table 2.1
Primary antibody Source Description Working
dilution
Supplier
Anti Cay(32a Rabbit Affinity purified 1:1000 Chein et al., 1996
Anti Cay2.2 Rabbit Affinity purified 1:1000 Raghib et al., 2001
Anti Akt/PKBa Rabbit Affinity purified 1:1000 Cell Signalling 
Technology
Anti-phospho- 
Akt/PKBa (Ser473)
Rabbit Affinity purified 1:1000 Cell Signalling 
Technology
Anti-phospho- 
Akt/PKBa (Thr308)
Rabbit Affinity purified 1:1000 Cell Signalling 
Technology
Anti HA Rat Monoclonal, 
Affinity purified
1:1000 Roche
Anti Glu-Glu Mouse Monoclonal, 
Afffinity purified
1:1000 Advanced 
Targeting Systems
Anti PI3 kinase pi 10 Rabbit Affinity purified 1:1000 Santa Cruz 
Biotechnology
Table 2.1. The primary antibodies used for western blotting in these experiments are listed above.
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2.2.7 Mammalian tissue culture and transfection
In these experiments, COS-7 and tsA201 cells were used. COS-7 cells are 
African green monkey kidney cells which have been transformed with an origin 
defective SV40 virus (Gluzman, 1981). Cells were cultured in Dulbecco’s modified 
eagle medium (DMEM) (Invitrogen) supplemented with 10% new bom calf serum 
(Invitrogen), 2mM glutamine, 5 units/ml penicillin and 0.5pg/ml streptomycin. Cells 
were cultured in 75cm2 at 37°C in 5% CO2 and diluted 1:12 when confluent.
TsA201 cells are SV40 transformed human embryonic kidney (HEK) cells 
which express the temperature sensitive T antigen. TsA201 cells were cultured in 
DMEM supplemented with 2mM glutamine, 10% foetal bovine serum (Invitrogen), 5 
units/ml penicillin and 0.5jug/ml streptomycin. Cells were cultured in 75cm flasks at 
37°C in 5% CO2 and diluted 1:12  when confluent.
COS-7 cells were transfected using Geneporter (Gene Therapy Systems) 
according to the manufacturer’s instructions. TsA201 cells were transfected using 
FuGENE 6 transfection reagent (Roche Diagnostics) according to the manufacturer’s 
instructions. Both COS-7 and tsA201 cells were split 1:6 prior to transfection and 
were used 48 hours after transfection.
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2.2.8 Immunoprecipitation and Co-immunoprecipitation
Immunoprecipitation was performed to isolate epitope tagged proteins from 
transfected mammalian cell lysates. Proteins of interest were engineered to contain 
the HA epitope tag derived from the influenza virus haemaglutinin protein. The 
antibodies used for immunoprecipitation were Rat monoclonal anti HA high affinity 
antibodies (Clone 3F10) (Roche Diagnostics). This antibody was selected specifically 
because its high affinity for the HA epitope sequence, this means that lower working 
concentrations can be used and less cross reactivity is observed, this is highly 
desirable in immunoprecipitation experiments.
For immunoprecipitation of HA tagged CavP2a subunits, transfected COS-7 
cells were used 48 hours post transfection. The cells were washed three times with 
phosphate buffered saline (PBS) and resuspended in 1ml of lysis buffer containing 
20mM Tris pH 7.4, 150mM NaCl, ImM EDTA, 1% Igepal, ImM sodium 
ortho vanadate, 50pM cantharidic acid, 20 pM bromotetramisole oxalate and protease 
inhibitors. Cells were disrupted by passing them through a fine needle until the 
solution was homogeneous and the cell lysate was cleared by centrifugation at 2 0 ,0 0 0  
x g for 20 min at 4°C. The protein concentration of the resulting supernatant was 
determined using the bicinchoninic acid (BCA) kit. HA tagged CavP2a subunits were 
precipitated from 500pg of supernatant using 3pg anti HA antibody, complexes were 
formed during incubation for 5 hours on a rolling platform. Immune complexes were 
recovered by addition of 50 pi protein G agarose which had been pre-equilibrated 
with lysis buffer and incubation for a further 2 hours at room temperature. Immune 
complexes were washed three times for 15 min with lysis buffer and once with lysis 
buffer containing 0.5 M NaCl before resuspension in lOOpl NuPAGE LDS sample 
buffer.
The same procedure was performed for co-immunoprecipitation experiments 
where COS-7 cells were transfected with either HA CavP2a and wildtype Akt/PKBa 
or HA tagged Akt/PKBa and untagged Cavp2a.
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2.2.9 Cell surface biotinylation
Cell surface biotinylation was used to measure the plasma membrane 
expression of Cay2.2 constructs. The technique takes advantage of the reagent 
sulfosuccinimidyl-2-(biotinamido)ethyl-l,3-dithiopropionate (EZ link sulfo-NHS-SS- 
biotin) (Pierce). This reagent is a thiol cleavable, water soluble biotinylation reagent 
which contains an A-hydroxysulfosuccinimide (NHS) ester group which reacts with 
the e-amine of lysine residues to produce a stable product. Although soluble in water, 
the biotinylation reagent will not cross the plasma membrane so only lysine residues 
exposed on the surface of proteins in the plasma membrane will be labelled. The 
structure of sulfosuccinimidyl-2-(biotinamido)ethyl-l,3-dithiopropionate is shown in 
Figure 2.1. After labelling, proteins containing the biotin label can be precipitated 
using streptavidin coupled to agarose beads, the presence of a disulphide linkage 
between the NHS group and the biotin group means that the precipitated proteins can 
be liberated from the streptavidin agarose by treatment with strong reducing agents.
TsA201 cells in 75cm flasks were transfected with Cay2.2 DNA and 
accessory subunits in the following ratio: lOpg Cay2.2 pMT2, 7pg CavP pMT2, 7pg 
a262 pMT2. After 48 hours, the cells were washed three times with PBS prior to 
labelling with 2ml per flask PBS pH 8.0 containing 800pM sulfosuccinimidyl-2- 
(biotinamido)ethyl-l,3-dithiopropionate, the reaction was allowed to proceed at room 
temperature for 15 min. The reaction was terminated by addition of 10ml lOOmM 
glycine in PBS. Labelled cells were collected by centrigugation at 1000 x g for 5 min 
at 4°C and washed a further three times with PBS to remove unincorporated 
biotinylation reagent which would interfere with subsequent precipitation.
Labelled cells were lysed by addition of 750pl of lysis buffer containing 
20mM Tris pH 7.4, 150mm NaCl, ImM EDTA, 1.5% Triton X-100 and protease 
inhibitors followed by brief sonication. After centrifugation at 20,000 x g for 20 min 
at 4°C the protein concentration of the resulting supernatant was determined using the 
bicinchoninic acid (BCA) kit (Pierce). Biotinylated proteins were precipitated by 
incubating 500pg of whole cell lysate with 50pl streptavidin agarose beads (Pierce) 
for 3 hours at room temperature on a rotating platform. The streptavidin agarose 
precipitates were washed 3 times for 10 min with lysis buffer before biotinylated
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Figure 2.1
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Figure 2.1. The molecular structure of sulfosuccinimidyl-2-(biotinamido)ethyl-1,3-dithiopropionate 
(EZ link sulfo-NHS-SS-biotin) used in cell surface biotinylation experiments. The biotin group, the 
/V-hydroxysulfosuccinimide group and the disulphide linkage are indicated.
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proteins were liberated from the beads by addition of 50j.il lysis buffer containing 
lOOmM DTT and incubation for 30 min at room temperature. As a control for cell 
leakiness, western blotting was performed on samples of precipitated proteins using 
antibodies to the cytoplasmic protein kinase Akt.
2.2.10 33~P metabolic labelling
Metabolic labelling was used to measure the change in incorporation of 
phosphate into Cav(32a constructs. Transfected COS-7 cells in 75cm2 flasks were 
transfected and used for 33'P labelling after 48 hours.
Cells were washed three times with phosphate free Dulbecco’s modified 
Eagle’s medium (DMEM) (ICN Biochemicals, Irvine, California.) containing 10% 
dialysed FBS (Invitrogen) and incubated in phosphate free media for 1 hour. The 
medium was replaced with phosphate free DMEM containing 30pCi/ml [33’P] 
orthophosphate and incubated for a further 6  hours. Labelled cells were washed 
twice with Tris Buffered Saline (TBS) containing protease inhibitors and ImM 
EDTA, harvested by centrifugation for 5 min at 1000 x g and either processed 
immediately as described in the protocol for immunoprecipitation or stored at -80°C 
until required.
2.2.11 In vitro phosphorylation
Phosphorylation in vitro was performed using recombinant Protein kinase B 
purified from insect cells (Upstate Biotechnology) and a recombinant positive control 
substrate BAD purified from E.coli (Upstate Biotechnology). The test substrates were 
Cayp2a C-terminus and CavP2a S574A C-terminus, both were over expressed in 
E.coli and purified by Ni-NTA chromatography as described.
Each reaction contained 2pg of substrate protein and 0.4pg purified kinase in 
a total volume of 40pl. The kinase and substrate were diluted in assay buffer which 
contained 20mM MOPS, 25mM p-glycerophosphate, ImM sodium orthovanadate, 
5mM EDTA and ImM DTT. y-32P ATP was diluted to 1 pCi/pl in Mg/ATP (75mM 
MgCh, 500pM cold ATP in assay buffer) and 10 pi were added to each reaction. 
Diluted ATP was the last component to be added to the reaction mixture. Reactions 
were incubated at 30°C for 15 min and stopped immediately by addition of an equal
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volume of 2 x SDS sample buffer followed by heating to 80°C for 5 min. Reaction 
mixtures were separated by SDS PAGE and phosphate incorporation was revealed by 
autoradiography and quantified using ImageQuant 5.2.
2.2.12 Precipitation of unknown proteins from native tissue
Purified Cay(31b subunit and N-terminal and C-terminal portions of the 
CavPlb subunit were used as bait in attempts to capture an identify novel binding 
partners for the CavPlb subunit from mouse brain lysates.
The CavPlb constructs were expressed and purified by Ni-NTA 
chromatography as described above. The purified proteins were then immobilised 
onto 1ml HiTrap NHS-activated columns (GE Healthcare). The columns were 
activated and the immobilisation performed according to the manufacturers 
instructions. The columns contain agarose beads coupled to epichlorohydrin and are 
activated by N-hydroxysuccinimide (NHS), the proteins are coupled to the matrix via 
free primary amine groups. Prior to coupling, the bait proteins were dialysed into 
coupling buffer which was composed of 200mM sodium hydrogencarbonate, 500mM 
NaCl pH8.3. Approximately 2mg of each bait protein was applied to each column 
and as a control, 1 column was activated and blocked but no protein was immobilised. 
Analysis of the column eluate by using the BCA protein assay and comparing protein 
concentrations before and after immobilisation showed that greater than 90% of the 
bait protein bound to the column. After immobilisation and blocking, the columns 
were washed with 5 volumes of 20mM glycine pH2.2 to remove any non-specifically 
bound proteins.
The brains of 10 adult C57BLKs/J mice (Naggert et al., 1995) were washed 
with TBS and homogenised in 20ml buffer containing 20mM Tris pH7.4, 150mM 
NaCl, ImM EDTA, 1% CHAPS and protease inhibitors. The homogenate was 
cleared by centrifugation at 20,000 x g for 30 min at 4°C. The resulting supernatant 
was divided into 4 equal parts and the same volume of lysate was applied to each 
column. The columns were washed with 20 volumes of lysis buffer and eluted in 3 
volumes of 20mM glycine pH2.0 containing 0.5% CHAPS. The pH of the eluates 
was immediately neutralised by addition of 1M Tris pH7.4.
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2.2.13 Identification of unknown proteins
Samples containing unknown proteins were prepared and analysed by SDS 
PAGE. Electrophoresis and subsequent staining with coomassie blue was performed 
under sterile conditions using equipment which had not previously been used for 
analysis of protein samples thus keeping contamination to a minimum. Protein bands 
of interest were excised from the polyacrylamide and stored at -80°C until required.
Unknown proteins were analysed by Matrix Assisted Laser Desorption 
Ionisation Time of Flight (MALDI-TOF) mass spectroscopy by Dr Dinah Rahman 
(Section of Proteomics, MRC Clinicial Sciences Centre, Imperial College London). 
The resulting spectra were analysed using Mascot software (Matrix Science, 
www.matrixscience.com).
2.3 Surface plasmon resonance spectroscopy
Surface plasmon resonance experiments were performed on a BIAcore 2000 
machine (BIAcore AB), using CM5 research grade sensor chips. The BIAcore 2000 
machine is able to regulate the temperature of the integrated microfluidic cartridge 
(IFC) and so all binding experiments were performed at a constant temperature of 
25°C. The CM5 Sensor chip is composed of a thin gold conducting film to which a 
layer of carboxymethyl dextran is coupled, the chip is enclosed in a protective plastic 
case. When docked with the machine, the chip is removed from the case and pressed 
against the IFC to make the flow cells or channels in which the binding events take 
place and are monitored. A diagram of the IFC, flow cells and sensor chip surface is 
shown in figure 2 .2 .
The surface of the CM5 sensor chips was prepared for the immobilisation of 
antibodies or ligand proteins by treating the surface with a mixture of 50mM N- 
hydroxysuccinimide (NHS) and 200mM N-ethyl-N’-(dimethylaminopropyl)- 
carbodiimide (EDC). The EDC/NHS mixture reacts with the carboxyl groups on the 
carboxymethyl dextran, modifying them to amine reactive NHS esters. The EDC first 
reacts with the carboxyl group on the dextran forming unstable intermediates which 
are susceptible to attack by amines, the NHS is present to stabilise the intermediates 
and promote the reaction yield (Staros et al., 1986).
Following chip surface activation, anti GST antibodies were injected at a 
concentration of lOpg/ml for 10 minutes. The antibodies were diluted in a buffer
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Figure 2.2
Flow cells
Integrated microfluidic cartridge (IFC)
Prism
Figure 2.2. In the BIAcore 2000 machine, binding experiments are performed in flow cells which are formed 
when the sensor chip surface is pressed against the integrated microfluidic cartridge (IFC). Buffer and 
interacting partners are delivered via the IFC to the sensor chip surface where other interacting partners 
or “ligands” are immobilised. Redrawn from BIAcore applications handbook.
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containing lOmM sodium acetate pH4.0 prior to injection. The lowered pH causes 
the proteins to become slightly positively charged and therefore attracted to the 
negatively charged carboxymethyl dextran of the sensor chip surface. This increases 
the coupling efficiency of the reaction meaning shorter times and lower ligand 
concentrations can be used. Following immobilisation, the surface was blocked by 
injecting 1M Ethanolamine pH8.5 this deactivated any remaining reactive groups on 
the chip surface and the high ionic strength removes any non-specifically bound 
protein. NusA fusion proteins were immobilised directly to the sensor chip surface 
using the same chemistry but the contact times used were shorter than for the anti 
GST antibody as lower ligand densities were required.
Binding experiments using GST fusion proteins of the Cayl-II linker were 
performed using a running buffer consisting of 20mM HEPES pH7.4, 500mM NaCl, 
1mm EDTA and 0.005% TWEEN-20. The GST fusion proteins were injected over 
the immobilised antibody at a concentration of lOpg/ml until 150 RU of protein was 
bound. The Cayp subunits were diluted to the appropriate concentrations in running 
buffer and injected for 5 min at 50pl/min followed by a dissociation period of 5 min 
at the same flow rate. For NusA C ay l-II linker fusions, a buffer consisting of 20mM 
HEPES pH 7.4, 150mM NaCl, ImM EDTA, 0.1% CHAPS was used. The Cavp 
subunits were diluted in running buffer injected for 5 min at 50pl/min. After each 
round of binding experiments, the chip surface was washed with 20mM glycine pH2.0 
followed by running buffer until a stable baseline was obtained upon which to 
perform the next experiments.
BIAcore sensorgrams were initially analysed using BIAevaluation 3.0 
software (BIAcore, AB). The software allows each set of curves to be aligned such 
that the injection start point is set to zero seconds in the x axis and zero response in 
the y axis. This allows the sensorgrams to be aligned relative to one another. Once 
aligned, any non-specific binding can is subtracted by subtracting the signal from the 
reference or negative control flow cell which contained GST alone in the GST fusion 
protein experiments and NusA alone in the NusA fusion protein experiments.
Once aligned, the BIAevaluation software made fits to the sensorgrams to 
determine the observed rate of analyte accumulation kon (obs) and the rate of 
dissociation koff. The fits were made using a model of 1:1 interaction where the on
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and off rates are fitted to single exponentials. The BIAevaluation software uses the 
following equations:
Association: R  =  Req (1 
Dissociation: R  =  Roe-kd^ ’t0^
Req is the response at equilibrium, R and Ro are the responses at time t and to 
respectively. From these values, the specific on rate kon and the dissociation Kd can 
be calculated.
The raw data from the sensorgrams was exported and evaluated using Origin 5 
software (Microcal). Single exponential fits were made to the association and 
dissociation phases of the sensorgrams and from this data the specific on rate kon was 
calculated using the following equation:
kpn(obs) ~ koff
kon= [Cavp]
The dissociation constant Kd was calculated as 
kpff
Kd = von
The data from the NusA fusion proteins was evaluated further by plotting the 
responses 250 seconds after the start of perfusion and plotting them against Cavp 
concentration. The resulting curves were fitted to a hyperbola function:
Bmax • [P]
Y =
Kd + [P]
where Y is the response at 250 seconds and Bmax is the maximum response.
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Chapter 3:
Surface plasmon resonance spectroscopy
77
3.1 Introduction
High voltage activated calcium channels are associated with a regulatory beta 
subunit. The CavP subunit binds to a highly conserved 18 amino acid motif in the 
intracellular linker between domains I and II of high voltage activated (HVA) calcium 
channels known as AID (Alpha Interaction Domain) (Pragnell et al., 1994). An 
alignment of L-type and non L-type calcium channel AID motifs is shown in figure
3.1. Cavp subunit binding to AID generally increases plasma membrane expression 
and causes a shift in the voltage dependence of activation and inactivation to more 
negative potentials (Catterall, 2000). Early work described the binding site on the 
Cavp subunit as a 41 amino acid sequence BID (Beta Interaction Domain) (De Waard 
et al., 1994,1995). The BID was reported to contain several residues which were 
critical for binding to AID (De Waard et al., 1995,1996). However, more recent 
structural studies on Cavp2, CavP3 and CavP4 (Van Petegem et al., 2004; Opatowsky 
et al., 2004; Chen et al., 2004) have shown that the site of interaction of CavP with 
AID is a groove on the GK like domain termed the AID binding pocket (ABP) (Van 
Petegem et al., 2004) and the residues previously believed to be important for binding 
were actually involved in maintaining the structural integrity of the GK module. The 
structures, all of which show Cavp subunits in complex with an AID peptide also 
show the importance of the conserved tryptophan in AID, it is deeply buried in the 
binding groove forming multiple interactions with surrounding amino acid residues, 
these findings confirm those of other studies which have shown this conserved 
tryptophan to be essential for CavP subunit binding (Pragnell et al., 1994; Berrou et 
al., 2002; Leroy et al., 2005).
The AID binds to CavP with very high affinity. This was demonstrated firstly 
by De Waard et al. (1995). Using glutathione-S-transferase fusion proteins of AID a 
and in vitro translated S labelled Cavp subunits, the dissociation constants (K d) for 
CavP subunits binding to AID a were found to be between 2.6 and 76 nM. The 
CavP4 subunit bound with the highest affinity and Cavp3 with the lowest affinity, 
CavP2a and 4 were reported to bind with two different affinities. More recently, 
similar experiments have been performed using surface plasmon resonance binding 
assays to determine the dissociation constants. Interactions between Cav2.1 AID and 
Cavp4 (Geib et al., 2002), Cav2.2 AID and CavPlb (Leroy et al., 2005), Cavl.3 AID 
and CavPlb (Bell et al., 2001) and between Cav2.2 AID and CavP3 (Canti et al.,
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2003) have been measured. In all cases the dissociation constants were found to be 
between 5nM and 20nM. Measurements of AID peptide binding to CavP have also 
been made by fluorescence polarisation spectroscopy (Opatowsky et al., 2003; 
Opatowsky et al., 2004), the dissociation constants were found to be 16 and 26 nM.
L type Q Q L E E D L  - G Y - - W I T Q A E  
Non L-type QQ I E R E L N G Y - - W I  - K A E
Figure 3.1 Alignment of L-type and non L-type AID motifs of HVA calcium channels. 
Conserved residues are shown in red, non-conserved in black. The sequence within 
AID of non L-type channels involved in interaction with Py subunits o f heterotrimeric 
G proteins is underlined.
The intracellular linker between domains I-II of non L-type calcium channels 
will also bind to py dimers of heterotrimeric G proteins (De Waard et al., 1997; 
Zamponi et al., 1997), this has been shown using overlay assays (De Waard et al., 
1997) and also by Bell et al. (2001) using surface plasmon resonance studies. The 
proposed site of interaction is within the conserved AID motif (Figure 3.1) and 
contains the sequence Q Q X X R which has previously been shown to be involved in 
interaction with G protein py subunits (Chen et al., 1995). Although the I-II linker 
has been shown to be important for G protein modulation of the Cav 2 class of 
calcium channels (De Waard et al., 1997; Zamponi et al., 1997; Herlitz et al., 1997), 
other regions of the channels especially the N-terminus have been shown to be 
involved (Canti et al., 1999; Agler et al., 2005).
The experiments described here were performed to investigate the interaction 
of purified CavP subunits with the GST fusion proteins of the I-II loop of HVA 
calcium channel a l subunits. The binding experiments were performed using surface 
plasmon resonance which allows on- and off- rates to be measured and a dissociation 
constant (K d ) for the interaction to be calculated. In addition, the interaction of G
nc\
protein (3y subunits with the I-II linkers of Cay 1.3 and Cay 2.2 was measured and 
compared.
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3.2 Results 
3.2.1 Preparation of GST I-II linker fusion proteins and purified CavP subunits.
The cytoplasmic linker between domains I and II of Gay 1.3, Cay 2.1 and Cay
2.2 were amplified by polymerase chain reaction (PCR) as described in Chapter 2 
using primers which introduced Bam HI and Eco RI restriction endonuclease sites to 
the 5’ and 3’ ends respectively. The resulting PCR products were subcloned in frame 
with Schistosoma japonicum glutathione-S-transferase in the bacterial expression 
vector pGEX-2T to create GST I-II linker fusion constructs. The GST fusion system 
was used here for several reasons. Firstly, it enables efficient purification of 
expressed proteins (Nygren, 1994), secondly it facilitates immobilisation of the 
“ligand” proteins in the surface plasmon resonance assay and finally, GST can 
sometimes function to enhance the solubility of its fusion protein partners.
The GST I-II linker fusion proteins were expressed in E.coli BL21 (DE3) RIL 
bacteria and purified by affinity chromatography using glutathione sepharose beads as 
described in Chapter 2. All Cay I-II linker fusion proteins were found to be insoluble 
despite the presence of GST. No full length GST I-II linker fusion proteins could be 
purified from the soluble fraction of the bacterial lysates. Instead, the insoluble 
material recovered after centrifugation of the lysates was treated with 1% Triton X- 
100 and 1% n-lauryl sarcosine, and proteins were purified from the resulting 
supernatant. Once purified, the fusion proteins remained soluble in 0.1% Triton X- 
100. The GST tag was found to contribute to the solubility of the proteins after 
purification as treatment of the purified proteins with the protease thrombin, which 
cleaves the protein between the I-II linker and the GST tag, resulted in Cay I-II linker 
protein which was completely insoluble (not shown). Glutathione-s-transferase alone 
was prepared by expressing empty pGEX2-T in E.coli BL21 (DE3) RIL bacteria. 
Highly purified GST was prepared by affinity chromatography on glutathione 
sepharose beads (not shown). Treatment with detergents was not necessary as GST 
was present in the soluble fraction after cell lysis. Samples of the purified GST I-II 
linker proteins are shown in figure 3.2 A after SDS PAGE and staining with 
coomassie blue.
Calcium channel beta subunits Cayplb, CayP2a and CavP3 were amplified by 
PCR using oligonucleotide primers which introduced restriction endonuclease sites
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Figure 3.2
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Figure 3.2. A. Coom assie blue stained SDS-PAGE on NuPage 4-12% Bis-Tris gel showing purified 
GST fusion proteins of Cay2.1 I-II linker (Lane 1), C a ^ .2 I-II linker (lane 2) and Cav1.3 I-II linker (lane 3) 
used in surface plasmon resonance analysis. B. Coomassie blue stained SDS-PAGE on NuPage 4-12% 
Bis-Tris gel showing purified Cavpib , Cavp2a and Cavp3 used in surface plasmon resonance analysis. 
Molecular weight markers are indicated.
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into the 3’ and 5’ ends suitable for subcloning into bacterial expression vector pET28. 
In the cases of CavPlb and CavP3 a hexahistidine tag was engineered into the reverse 
primer so that the stop codon was removed and replaced by the His(6) tag followed by 
a new stop. These procedures are described in Bell et al. (2001) and Canti et al.
(2001). The resulting PCR products were subcloned into bacterial expression vector 
pET28 (Novagen). In the case of CavP2a, the PCR product was inserted in frame 
with the hexahistidine tag encoded by the expression vector making an N-terminally 
His(6> tagged Cavp2a.
All three CavP subunits were expressed in E.coli BL21 (DE3) RIL bacteria. 
They could be purified from the soluble fraction after bacterial lysis by affinity 
chromatography using Ni-NTA resin as described in Chapter 2 and also in Bell et al. 
(2001) and Canti et al. (2001). Once purified, the CavP subunits were stable for 
several weeks. Samples of purified CavPlb, Cavp2a and CavP3 can be seen in Figure
3.2 B after separation by SDS PAGE and staining with coomassie blue. The 
purified CavPl and P3 subunits appear as single bands of the correct molecular 
weight after SDS PAGE whereas the CavP2a subunit preparation appears to contain 
several truncations or degradation products. The probable reason for this is the 
position of the His(6) tag as a C-terminal tag means that only full length proteins will 
be purified whereas with an N-terminal tag truncated products as well as full length 
proteins can be captured. In the case of CavP2a, greater than 80% of the protein was 
full length and it was not considered necessary to move the position of the His(6> tag.
3.2.2 Surface Plasmon Resonance Spectroscopy
Surface plasmon resonance (SPR) spectroscopy relies on the phenomenon of 
surface plasmon resonance. The technique allows real time measurement of 
biological interactions and provides a means for quantifying kinetic and equilibrium 
constants, without the need for fluorescent or radioactive labels.
Surface plasmon resonance is an optical-electrical phenomenon which arises 
from the interaction of light with metallic surfaces. Under conditions of total internal 
reflectance (TIR), energy carried by photons of light is transferred to packets of 
electrons known as plasmons on the surface of the metal. At the same time, an 
evanescent electromagnetic wave propagates away from the interface (Figure 3.3 A). 
Surface plasmon resonance occurs when a thin conducting film is placed at the
83
Figure 3.3
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Figure 3.3 A. Propagation of an evanescent electromagnetic wave. At the boundary between high and low 
refractive index media and under conditions of total internal reflection (TIR) (TIR occurs above the critical 
angle 0 (theta)) energy from incident light is transferred to packets of electrons known as plasmons and at the 
sam e time, an evanescent electromagnetic wave propagates away from the interface. B. Basic principle of the 
BIAcore system showing polarised incident light being focused onto the surface of a sensor chip. Analyte in the 
flow cell interacts with the chip surface, this causes a change in m ass which changes the position of the light 
extinction by SPR. (Adapted from Hall, 2001).
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interface between two optical media. At angles greater than the TIR angle, the 
surface plasmons in the thin conducting film couple with the light energy because 
their frequencies are the same. During this coupling, energy is absorbed and the 
intensity of reflected light is reduced at the angle where SPR is occurring (Figure 3.3 
B). The evanescent electromagnetic wave propagates approximately lOOnm across 
the surface of the thin conducting film, into the media beyond. Any changes in the 
mass or chemical composition within the proximity of the evanescent field result in a 
change in the wavelength of light which is absorbed, this change is directly related to 
the magnitude of the mass or chemical change in the proximity of the evanescent 
field. These changes in wavelength can be measured using reflectance 
spectrophotometers, this is the principal by which biosensors use SPR to measure 
changes in mass.
In these experiments a BIAcore 2000 machine (BIAcore AB) was used. 
BIAcore uses gold as the thin conducting film which is arranged inside a sensor chip. 
One side of the gold surface interfaces with a prism which focuses the incident light 
onto the thin gold surface (Figure 3.3 B), the other side of the thin gold surface forms 
the flow cell and interfaces with the aqueous compartment. Each sensor chip contains 
4 flow cells, each of which can be monitored separately. The side of the thin gold 
film which interfaces with the aqueous compartment is covalently coupled to a 
carboxymethyl dextran matrix. This carboxymethyl dextran can be chemically 
manipulated such that biological macromolecules such as antibodies can be coupled 
to it to serve as ligands in binding assays. Other sensor chips with different surface 
properties such as Ni NT A, for capture of His tagged proteins or with lipophilic 
groups for incorporation of proteins into lipid bilayers are available but in these 
experiments the standard carboxymethyl dextran CM5 chip was used.
The CM5 sensor chips were prepared as described in Chapter 2. High affinity 
goat anti-GST antibodies purified from the sera of goats immunized with purified 
schistosomal GST were covalently coupled to the dextran matrix of all flow cells.
The high affinity antibodies are polyclonal and can recognise more than one epitope 
on GST, thereby improving their capacity for recognizing GST fusion proteins, these 
antibodies were used to capture the GST fusion proteins. The use of antibodies has 
several advantages over direct cross-linking of ligand proteins to the surface of the 
chip. Firstly, the ligand can be removed by washing with glycine pH2.2 and replaced 
with fresh protein and secondly, the ligand protein is orientated such that the I-II
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linker part of the fusion protein is furthest away from the dextran matrix and 
uniformly presented so binding to the analyte, which in this case is the Cavp subunit, 
is not hindered.
Equimolar amounts of GST Cay I-II linker fusion proteins were loaded onto 
individual flow cells and as a control, an equimolar amount of GST alone was loaded 
onto a flow cell which could then be used as a reference to control for non-specific 
binding. 100 Response Units (RU) of GST and 150 RU of the GST I-II linker fusion 
proteins were loaded. 100 RU corresponds to Ing/nL of protein (Van Der Merwe et 
al., 2000) this corresponds to approximately 3.4 fmol of each protein.
Solutions of purified CavP subunits from 5nM to 200nM were perfused across all 
flow cells, each injection lasted 5 minutes and was followed by a 5 minute dissociation 
period. An example sensorgram showing ligand loading, injection of analyte followed by the 
dissociation phase followed by a regeneration step is shown in Figure 3.4.
Preliminary experiments showed that using a running buffer which contained lOmM 
HEPES pH7.4, 150mM sodium chloride and 0.005% TWEEN-20, injection of purified CavP 
lb, 2a or 3 subunits over a flow cell containing just immobilised GST produced substantial 
non-specific binding (not shown). In a previous study by Geib et al. (2002), 1% glycerol, 
0.1% Triton X-100 and 200mM sodium chloride were included in the running buffer, this 
may have been for a similar reason. Subsequent experiments showed that inclusion of 
500mM sodium chloride in the running buffer virtually abolished the non-specific binding to 
GST without affecting the GST I-II linker / Cavp subunit interaction.
Under these conditions, specific, concentration dependent binding of CavPlb, Cavp2a 
and CavP3 subunits was observed to the GST I-II linkers of Cay 1.3, Cay2.1 and Cay2.2 but 
negligible concentration-dependent binding was seen in the flow cell containing GST only. 
The signal from the GST only negative control flow cell was subtracted from the data 
obtained from the CavP subunits binding to the GST Cay I-II linker fusion proteins. The 
resulting sensorgrams were aligned using BIAevaluation 3.0 software (BIAcore AB) and are 
shown in Figures 3.5, 3.6 and 3.7. From the data in these figures, single exponential fits were 
made to the dissociation phases of the sensorgrams to establish the off rates (koff). The 
dissociation rates (Wf) for GST Cay 1.3 I-II linker, GST Cay2.1 I-II linker and GST Cay2.2 
I-II linker binding to lOOnM concentrations of CayPlb, CayP2a or CayP3 are shown in table
3.1. There is little variation in the koff for within each Cay I-II linker / Cayp subunit
86
Figure 3.4
Example BIAcore sensorqram
GST
fusion Buffer Analyte Buffer Regeneration
> r S
Time (s)
Figure 3.4. Example BIAcore sensorgram. GST fusion proteins are captured via an anti GST antibody, 
buffer is perfused until the baseline is stable before the required concentration of analyte is injected. Buffer is 
continually perfused and the dissociation phase is measured for as long as is required. Finally, any remaining 
ligand/analyte complex is removed with a pulse of 10mM Glycine pH 2.2 and the next cycle can begin.
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Table 3.1
CayPlb Cav^2a C a ^
GST Cayl.3 I-II linker 0.0068 s-1 0.0044 s-1 0.0067s-1
GST C a^.1  I-II linker 0.0061 s*1 0.0039 s-1 0.0088 s-1
GST Cav2.2 I-II linker 0.0056 s-1 0.010 s-1 0.018 s-1
Table 3.1. Showing dissociation rates (k^) for GST Cay I-II linker fusion proteins binding to 100nM 
concentrations of Cavp1b, Cayp2a or Cayp3. The values were calculated by making single exponential fits 
to the dissociation phases of the BIAcore sensorgrams.
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Figure 3.5
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Figure 3.5. Representative BIAcore sensorgram s showing interactions between GST C s^l.3  I-II linker fusion
proteins and Cav(31b (top panel), Cayp2a (middle panel) and C a ^  (bottom panel). Concentrations of 5nM -
200nM (as indicated) were applied.
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Figure 3.6. Representative BIAcore sensorgram s showing interactions between GST C a^ .1  l-ii linker fusion
proteins and CayPlb (top panel), Cavp2a (middle panel) and C a ^  (bottom panel). Concentrations of 5nM -
200nM (as indicated) were applied.
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Figure 3.7
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Figure 3.7. Representative BIAcore sensorgram s showing interactions between GST Ob^ . 2  I-II linker fusion
proteins and C a ^ lb  (top panel), C a ^ a  (middle panel) and C a ^  (bottom panel). Concentrations of 5nM -
200nM (as indicated) were applied.
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Table 3.2
Cavpib Cavp2a Cavp3
GST Cav 1.3 I-II 
linker
13.2 ±3.6 nM 12.1 ±3.7 nM 12.7 ±2.7 nM
GST Cav 2.1 I-II 
linker
13.7 ± 5.4 nM 18.0 ±3.6 nM 11.9 ± 4.3 nM
GST Cav 2.2 I-II 
linker
17.6 ± 2.0 nM 20.0 ± 2.9 nM 19.0 ±2.8 nM
Table 3.2. Showing dissociation constants (Kg) calculated from the data shown in figures 3.5, 3.6 and 3.7. 
Fits were made to each data set using BIAevaluation 3.0 software using a model of 1:1 interaction.
Data are mean ± SEM of 4 experiments. All data shown were obtained using the same protein preparations.
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Figure 3.8. A. Examples of single exponential fits made to BIAcore sensorgrams. A. Single 
exponential fits of the association and dissociation phases of 50nM concentrations of CayP1b binding to 
immobilised GST Cay 1.3 I-II linker, GST Cay2.1 I-II linker or GST Cay2.2 I-II linker. The table shows 
calculation of the specific on rate (k^) calculated as k^ = (kon(obs) -  k^/fCayP ] and the dissociation 
constant ( K q )  calculated as K q  = k ^ k ^  from the values obtained from the fits.
B. Single exponential fits of the association and dissociation phases of 50nM concentrations of Cayp2a 
binding to immobilised GST Cayl.3 I-II linker, GST Cay2.1 I-II linker or GST Cay2.2 I-II linker. The 
table shows calculation of the specific on rate (k^) calculated as k^  = ( k ^ ^  -  k^/lCayP] and the 
dissociation constant (K q )  calculated as K q  = k^k^, from the values obtained from the fits.
C. Single exponential fits of the association and dissociation phases of 50nM concentrations of Cayp3 
binding to immobilised GST Cay1.3 I-II linker, GST Cay2.1 I-II linker or GST Cay2.2 I-II linker. The 
table shows calculation of the specific on rate (k^,) calculated as k^  = (kon(ob8) -  k^/ICayP ] and the 
dissociation constant (K q )  calculated as K q  = k ^ k ^  from the values obtained from the fits.
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combination across the range of CavP subunit concentrations tested and this is to be expected 
as the koff should be independent of CavP subunit concentration. There was some variation 
however between the different combinations with Cav 2.2 I-II linker / CavP3 showing the
fastest off rate (0.018 s'1) and Cay2.1 I-II linker / Cayp2a showing the slowest off rate 
(0.0039 s'1). The dissociation constants (Kd) were calculated using two methods. Firstly, 
using the data from Figure 3.5, fits were made as described in Chapter 2 using BIAevaluation 
3.0 software. In addition to models of 1:1 stoichiometry, other models were tested however 
single exponential fits were most appropriate for this data as determined by the chi squared 
statistical test. The mean Kd values were found to be between 11.9 ± 4.3 nM and 20 ± 2.9 
nM, the values calculated for each subunit combination are shown in Table 3.2. Analysis of 
variance (ANOVA) followed by Tukey’s post hoc test was used to analyse the data from 
Table 3.2. There was no significant difference between the Kd values calculated for CavPlb 
binding to Cay2.1, Cay2.2 or Cavl.3 I-II linker (P = 0.802), no significant difference between 
the Kd values calculated for CavP2a binding to Cay2.1, Cay2.2 or Cay 1.3 I-II linker (P = 
0.247) and no significant difference between the Kd values calculated for CavP3 binding to 
Cay2.1, Cay2.2 or Cayl .3 I-II linker (P = 0.460). Secondly, single exponential fits were 
made to the first 120 seconds of the association phase and the dissociation phase of the data 
shown in Figure 3.5. From these fits, the specific association rate (kon) was calculated as kon 
= (kon(obs) - koff)/[Cayp], and the dissociation constant Kd was calculated as Kd = Wf/kon. 
These fits and calculations are shown in Figure 3.8. In addition, these experiments were 
performed in reverse by immobilising CayP subunits on the chip surface and using the GST 
Cay I-II linker proteins as analyte, similar results were obtained and similar Kd values were 
obtained after evaluation of the data.
These results agree with those of other studies which have shown that the I-II linker 
of HVA calcium channels binding with high affinity to the CayP subunit (De Waard et al., 
1995; Bell et al., 2001; Canti et al., 2001; Leroy et al., 2005; Geib et al., 2002; Pragnell et 
al., 1994; Witcher et al., 1995). There is little variation in the dissociation constants 
determined here between the combinations of subunits tested although the Cayl .3 I-II linker 
may bind CayP subunits with a slightly higher affinity than the Cay2 class of channels.
3.2.3 GPy subunits of heterotrimeric G proteins interact with the I-II linker of Cay2.2 
but not Cayl.3
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Figure 3.9.A. Representative BIAcore sensorgrams showing interaction between GST Cav2.2 Ml linker and 
purified G protein py subunits. Concentrations of 10nM -  50nM (as indicated) were applied. Also shown is the 
lack of interaction between GST Cayl.3 Ml linker and G protein Py subunits, no binding was observed even with 
100nM Gpy.
B. Single exponential fits of the association and dissociation phases of 10nM concentration of Gpy binding to 
immobilised GST Cay2.2 Ml linker. The table shows calculation of the specific on-rate (k^) and the dissociation 
constant (KD) from the values obtained from the fits.
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In addition to interacting with the Cavp subunit, the I-II linker of the Cay2 class of calcium 
channels is involved in interaction with the Py subunits of heterotrimeric G proteins. These 
interactions have been demonstrated previously using overlay assays (De Waard et al., 1997; 
Zamponi et al., 1997; Herlitz et al., 1997). The interaction of G protein Py subunits with the 
GST I-II linker proteins was investigated using surface plasmon resonance. GST I-II linker 
fusions of Cay 1.3 and Cav2.2 and GST alone were prepared as described previously and 
immobilised via a GST antibody onto a CM5 sensor chip. As before, 150 RU of GST I-
These interactions have been demonstrated previously using overlay assays (De 
Waard et al., 1997; Zamponi et al., 1997; Herlitz et al., 1997). The interaction of G 
protein py subunits with the GST I-II linker proteins was investigated using surface 
plasmon resonance. GST I-II linker fusions of Cayl.3 and Cav2.2 and GST alone 
were prepared as described previously and immobilised via a GST antibody onto a 
CM5 sensor chip. As before, 150 RU of GST I-
II linkers and the corresponding molar equivalent of GST were applied. Prior to injection of 
py subunits, the integrity of the I-II linker fusion proteins was tested by applying a low 
concentration of purified CavPlb. CavPlb specifically bound to both GST I-II linker fusions 
(not shown).
G protein Py subunits purified from bovine brain (Exner et al., 1999) were a 
generous gift from Professor Bemd Niimberg (Institut fur Pharmakologie, Freie 
Universitat Berlin, Thielallee 69-73, D-14195 Berlin (Dahlem), Germany). The G 
protein Py subunits were preparations containing mixed isoforms of p and y subunits 
extracted from membranes and stored in detergents. Solutions of purified G Py 
subunits from lOnM to lOOnM were perfused across all flow cells, each injection 
lasted 5 minutes and was followed by a 5 minute dissociation period. Specific 
binding was observed to the GST Cay2.2 I-II linker whilst minimal binding was 
observed to the GST only or to the GST Cavl .3 I-II linker. The signal from the GST 
only flow cell was subtracted and the resulting sensorgrams were aligned using 
BIAevaluation 3.0 software (Figure 3.9 A). Single exponential fits were made to the 
association and dissociation phases of the sensorgram obtained from the lOnM 
injection of GPy. From this data, the dissociation constant for GPy binding to the 
GST Cav2.2 I-II linker was 61.1nM (Figure 3.9 B).
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3.3 Discussion
High voltage activated calcium channels are associated with a regulatory beta 
subunit. The intracellular loop between domains I and II contains the AID motif to 
which Cavp subunits bind (Pragnell et al., 1994). Binding of CavP subunits to the 
AID motif enhances functional expression of the channels as well as hyperpolarizing 
the voltage dependence of activation and hyperpolarizing the voltage dependence of 
steady state inactivation.
Surface plasmon resonance binding assays using GST fusion proteins of the 
entire I-II linker of Cay 1.3, Cay2.1 and Cay2.2 and purified CavPlb, Cayp2a or 
Cayp3 subunits showed the dissociation constant for these interactions to be between 
12.1nM and 20nM. These results are in agreement with other studies which have also 
determined the dissociation constants for AID / CayP subunit interactions to be in the 
low nanomolar range (De Waard et al., 1995; Scott et al., 1996; Geib et al., 2002).
De Waard (1995) also found that there was considerable variation between the 
dissociation constants determined for the four different CayP subunits and that 
Cayp2a and CayP4 bound with two different affinities suggesting two different 
binding sites. The data from surface plasmon resonance binding assays described 
here does not show a substantial difference between the affinities of the different 
CayP subunits for the GST Cay I-II linker fusions although Cay 1.3 I-II linker may 
bind with a slightly greater affinity than the members of the Cay2 class of channels 
tested here. Although CayP4 was not tested, the data from the other three Cayp 
subunits fitted well to a model of 1:1 interaction. If in the case of Cayp2a or Cayp4, a 
second beta subunit can bind, the affinity of this interaction may be so low that it 
cannot be measured by this method.
It seems clear from the data here and from other studies (De Waard et al.,
1995; Scott et al., 1996) that all CayP subunits are capable of binding to the AID 
motif of all HVA Cayal subunits. The differences in the non-conserved amino acid 
residues between the different channel types does not seem to have a substantial effect 
upon Cavp binding although one study has implicated the non-conserved residues in 
the AID motif of Cay2.3 as being determinants of voltage dependent inactivation 
(Berrou et al., 2001). In native tissue the Cayal / CayP subunit combinations display 
a tissue specific distribution with for example, Cay 1.1 and Cayp la are predominantly
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expressed in skeletal muscle and Cay2.1 and CayP4 are predominantly expressed in 
Purkinje cells of the cerebellum. Interaction of Cavp with AID promotes trafficking 
of the Cayal subunit to the membrane as Cayal subunits which cannot interact with 
CayP or Cayal coexpressed with Cayp subunits which lack the GK domain are not 
trafficked to the plasma membrane (Leroy et al., 2005; Cohen et al, 2005). As well 
as interaction with AID, other Cayal / CayP subunit interactions have been reported, 
these include additional Cayp binding sites within the N and C termini of certain 
Cayal subunits and elsewhere within the I-II linker (Walker et al., 1999; Stephens et 
al., 2000; Maltez et al., 2005). The CayP4 subunit specifically interacts with the C- 
terminus of Cay2.1 and regulates the kinetics of voltage dependent inactivation 
(Walker et al, 1999) and the SH3 domain of CayP2a was shown to interact with the I- 
II linker of Cay2.1 and increase current amplitude (Maltez et al., 2005). In addition, 
the Cayp2a subunit is unique in that it can be palmitoylated at its N-terminus, this has 
the effect of reducing voltage dependent inactivation (Restituto et al., 2000). As each 
Cayp subunit is able to impart specific regulatory properties to particular Cayal 
subunits (Dolphin, 2003), these secondary interactions may represent the mechanism 
by which different CayP subunits finely adjust the biophysical properties of the Cay. 
a l .
Surface plasmon resonance binding assays using GST fusion proteins of the 
entire I-II linker of Cay 1.3, Cay2.2 and G protein py subunits purified from bovine 
brain showed that the py subunits specifically bound to the Cay2.2 I-II linker. The Kd 
for this interaction was calculated to be 62.2 nM. These findings are in agreement 
with those of previous studies (De waard et al, 1997; Zamponi et al, 1997) which 
showed that Gpy binds to the I-II linker of the Cay2 class of channels. The lack of 
interaction of G protein Py subunits with the I-II linker of Cay 1.3 is consistent with 
the findings of Bell et al. (2001). In these studies, the biophysical properties of 
Cavl .3 were characterised and this channel was found to be resistant to modulation 
by G proteins when compared to Cay2.2.
Although direct binding of G protein Py subunits to the I-II linker is an 
important step in G protein modulation, other regions of the channel have also been 
shown to be essential determinants. The C-terminus of the Cay2 class of channels 
was shown to bind G protein Py subunits via a site in their C-termini (Qin et al.,
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1997), when this site was removed, G protein modulation was prevented. Subsequent 
studies revealed an 11 amino acid motif in the N-terminus of Cay2.2 which is 
conserved in both Cay2.1 and 2.3 (Page et al., 1998). Transfer of the N-terminus of 
Cay2.2 containing the motif Y K Q S I A Q R A R T t o  Cayl .2 which does not show 
G protein modulation enabled Cay 1.2 to be modulated (Canti et al., 1999), 
furthermore, mutations within this motif abolished G protein modulation of Cay2.2.
The AID motif remains an important feature of VDCC modulation, in the case 
of the Cay2 class of channels, it has been shown in this work and by others to bind to 
both CavP and to G protein Py subunits. However, whether both CavP and G Py can 
bind at the same time remains controversial. As many effects of G protein Py 
binding seem to oppose the effects of CavP, it was believed that Py dimers could 
displace CavP from the I-II linker. However, Canti et al. (1999) showed that a Cay2.2 
channel in which the I-II linker was replaced with that of Cay 1.2 was still 
substantially modulated by G proteins. Displacement of G Py was demonstrated using 
fluorescence resonance energy transfer (FRET) by Sandoz et al. (2004), the authors 
suggested that displacement of Cayp from the I-II linker is a key step in G protein 
regulation of Cay2.1 calcium channels. This contradicts findings of Hummer et al. 
(2003) who found, again using FRET that CayP and G protein p can bind to the I-II 
linker at the same time. This study also reported interaction of G protein p subunit 
with the C terminus of Cay2.2 and a possible role for the C-terminus in G protein 
modulation. The recent structural studies showing AID peptide embedded in the AID 
binding pocket of CayP suggested that either G protein py subunits would be unable 
to bind to AID in addition to CayP or that they would be unable to displace CayP 
(Van Petegem et al., 2004; Opatowsky et al., 2004). This casts doubt on the 
possibility that G protein py binds to AID at all under physiological conditions where 
the majority of HVA a l  subunits will be associated with Cayp.
Attempts were made here to take advantage of the SPR binding assay 
developed to measure the interaction of Cayp and G protein py subunits for AID and 
perform experiments which might show if G protein Py can bind to the I-II linker in 
addition to CayP or if they will displace Cayp from its binding site. The experiments 
were performed using the Cay2.2 I-II linker, CavPlb and G protein Py subunits all 
prepared as described previously. Unfortunately, the outcome of these experiments
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was impossible to interpret. Although it was possible to demonstrate binding of CavP 
and G py subunits individually, if CavPlb was first bound to the immobilised I-II 
linker, the outcome of subsequent applications of G protein Py subunits could not be 
measured as the G protein Py association phase coincided with the CavPlb 
dissociation. It was impossible to distinguish between these two events and no further 
experiments were performed. An alternative strategy would have been to include one 
component in the running buffer thus holding it at a constant concentration, 
subsequent injections of the second component could then be made, this however 
would require preparation of large quantities of either CavP or G Py. Mathematical or 
physical subtraction of the dissociation curve for one component from the data could 
also be performed.
It is clear that the mechanism by which the Cay2 class of channels interacts 
with G protein Py subunits is highly complex. Recent work revealed interactions 
between the Cay2.2 N-terminus, the I-II linker and G Py (Agler et al., 2005) and 
appears to bring together work regarding the role of the N-terminus and the I-II linker. 
A model is proposed in which the N-terminus acts as an initiatory G protein Py 
binding site and this N-terminus / G protein py complex interacts with the I-II linker 
to inhibit the channel.
Further work is clearly necessary to understand fully the interactions between 
the channel domains, accessory subunits and intracellular signalling molecules.
Future experiments should perhaps focus on the nature of the interaction between the 
N-terminus and the I-II linker.
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Chapter 4:
The effects of specific mutations within the I-II linker 
on Cav(3 subunit binding and channel trafficking
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4.1 Introduction
The Cayp subunit is responsible for regulation of HVA calcium channels in 
several ways. Cayp subunit binding enhances expression of functional channels, 
modulates their biophysical properties and can promote the voltage dependence of 
modulation of Cav2.2 channels by GPy dimers (Dolphin, 2003). Studies which 
originally identified the highly conserved AID motif in the I-II linker of HVA calcium 
channels to be the Cavp binding site also identified specific residues which were 
critical for binding (Pragnell et al, 1994; Witcher et al 1995; De Waard et al., 1995). 
An alignment of the AID motif from L-type and non L-type HVA calcium channels is 
shown in figure 4.1. Work by De Waard et al. (1995) showed that a tryptophan to 
alanine mutation abolished Cayp lb subunit binding to GST fusion proteins containing 
the Cav2.1 AID motif, mutation of isoleucine to alanine also disrupted binding but to 
a lesser extent. Subsequent studies have shown the tyrosine residue in AID to also be 
essential for Cayp binding. Mutation of tyrosine to serine disrupted binding to 
Cayp lb and caused a depolarising shift in the voltage dependence of activation and 
altered the kinetics of inactivation of Cay 2.1/plb currents in Xenopus oocytes 
(Pragnell et al., 1994; Witcher et al 1995).
L type Q Q L E E D L  - G Y - - W I I T Q A E
Non L-type Q Q I E R E L N G Y - - W I- K A E
Figure 4.1 Alignment of L type and non L type AID motifs of HVA calcium 
channels Conserved residues are shown in red, non conserved in black.
These findings would seem to be supported by recent structural studies on 
Cayp subunits in complex with AID peptide which showed the aromatic rings of the 
tryptophan and tyrosine residues to be stacked together forming a hairpin in the AID 
binding pocket. Figure 4.2 shows a representation of Cayl.l AID in complex with 
Cayp3, the conserved tryptophan and tyrosine residues are indicated. These two 
residues contribute very significantly to the network of direct and indirect hydrogen 
bonds and Van der Waals interactions which are formed between AID and Cayp. 
(Chen et a l, 2004; Opatowsky et al, 2004; Van Petegem et al, 2004).
1 (
Several studies have disputed the functional importance of the tyrosine residue,
Berrou et al. (2002) found that although no direct binding of [35S] labelled CavP3 
subunit to a GST Cav2.3 AID containing the Y to S mutation could be detected, 
Cav2.3 Y383S was still in part modulated by the Cavp3 subunit when co-expressed in 
Xenopus oocytes. Berrou et al. (2004) subsequently found that both conserved and 
nonconserved mutations in Y383 of Cav2.3 had little effect on Cavp modulation of 
whole cell currents in Xenopus oocytes but the same mutations in an AID peptide 
greatly reduced [35S] labelled CavP3 binding. In addition, Neuhuber et al. (1998) 
found that whilst Y366S mutation in Cavl.l prevented co-localization of Cavl.l with 
Cavp la in the ER of transfected tsA 201 cells, expression of Cavl.l currents was not 
affected.
Cdy P3
Q 4 2 8
van der Waals interaction 
-►  salt bridge 
—*• hydrogen bond
- -*■  hydrogen bond via a water molecule
Figure 4.2. Left, Multiple interactions formed between Cavl.l AID peptide and Cav(33, conserved 
tryptophan and tyrosine residues are highlighted (red circles). Right, Structure of Cay 1.1 AID - (33 
complex shown as ribbon diagram, with AID peptide tightly packed into the AID binding pocket of the 
guanylate kinase like domain. Taken from Richards, Butcher and Dolphin (2004).
The experiments described here have investigated the effects of mutating 
tryptophan (W391) to alanine and tyrosine (Y388) to serine or phenylalanine in the I- 
II linker of Cav2.2. The effects of mutating these residues on CavP subunit binding
i n / :
has been studied using a surface plasmon resonance binding assay and the effects on 
trafficking measured using cell surface biotinylation assays. These experiments were 
done in collaboration with Dr. Jerome Leroy who performed electrophysiological 
experiments.
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4.2 Results
4.2.1 Specific mutation in the I-II linker of Cay2.2 disrupt Cay|31b subunit binding
The effects of mutating tryptophan 391 and tyrosine 388 in the I-II linker of Cay2.2 on 
CavPlb subunit binding were first investigated using a surface plasmon resonance binding 
assay. Tryptophan 391 and tyrosine 388 in the AID of the full I-II linker of Cay2.2 were 
changed by site directed mutagenesis as described in Chapter 2 to alanine and serine or 
phenylalanine. These residues were chosen as they have previously been used to replace 
tryptophan and tyrosine at these positions in mutagenesis studies and have been shown to 
disrupt CayP subunit binding. These mutated linkers along with the wild-type I-II linker 
were joined to the C-terminus of the N utilisation substance protein (NusA), to make NusA 
Cay2.2 I-II linker fusion proteins. The expression vector encoding the NusA fusion protein 
was a modified version pET44(b) (Novagen) and was a generous gift from Dr Andrei 
Okorokov (Wolfson Institute for Biomedical Research, University College London). NusA 
was chosen as the fusion protein as it has been shown to enhance solubility of its fusion 
partners and can be easily purified via an N-terminal His(6) (De Marco et al, 2004; 
Nallamsetty et al., 2006).
The fusion proteins along with NusA alone and the CavPlb subunit were expressed in 
E.coli BL21 (DE3) RIL bacteria and purified by immobilised metal affinity chromatography 
using Ni-NTA resin as described in chapter 2.2.2. Although fused to a protein which should 
aid solubility, purification of proteins from the soluble fraction after cell lysis yielded a 
mixture of products ranging from NusA alone up to and including the full length NusA I-II 
linker (not shown). The majority of full length NusA I-II linker protein was found associated 
with the insoluble fraction after cell lysis. Solublisation of this material using 1.5% CHAPS 
was required prior to purification to ensure efficient capture of the full length fusion proteins. 
Nus Alone was purified from the soluble fraction after cell lysis without the need for a 
solublisation step. CavPlb was prepared by Ni-NTA chromatography using methods 
described by Bell et al (2001). The purified proteins are shown in Figure 4.3 after SDS 
PAGE and coomassie blue staining.
The NusA wild-type, Y388F, Y388S I-II loop fusion proteins and NusA only were 
chemically coupled directly on to the surface of a CM5 sensor chip. 2000 RU (Response 
Units) of each of the I-II linker proteins was immobilised and the molar equivalent of NusA 
alone, 1600RU was immobilised as a reference to control for non-specific binding. Solutions
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Figure 4.3
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Figure 4.3: Coomassie blue stained SDS-PAGE on NuPage 4-12% Bis-Tris gel showing purified wild-type 
and mutant NusA I-II linker fusion proteins and the C a ^ b  subunit used in surface plasmon resonance analysis. 
NusA only (lane 1), Cav 2.2 I-II linker (lane 2), Cav2.2Y388F (lane 3), Cav2.2Y388S (lane 4), Cav2.2W391A 
(lane 5), C a ^ b  (lane 6). Molecular weight markers are indicated.
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of purified CavPlb subunit from 20nM to lpM were perfused across all flow cells, each 
injection lasted 5 minutes and was followed by a 5 minute dissociation period.
Specific binding was observed to the wild-type linker and to both the Y388S and the Y388F 
mutants (Figure 4.4) whilst negligible CavPlb binding was observed to the flow cell 
containing NusA only. The dissociation phases of the sensorgrams obtained for the GST Cay 
I-II linker fusion proteins described in Chapter 3 and the NusA I-II linker fusion proteins 
binding to Cayp subunits described here appear not to return to baseline when high 
concentrations of analyte were used. If the dissociation phase was allowed to proceed for 
sufficient time, the curves did return to a value approaching baseline (not shown). The 
reason for this slowed dissociation may be that at high concentrations of analyte, the Cayp 
subunits can dissociate from one Cay I-II linker and bind to another before being washed 
from the chip surface. An increase in the flow rates used for the experiments may have 
prevented this phenomenon by washing the analyte from the chip surface before it is able to 
re-bind.
After subtraction of the signal from the NusA only negative control, single exponential 
fits were made to the dissociation phases of the sensorgrams, the dissociation rates (koff) for 
Cay 2.2, Cay2.2 Y388F and Cay 2.2 Y388S after a 20nM concentration of CayP were 0.0081 
s'1, 0.016 s'1 and 0.039 s'1 respectively, there was little variation in the dissociation rates for 
each mutant across the range of CayP concentrations used in these experiments. Little or no 
change in the koff is to be expected as this rate should be independent of the Cayp 
concentration. The dissociation constant Kd for CayP subunit binding to the wildtype Cay2.2 
I-II linker was calculated using the three methods described in chapter 2. Firstly, the data 
from Figure 4.4 was fitted using the BIAevaluation 3.0 software package (Biacore AB), the 
Kd values for the wild-type I-II linker, Y388F and Y388S were 11.6 ± 1 nM n=6, 90.4 ± 20 
nM n=6 and 209 ± 32 nM n=6 respectively. The Kd values obtained using GST fusions and 
NusA fusions of wildtype Cay2.2 I-II binding to Cayp lb were compared using analysis of 
variance (ANOVA) followed by Tukey’s post hoc test and were found not to differ 
significantly (P = 0.177). Secondly, single exponential fits were made to the first 120 
seconds of the association phase and the dissociation phase of the data shown in Figure 4.5, 
the specific association rate, kon, was calculated as kon = (kon(obs) - koff)/[Cayp], and the 
dissociation constant Kd as Kd = koff/kon- These fits and calculations are shown in Figure 4.5. 
Finally, from the data in Figure 4.4, the responses of the wild-type I-II
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Figure 4.4 Representative Biacore sensorgram s showing interactions between Cayp 1b and NusA I-II linker fusion
Proteins from Cay2.2 (top panel), Cay2.2 Y388F (middle panel) and CayY388S (bottom panel), concentrations
of 20 nM - 1  pM CaVplb (as indicated) were applied.
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Figure 4.5. Examples of single exponential fits made to Biacore sensorgrams. A. Single 
exponential fit of the association and dissociation phases of wild-type Cav2.2 binding to Cavpib.
B. Single exponential fit of the association and dissociation phases of wild-type CaV2.2Y388S binding to 
Cavpib. C. Table showing calculation of the dissociation constant KD from the data obtained in A and B
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Figure 4.6 Plot showing relationship between response at 250 seconds after sample injection from NusA Cay2.2 I-II 
Linker (squares), Cay2.2 Y388F (circles) and CayY388S (triangles) and CayPlb concentration. Curves were 
fitted using a hyperbola function.
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Figure 4.7 Representative Biacore sensorgram s showing lack of interaction between NusA Cay2.2 W391A
I-II linker and CayPlb. concentrations of 20 nM - 1  pM CayPlb (as indicated) were applied.
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linker and both mutants 250 seconds after the start of perfusion were plotted against Cavp 
concentration (Figure 4.6) these curves fitted well to a hyperbola function:
y  _  Bmax X [P]
Kd + [P] Bmax = Maximum binding
From this plot, the dissociation constants Kd for CavPlb binding to wild-type I-II linker and 
both mutants were 13.7nM, 78nM and 329nM respectively. No binding of the CavPlb 
subunit was detected to the Cay2.2W391 A I-II linker even at the highest concentration so 
further analysis was not possible and Kd values could not be determined (Figure 4.7).
These results agree with previous studies which have shown that the tryptophan in AID is 
critical for CavP binding. The affinity of CavPlb for the Cay2.2 I-II linker calculated from 
these data are also similar to those found in other studies (De Waard et al., 1995; Bell et al.,
2001; Canti et a l , 2001; Leroy et al., 2005). The results show however that mutation of the 
tyrosine residue to serine or phenylalanine reduces the affinity with which CavP can bind by 
24-fold and 5.6-fold respectively but does not completely prevent interaction as has been 
suggested previously (Witcher et al,. 1995; De Waard et al., 1995).
4.2.2 The effect of specific mutations in AID on Trafficking of Cay2.2 calcium channels 
to the plasma membrane.
The W391A mutation abolished CavPlb binding and Y388S mutation reduced the 
affinity of Cavpib for the Cay2.2 I-II linker to a greater extent than Y388F. Experiments 
were performed to establish what effects if any this had on the ability of the p subunit to 
traffic Cay2.2W391 A and Cay2.2Y388S channels to the plasma membrane.
Binding of the Cavp subunit is crucial for Cay2.2 channel trafficking to the plasma 
membrane (Bichet et al., 2000; Canti et al., 2001; Leroy et al., 2005). The I-II linker of HVA 
calcium channels has been suggested to contain an endoplasmic retention signal which causes 
nascent channels to remain in the ER (Bichet et al., 2000). CavP binding to the AID masks
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or antagonises this signal causing the channels to be released from the ER and proceed 
forward to the plasma membrane although no ER retention signal has yet been identified. In 
experiments in Xenopus oocytes, removal of most of the AID sequence of Cav2.1 or 
mutation of tyrosine 392 to serine disrupted trafficking to the plasma membrane when 
coexpressed with Cayp3 (Bichet et a l, 2000). The reduction in the affinity of CayPlb for 
W391A and Y388S in Cay2.2 may therefore be expected to reduce its trafficking effects on 
the channels.
To investigate the effects on trafficking, a cell surface biotinylation assay was used to 
measure the expression of Cay2.2 channels in the plasma membrane of transiently transfected 
tsA 201 cells. The assay involves treating cells with EZ link sulfo NHS-SS biotin (Pierce, 
Rockford, IL) which reacts with primary amine groups of lysine residues present in proteins 
located on the cell surface thus incorporating the biotin label into the protein. Biotinylated 
surface proteins can then be precipitated using agarose beads coupled to streptavidin which 
binds biotin with very high affinity (Green, 1990). The amounts of target protein present in 
the plasma membrane can then be quantified relative to the total amount of protein expressed. 
This approach has previously been used to study the surface expression of ion channels 
(Cohen et al., 2005; Ding et al., 2005; Huang et al 2004).
Tryptophan 391 was changed to alanine and tyrosine 388 was changed to serine in full 
length Cay2.2 using the PCR based site directed mutagenesis technique described in chapter 
2. TsA 201 cells were transfected with the following Cay calcium channel subunits: Cay2.2/ 
Cay2.2 W391A/Y388S lOpg, 7pg CavPlb, 7pg oi25-2. Empty pMT2 vector (24pg) was used 
as a negative control or to replace subunits which were omitted. Cell surface biotinylation 
and precipitation of biotinylated proteins was performed 48 hours after transfection.
4.2.3 Cay2.2W391A prevents trafficking to the plasma membrane
Western blotting of whole cell lysates (lOpg) from transfected tsA201 cells showed no 
effect of the W391A mutation on the total expression of Cav2.2 (Figure 4.8, top panel).
When cotransfected with CayPlb, western blot analysis of the biotinylayed proteins using 
antibodies to the Cay2.2 II-III linker showed a large reduction in the amount biotinylated 
Cay2.2W391 A compared to wild-type Cay2.2. A similar reduction in surface expression was 
seen for wild-type Cay2.2 expressed without a CayP subunit (Figure 4.8, lower panel). 
Cotransfection with CayP2a resulted in a similar although less drastic reduction in surface
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Figure 4.8 Cell surface expression of either Cay2.2 or Cav2.2W391A expressed with a25-2 and Cavp ib  or 
Cavp2a. Left, Total expression of Cav2.2 is shown by western blot in the upper row and biotinylated Cav2.2 
in the lower row. Cells were transfected with empty Vector (lane 1), Cav2.2/a26-2/pib (lane 2),
Cav2.2W391A/a26-2/pib (lane 3),Cav2.2/a26-2 (lane 4), Cav2.2/a26-2/p2a (lane 5), Cav2.2W391A/a26-2/p2a 
(lane 6). Right panel, histogram showing quantification of the mean amount of Cav2.2W391A expressed at the
plasma membrane when expressed alone, with (31 b, or p2a given as  a percentage of the amount of C a ^ ^  
expressed under the sam e conditions. Data are mean ± SEM of 3 independent experiments. (*) P < 0.05 compared 
to controls.
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expression. Expression of channel proteins at the cell surface was quantified using 
ImageQuant 5.2 (Molecular Dynamics, GE Healthcare) and expressed as a percentage of 
biotinylated wild-type Cav2.2 measured under the same conditions (figure 4.8, right). 
Cay2.2W391 A reduced surface expression by 65 ± 5 % n=3 when coexpressed with (31b and 
37 ± 3 % n=3 when coexpressed with P2a, surface expression of wild-type Cay2.2 without a 
P subunit was reduced by 52 ± 6 % n=3. These results suggest that in addition to preventing 
Cavpib binding to the AID in vitro, W391A prevents binding to the AID of Cay2.2 in vivo 
and is unable to efficiently traffic the Cay2.2 channels as surface expression of 
Cav2.2W391A/pib combination was reduced to levels observed for wild-type Cay2.2 
without a p subunit.
4.2.4 Cay2.2Y388S does not prevent trafficking to the plasma membrane
Western blotting of whole cell lysates (lOpg) from transfected tsA 201 cells again 
showed no effect of the Y388S mutation on the amount of channel protein expressed 
compared to wild-type Cay2.2 (Figure 4.9, left panel). Analysis of the biotinylated proteins 
by the same method showed a consistent elevation in the amount of Cay2.2 Y388S channel 
protein present at the plasma membrane (Figure 4.9, lower panel). The amount of Y388S 
protein at the membrane was quantified relative to wild-type Cay2.2 and found to be elevated 
by 38 ± 19% (n=3) (Figure 4.9, right). These results suggest that although the affinity of the 
CayPlb for Y388S is reduced this does not translate into a reduction in the amount of channel 
protein in the plasma membrane. This suggests that in vivo CavPlb can still associate with 
the Cay2.2Y388S channels and effectively exert its trafficking effects despite a 24-fold 
decrease in affinity.
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Figure 4.9
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Figure 4.9 Cell surface expression of either Cay2.2 or C3V2.2Y388S expressed with a25-2 and Cayp1b (left) 
Total expression of 03^2.2 is shown by western blot in the upper row and biotinylated Cd^2.2 in the lower row. 
Cells were transfected with empty vector (lane 1), Cav2.2/a25-2/pib (lane 2), Cav2.2Y388S/a26-2/pi b (lane 3) 
The cell surface expression is increased slightly by the Y388S mutation. Right panel, histogram showing 
quantification of the mean amount of C3V2.2Y388S expressed at the plasma membrane when co-expressed 
with pib , given as  a percentage of the amount of C a ^ ^  expressed under the sam e conditions.
Data are mean ± SEM of 3 independent experiments, there was no significant difference between the 
conditions P = 0.110.
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4.3 Appendix to Results
4.3.1 The effect of W391A and Y388S mutations on the functional expression of Cay2.2
Since the Y388S mutation in Cay2.2 reduces the affinity of CavPlb subunit binding but 
seems to have no effect on channel trafficking, we were interested to see what effect if any 
this mutation has on the biophysical properties of the channel. Whole cell 
electrophysiological recordings were made from tsA 201 cells transiently transfected with the 
same Cav calcium channel subunits and in the same ratios as used for cell surface 
biotinylation studies. To analyse the recordings, normalized current traces are plotted against 
the test potential. From the current -  voltage relationship (I-V), a Gmax value can be 
determined, this value describes the size of the currents recorded from the various channel 
subunit combinations. These experiments were performed by Dr Jerome Leroy.
4.3.2 W391A prevents functional expression of Cay2.2
Plots of voltage dependence of activation for wild-type Cay2.2 and Cay2.2W391 A 
expressed with and without CavPlb and P2a and for wild-type Cay2.2 and Cay2.2Y388S 
with and without Cayplb are shown in Figure 4.10. Figure 4.10 A shows the peak amplitude 
of the currents recorded from Cay2.2W391A/pib/a282 and Cay2.2/a282 without p lb 
compared to wild-type Cay2.2/plb/a282. The size of the currents from 
Cay2.2W391 A/pib/a282 was reduced by 81 ± 3% compared to the Cay2.2/pib/a28 
combination to levels comparable with Cay2.2/a282 without a p subunit. Figure 4.10 B 
shows a similar reduction in current size for the Cay2.2W391 A/p2a/a282 combination 
compared to Cay2.2/p2a/a282 the reduction in this case was 72%. These results correlate 
well with the results from surface plasmon resonance and cell surface biotinylation assays 
suggesting that the CayP subunit can no longer associate with and traffic the Cay2.2W391 A 
channels.
4.3.3 Y388S has no effect the functional expression of Cay2.2
Recordings were made from tsA 201 cells transiently transfected with Cay2.2Y388S 
and compared to wild-type Cay2.2. Figure 4.10 C shows the peak amplitude of currents 
recorded from Cay2.2/pib/a282 compared to Cay2.2/a282 without a P subunit and
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Figure 4.10 Functional expression of Cay2.2, Cay2.2W391A and Cay2.2Y388S. A. Current -  Voltage relationship 
for Cav2.2/oc28-2 (filled squares), compared to Cav2.2/a28-2/Cavpi b (filled circles) and 
Cay2.2W391 A /o ^ ^C ay P I b (filled stars). B. Current -  Voltage relationship for Cay 2.2/a25-2/Cavp2a 
(filled diamonds), compared to Cav2.2W391A/a25-2/CaVp2a (filled triangles). Taken from 
Leroy et al. (2005). C. Current -  Voltage relationship for CayJ2.2/a2b-2/CaVfi 1 b (filled squares) 
compared to Cay2.2/a28-2 (filled triangles) and Cay2.2Y388S/a25-2/CaVp1b (filled circles).
0. Plot showing Voltage dependence of steady state inactivation for Cav2.2/a25-2/CaVpib (filled squares) 
compared to Cav2.2/a25-2 (filled triangles) and Ca^^YSSSS/c&S^CayPlb (filled circles).
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Cay2.2Y388S/pib/a282 combination. There is no significant difference between the 
amplitude of the currents recorded from Cay2.2 and Cay2.2Y388S, both are greatly enhanced 
compared to Cay2.2 expressed without a p subunit. Figure 4.10 D shows the voltage 
dependence of steady-state inactivation curves for Cay2.2 and Cay2.2Y388S, both show a 
leftward shift to more hyperpolarized potentials compared to Cay2.2 without a P subunit.
This hyperpolarisation of steady state inactivation is a classic feature of CavP subunit 
modulation and suggest that although the CavP has reduced affinity for the Cay2.2Y388S I-II 
linker these channels can still be trafficked and normally modulated by the CavPlb subunit.
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4.4 Discussion
HVA calcium channels are modulated by auxiliary p subunits, CavP subunit binding to 
the AID motif enhances functional expression of the channels as well as hyperpolarizing the 
voltage dependence of activation and hyperpolarizing the voltage dependence of steady state 
inactivation. Mutation of a single tryptophan residue, W391 in Cay2.2 abolished CavP 
subunit binding. The importance of this tryptophan has been shown previously in both 
biochemical and structural studies and is regarded as the key residue involved in the 
Cayp/AID interaction (De Waard et al., 1995; Chen et al., 2004; Opatowsky et a l, 2004; Van 
Petegem et al., 2004; Leroy et al., 2005).
Coexpression of Cav2.2W391A with CavPlb reduced trafficking to the plasma 
membrane and reduced the functional expression compared to wild-type Cav2.2/pib 
combination to levels similar to wild-type Cay2.2 expressed without a p subunit, so it appears 
that Cay2.2W391A cannot be regulated by the Cayplb subunit. However, whilst cell surface 
biotinylation experiments showed that coexpression of Cayp2a with Cay2.2W391 A also 
reduced surface expression, subsequent experiments by Dr Jerome Leroy in our laboratory 
showed that those mutant channels which did reach the plasma membrane were still fully 
modulated by Cayp2a (Leroy et al., 2005). This was found to be due to the ability of Cayp2a 
to be palmitoylated at its N-terminus. Palmitoylation alters its subcellular location and 
causes it to be associated with the plasma membrane (Restituto et al., 2000). This 
presumably brings the CayP2a into close proximity with the channels. In agreement with 
this, non-palmitoylatable CayP2a was unable to modulate Cay2.2W391 A, whilst the addition 
of a palmitoylation motif to CavPlb caused it to modulate Cay2.2W391 A channels.
It has previously been proposed that trafficking and modulation by CayP are 
independent processes, Canti et al. (2001) reported that trafficking of Cay2.2 requires a low 
concentration of Cayp3 and that the Kd for this process was approximately 17nM. Full 
modulation was dependent upon a lower affinity interaction with a Kd of approximately 
120nM, suggesting an additional CayP interaction site on the Cay 2.2 protein. Cohen et al. 
(2005) reported that a small splice variant of CavPlb found in heart and named pId, lacks the 
GK like domain containing the AID binding pocket and presumably cannot interact with 
AID. This protein could still modulate the open probability of Cayl .2 channels whilst having 
no effect upon channel trafficking, again suggesting secondary sites of interaction between 
the Cay a l  and the p subunit. In addition, CayP binding sites other than AID have been
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reported in the N and C termini of HVA calcium channels (Walker et al., 1999; Stephens et 
al., 2000) and elsewhere in the I-II loop (Maltez et al., 2005). Maltez et al. (2005) reported 
direct binding of the CavP subunit SH3 domain to a site in the I-II linker of Cay2.1 close to 
but different from the AID motif. The surface plasmon resonance binding assay described 
here included the entire I-II linker of Cay2.2 and the full length CavP lb yet no binding was 
detected to the W391A mutant linker even at the highest CavP lb concentration tested. This 
may be due to the affinity of this interaction being too low to measure by this method as the 
lower limit for weak interactions is approximately 10pM, alternatively, the interaction may 
be specific for Cav2.1.
In the case of Cav2.2W391 A/CavP2a, it is seems that whilst the trafficking effects of 
CavP are virtually abolished by the mutation, palmitoylation increases the local concentration 
of CavP around the channels in the plasma membrane to levels where low affinity 
interactions sufficient to modulate the channels can occur. It seems clear that the high 
affinity AID/CavP interaction is crucial for channel trafficking and may also serve to bring 
the CavP subunit to a location relative to the channel where secondary, lower affinity 
interactions can occur.
Mutation of tyrosine 388 to serine had a large effect on its ability to bind Cavplb 
reducing the affinity approximately 24 fold, however binding was not abolished as has been 
reported previously (Pragnell et al., 1994; Witcher et al., 1995; Berrou et al., 2004; Berrou et 
al., 2005). Mutation of tyrosine 388 to phenylalanine had a lesser impact upon Cavp 
binding, these two residues are similar in structure differing by only one hydroxyl group.
This group is reported to form hydrogen bonds to the p subunit via two water molecules 
(Opatowsky et a l , 2004). The moderate reduction in affinity for the phenylalanine mutant 
may simply reflect the absence of these interactions whilst replacement of tyrosine with 
serine represents a more drastic structural change preventing AID from interacting properly 
with the AID binding pocket.
This reduction in affinity caused by Y388S did not result in any detrimental effects on 
channel function, Cav2.2Y388S channels were still trafficked to the plasma membrane, 
expression of functional channels was enhanced and the voltage dependence of steady state 
inactivation was hyperpolarised when coexpressed with CavPlb. The lack of effect may be 
due to the large amounts of Cavp subunit protein produced in the expression system used in 
the study. The excess of CavP may be sufficient to compensate for the reduction in affinity
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of CavP for the I-II linker by being able to constantly occupy the AID and so cause the 
channels to be trafficked and modulated as normal.
To further investigate the trafficking and modulation of CavPlb on Cay2.2Y388S, an 
approach similar to that taken by Canti et al. (2001) could be used. Using a Xenopus oocyte 
expression system, the amount of overexpressed CavP subunit can be more tightly controlled 
as the DNA or RNA to be expressed is injected directly into the nucleus or cytoplasm 
respectively of each oocyte. If the amount of CavP could be systematically reduced, the 
effect on trafficking and modulation of Cay2.2Y388S could then be measured relative to the 
wild-type channel. It may then be possible to determine if there are any functional 
differences between Cay2.2 and Cay2.2Y388S channels.
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Chapter 5:
The role of Cavp2a in PI3 kinase induced voltage 
dependent calcium channel trafficking
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5.1 Introduction
Voltage Dependent Calcium Channels (VDCC) are the major route of calcium 
entry in excitable cells (Catterall, 2000). High Voltage Activated (HVA) calcium 
channels are primarily modulated by the CavP subunit which enhances functional 
expression as well as hyperpolarizing the voltage dependence of activation and 
hyperpolarizing the voltage dependence of steady state inactivation, (Walker et al., 
1998; Bichet et al., 2000; Leroy et al.,2005). This is true of all CavP subunits except 
Cavp2a which slows inactivation and causes a depolarizing shift in the voltage 
dependence of steady state inactivation (Stea et al., 1994). Calcium influx through 
VDCC’s can also be modulated by extracellular stimuli binding to receptors which in 
turn relay these signals via signaling intermediates such as heterotrimeric G-proteins 
and phosphoinositides which can directly or indirectly regulate the channels (Dolphin, 
2003; Wu et al., 2002).
The Gpy dimers of heterotrimeric G proteins inhibit the Cay2 class of voltage 
dependent calcium channels. This inhibition manifests itself as a slowing of the 
activation kinetics and a shift in the voltage dependence of activation towards more 
depolarised potentials, for review see (Dolphin, 2003). The molecular mechanism 
behind this inhibition is complex but has been shown to involve direct binding of the 
Gpy dimers to the cytoplasmic linker between domains I and II (De Waard et al., 
1997; Zamponi et al., 1997) and also essential determinants in the cytoplasmic N- 
terminus (Canti et al., 1999; Agler et al., 2005).
Production of GPy dimers can modulate voltage dependent calcium channel 
activity in other ways. Viard et al. (1999) reported that stimulation of the angiotensin 
receptor AT 1a can mediate an increase in L-type current in vascular myocytes. This 
effect was shown to be partially due to a GPy sensitive phosphoinositide 3-kinase (PI3 
kinase) as the effect could be blocked by the PI3 kinase inhibitor wortmannin and 
mimicked by infusion of the GPy sensitive PI3 kinase y, there was also a component 
mediated by protein kinase C. In addition, Blair et al. (1997) reported the stimulation 
of native L and N-type calcium channels in cerebellar granule neurons after treatment 
with insulin-like growth factor (IGF-1). This effect was also demonstrated to be 
mediated by PI3 kinase as incubation with the PI3 kinase inhibitor wortmannin or 
introduction of a dominant negative PI3 kinase abolished the effect.
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Phosphoinositide 3-kinases are lipid kinases which phosphoryate the 3’ 
hydroxyl group of the inositol ring of inositol phospholipids, producing 
Phosphatidylinositol(3)P, Phosphatidylinositol(3,4)P2 or Phosphatidylinositol 
(3,4,5)P3 (Rameh et al., 1999). Phosphoinositide 3-kinase enzymes are divided into 
three classes, of these, class I PI3 kinases have been the focus of most work as they 
are coupled to extracellular stimuli. Class IPI3 kinases are further subdivided into 
class IA and class IB isoforms. Class LA PI3 kinases are composed of one of three 
regulatory subunits p85a, p85p and p55y and one of three catalytic subunits pi 10a, 
pi 10p and pi 108. The regulatory subunit interacts with high affinity with the 
tyrosine phosphorylated sequence pYxxM in the C-termini of receptor tyrosine 
kinases and other molecules via two Src-homology 2 (SH2) domains (Pawson 1995), 
this interaction recruits the catalytic pi 10 subunit to the plasma membrane where it 
can phosphorylate its lipid substrate. Class IB PI3 kinases are regulated differently, 
the regulatory p i01 subunit interacts with the catalytic pi lOy (Krugmann et al., 1999) 
and this complex can be activated by GPy dimers of heterotrimeric G proteins (Brock 
et al., 2003; Stephens et al., 1997).
Activation of class I PI3 kinases and production of Phosphatidylinositol(3,4)P2 
or Phosphatidylinositol (3,4,5)P3 causes recruitment of plekstrin homology (PH) 
domain containing proteins from the cytosol to the plasma membrane. Plekstrin 
homology (PH) domains are approximately 100 amino acid residue regions which are 
capable of interacting with phosphoinositides (Haslam et al, 1993). Over 200 genes 
containing PH domains have been identified in the human genome (Venter et al., 
2001), the best characterised of which is the serine / threonine kinase protein kinase B 
(PKB)/Akt. Membrane recruitment followed by phosphorylation on threonine 308 
and serine 473 is required for full activation of PKB, which can then leave the plasma 
membrane to phosphorylate its many target proteins. Many PKB substrates have so 
far been identified, these include the Bcl-2 like agonist of cell death (BAD) (Data et 
al., 1997), glycogen synthase kinase-3 (GSK-3) (Cross et al., 1995) and mammalian 
target of rapamycin (mTOR) (Sekulic et al., 2000).
Protein kinase B is an important regulator of many important cellular 
processes such as cell death (Testa et al., 2001), cell cycle progression and cell 
growth (Blume-Jensen and Hunter., 2001). It is therefore no surprise that changes in 
PKB activity or the proteins which regulate it are involved in a number of human
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cancers and in diabetes (Cheng et al., 1996; Ruggeri et al., 1998; Nicholson and 
Anderson., 2002; Weston et al., 2001; Brazil and Hemmings., 2001). In addition to 
these processes, the PI3K/ PKB pathway has been implicated in the trafficking and 
membrane insertion of certain membrane proteins and ion channels. Kanzaki et al. 
(1999) reported that a calcium permeable cation channel named growth factor 
regulated channel (GRC) of the transient receptor potential (TRP) channel family was 
trafficked to the plasma membrane after stimulation with IGF-1 in Chinese hamster 
ovary (CHO) cells. Furthermore, this effect was blocked by wortmannin, implicating 
effectors downstream of phosphoinositide 3-kinase. Lhullier et al. (2002) described 
the regulation of membrane insertion of calcium-dependent potassium channels (Kca) 
in response to the target growth factor TGFjil. Application of TGFpi to neurons of 
the chick ciliary ganglion caused activation of PKB and the mitogen activated protein 
kinase (MAP) Erk and promoted the insertion of Kca channels into the plasma 
membrane from intracellular stores. These effects were blocked by the 
PI3Kinhibitors wortmannin and LY294002. In addition, Wang et al. (1999) reported 
abolition of translocation of the glucose transporter GLUT4 in L6 myoblast muscle 
cells in response to insulin treatment after introduction of a dominant negative PKB 
(AAA-PKB) in which the regulatory phosphorylation sites threonine 308 and serine 
473 and phosphate transfer residue lysine 179 are changed to alanine. Although 
these studies suggest that activation of PKB is necessary for plasma membrane 
targeting, the precise mechanism of action is not clear.
More recently, Viard et al. (2004) reported that in COS-7 cells, PI3 Kinase 
acting through PKB promotes translocation of voltage dependent calcium channels to 
the plasma membrane, this was measured by whole cell electrophysiology and 
confocal microscopy. Furthermore this effect is specific for channel combinations 
which include the CavP2a subunit. The Cavp2a subunit was found to contain a 
putative PKB phosphorylation motif RxRxxS/T in its C-terminus. Mutations of 
residue 574 in CavP2a to alanine or glutamic acid which abolish or mimic 
phosphorylation respectively were shown to abolish or promote Cay2.2 trafficking to 
the plasma membrane and so to mimic the effect of PI3 kinase and PKB. In acutely 
isolated rat dorsal root ganglion (DRG) neurons, application of IGF-1 induced 
translocation of transiently transfected Cay2.2 channels to the plasma membrane and 
in COS-7 cells introduction of constitutively active PKB which can be myrisoylated at
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its N-terminus and therefore localised at the plasma membrane also induced 
translocation suggesting that PKB may act directly on the Cay2.2/CavP2a channel 
complex.
The experiments described here were performed to investigate whether 
Cavp2a can be a substrate for PKB both in vitro and in vivo. By using in vitro and in 
vivo phosphorylation assays combined with immunoprecipitation, the amounts of 
radioactive phosphate incorporated into wild-type Cayp2a compared to Cavp2a 
S574A were measured. Antibodies directed specifically to the phosphorylated form 
of threonine 308 or serine 473 of PKB were used to probe its activation state after co­
transfection with phosphoinositide 3-kinase. Finally, co-immunoprecipitation was 
used to probe for a direct interaction between Cayp2a and PKB.
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5.2 Results
5.2.1 Expression of PI3 kinase y induces activation of endogenous protein kinase 
B in COS-7 cells
The GPy sensitive PI3 Kinase y is composed of a regulatory PI 01 subunit and 
a catalytic subunit PI lOy (Krugmann et al., 1999). COS-7 cells were transiently 
transfected with P I01 in expression vector pcDNA3 and PI lOy in expression vector 
pMT2. Western blot analysis was performed on whole cell lysates (lOpg) three days 
after transfection. The P I01 subunit contained a Glu-Glu epitope tag at its N- 
terminus (sequence EEEEYMPME) (Grussenmeyer et al., 1985) and this was 
detected with anti Glu-Glu tag antibodies. PI lOy subunits were detected with anti 
PI 10 antibodies (Santa Cruz biotechnology). Figure 5.1a shows expression of both 
subunits compared to untransfected COS-7 cells, in agreement with previous reports, 
no endogenous PI lOy subunits are detected (Murga et al,. 1998).
Full activation of PKB requires production of Phosphatidylinositol(3,4)P2 or 
Phosphatidylinositol (3,4,5)P3 which PKB binds via its PH domain causing 
translocation to the plasma membrane (Burgering et al., 1995; Franke et al., 1997). 
At the membrane, PKB is phosphorylated at a threonine at position 308 in the kinase 
loop or T loop by phosphoinositide dependent kinase 1 (PDK1) (Alessi et al., 1997) 
and at position 473 in the hydrophobic C-terminal domain by a second kinase. The 
molecular identity of the serine 473 kinase has been controversial for many years, 
many candidates have been put forward such as PDK1 (Balendran et al., 1999), 
integrin linked kinase (ILK) (Persad et al., 2001) and even PKB itself (Toker et al., 
2000). Recently however, Sarbassov et al. (2005) reported that the large protein 
kinase mammalian target of rapamycin kinase (mTOR) complexed with another 
protein Rictor is necessary for serine 473 phosphorylation and that this complex can 
phosphorylate serine 473 on PKB in vitro.
The ability of PI3 kinase y to activate endogenous PKB in COS-7 cells was 
assessed using structural and phosphospecific antibodies to PKB. It has been shown 
previously that PI3 kinase y expressed in COS-7 cells is active without the need for 
further activation (Lopez-llasaca et al., 1997) this may be due to the endogenous pool 
of free G protein Py subunits reported to be present in COS-7 cells (Stephens et al., 
1998). Figure 5.1b shows western blots of whole cell lysates (lOpg) from COS-7
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Figure 5.1. Expression of PI3 kinase y and activation of endogenous protein kinase B in COS-7 cells.
A. Western blot showing expression of P101 (upper panel) and P110y (lower panel) in transfected COS-7 cells.
B. PI3 kinase y induces phosphorylation of endogenous PKB. PKB is detected in both transfected and 
untransfected COS-7 cells (upper panel) but phosphorylation on threonine 308 and serine 473 (lower panels) is 
only detected when PI3 kinase y is transfected.
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cells transfected with PI01 and PllOy. Antibodies specific for the phosphorylated 
forms of threonine 308 or serine 473 (Upstate biotechnology) of PKB were used to 
probe the phosphorylation states of these residues after transfection of PI3 kinase y. 
PKB is present endogenously in COS-7 cells (Figure 5.1b, top panel) and transfection 
of PI3 kinase y induced an increase in phosphorylation at threonine 308 and serine 
473 on PKB (Figure 5.1b, lower panel).
5.2.2 The role of serine 574 in Cavp2a
Experiments performed by Dr Patricia Viard in our laboratory suggested that 
the PI3 kinase/PKB pathway was involved in the translocation of Cay2.2 calcium 
channels to the plasma membrane and furthermore that the Cayp2a subunit was 
required for this to happen. PKB will phosphorylate proteins containing the 
consensus motif R-x-R-x-x-S/T-F/L, where x can be any amino acid residue (Alessi et 
al,. 1996). A unique putative PKB phosphorylation motif was identified in the C- 
terminus of CavP2a which would result in the phosphorylation of serine 574.
Mutation of this serine to alanine or glutamate abolished or mimicked the effects of 
transfection of PI3 kinase y and PKB on Cay calcium channel trafficking. Figure
5.2 shows the putative phosphorylation site in CavP2a aligned with some known, 
published PKB phosphorylation sites.
Figure 5.2 Phosphorylation Protein
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Figure 5.2. Alignment of proteins containing published PKB phosphorylation sites against the putative 
site in the C-terminus of Cav(32a. The sites of potential phosphorylation are marked in red. Taken 
from Brazil and Hemmings. (2001).
To investigate whether serine 574 of Cav(32a is a substrate for PKB, 
experiments were performed where Cayp2a wets immunoprecipitated from 33T 
labelled transfected COS-7 cells and the amounts of 33'P incorporated into wildtype 
CavP2a was compared to CayP2a where serine 574 was changed to alanine.
The CavP2a and CavP2a S574A were modified so that a haemaglutinin 
(HA) epitope tag was fused to their N-terminus, this was performed by polymerase 
chain reaction as described in Chapter 2. The CavP2a subunit is palmitoylated at its 
N-terminus (Chien et al., 1996) and this enhances its ability to traffic Caycil subunits 
to the plasma membrane. In Dr Viard’s experiments palmitoylation was not required 
for PI3 kinase induced modulation of Cav calcium channels. Experiments were 
performed nevertheless to try to immunoprecipitated HA tagged wildtype CavP2a 
from transfected cells. However, western blotting and immunoprecipitation 
experiments showed that the HA tag could barely be detected by western blotting with 
anti HA antibodies and the protein could not be captured by anti HA antibodies in 
immunoprecipitation (not shown). Interestingly, the same construct did behave 
similarly to CayP2a without an HA tag when expressed in Xeopus laevis oocytes with 
Cay2.2 and a252 (not shown). These result suggest that the lipid modification may 
hinder antibody binding or the HA tag may be removed during the post-translational 
modification. In the light of this data and to follow Dr Viard’s experiments as closely 
as possible, these constructs were modified so that they were no longer able to be 
palmitoylated, this was done by substituting cysteine at positions 3 and 4 for serine 
(Stephens et al., 2000). Metabolic labelling was performed as described in Chapter 
2, COS-7 cells were transfected with Cayp2a or CayP2aS574A and with or without 
PI3 kinase y. Cells were deprived of phosphate for 1 hour prior to labelling with 
30pCi/ml [33'P] orthophosphate. HA tagged CayP2a subunits were 
immunoprecipitated using anti HA monoclonal antibodies (Roche Diagnostics).
133
5.2.3 Mutation of serine 574 to alanine prevents PI3 kinase y induced 
phosphorylation of CayP2a in COS-7 cells
Immunoprecipites from 33'P labelled COS-7 cells were separated by SDS 
PAGE, transferred to a PVDF membrane and the amounts of incorporated phosphate 
were measured using autoradiography. It was necessary to transfer the proteins from
'X'Xthe polyacrylamide gel to the membrane as 'P has a much weaker signal than 'P 
and even a thin layer of gel can retard the signal significantly. Figure 5.3 shows 
western blot using anti CayP2 antibodies (Chien et al., 1996) and autoradiogram of 
immunoprecipitated ‘P labelled CayP2a. The amount of precipitated CavP2 protein 
is similar in all conditions (top panel) but the amount of incorporated phosphate is 
substantially increased in the condition where PI3 kinase y is cotransfected with 
wildtype CavP2a (lower panel). The amounts of incorporated phosphate was 
quantified using ImageQuant 5.2 (Molecular Dynamics, GE Healthcare) and 
expressed as a percentage of wildtype CavP2a phosphorylation where PI3 kinase y is 
not co-transfected (Figure 5.4). Coexpression of PI3 kinase y caused an 83 ± 35 % 
(n=3) increase in wildtype CavP2a phosphorylation whereas phosphorylation of 
Cayp2aS574A was reduced by 33 ± 14 % (n=3) when expressed alone and by 14 ± 10 
% (n=3) when PI3 kinase was coexpressed.
These results show that in COS-7 cells, coexpression of PI3 kinase y causes 
an increase in phosphorylation at position 574 on Cayp2a. This data does not 
however implicate PKB in the direct phosphorylation of CavP2a, other protein 
kinases can be activated by PI3 kinase and this putative phosphorylation motif could 
be a target for other enzymes.
5.2.4 Protein kinase B can associate directly with CayP2a
Having shown that coexpression of PI3 kinase y resulted in increased 
phosphorylation on serine 574 of CavP2a and in view of the results from Dr Viards 
experiments in which coexpression of a constitutively active PKB induced trafficking 
of CayP2a containing voltage dependent calcium channel complexes to the plasma 
membrane, coimmunoprecipitation experiments were performed to determine whether 
PKB could interact directly with CayP2a. The interaction of protein kinases with 
their substrates is not considered to be stable or long lasting as rapid rates of
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Figure 5.3. A. Cavp2a S574A prevents PI3 kinase y induced phosphorylation of Cavp2a in COS-7 cells. 
Western blot using anti Cavp2a antibodies shows Cavp2a precipitated from 33*P labelled COS-7 
cells (upper panel). Lower panel, autoradiogram showing 33’P incorporation into Cavp2a.
B. Histogram showing mean increase in 33_P incorporation into Cavp2a alone or coexpressed with PI3 kinase y 
or Cavp2aS574A alone or coexpressed with PI3 kinase y given as a percentage of 33'P  incorporation into Cavp2a 
expressed alone. Data are mean ± SEM of 3 independent experiments.
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Figure 5.4
HA Cavp2a 
PKB
HA Cavp2a 
protein kinase B
Figure 5.4. Protein kinase B can associate directly with Cavp2a. Western blot analysis of immune complexes 
from COS-7 cells transfected with HACavp2a, PKB or HACavp2a and PKB together. Top panel shows 
Cavp2a protein precipitated by anti HA antibodies. Lower panel, anti PKB antibodies detect PKB protein 
coprecipitating with HACavp2a.
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phosphorylation are often required in intracellular signalling cascades (Brazil and 
Hemmings., 2001) however PKB has previously been shown to form stable 
complexes with some of its protein partners (Lee et al., 2001; Zhou et al., 2001).
HA tagged CavP2a was immunoprecipitated from transfected COS-7 cells 
and the resulting complexes were analysed by western blotting with anti PKB 
antibodies. No endogenous PKB was detected in the precipitates (not shown). Next, 
COS-7 cells were cotransfected with HA tagged CavP2a and wildtype PKB together. 
HACavP2a was immunoprecipitated with anti HA antibodies and the complexes 
analysed by western blotting with anti PKB antibodies. Figure 5.4 shows western 
blots using anti CavP2a and anti PKB antibodies of immunoprecipitates from COS-7 
cells transfected with either HACayp2a, PKB or both. PKB clearly coprecipitates 
with HACavP2a although a small amount of PKB protein is precipitated in the 
condition where no CavP2a is present. The result is representative of three 
experiments.
5.2.5 Phosphorylation of CayP2a in vitro
Previous experiments have shown that cotransfection of PI3 kinase y with 
Cayp2a leads to an increase in phosphorylation on serine 574 which is part of a 
putative PKB phosphorylation site and that PKB can coimmunoprecipitate with 
Cayp2a from transfected COS-7 cells. Although these data suggest that PKB is 
involved, there is no evidence that it can directly phosphorylate this site in CavP2a. 
Further experiments were performed to determine whether CavP2a is really a 
substrate for PKB, this was done by preparing purified CavP2a and CavP2a C- 
terminus and incubating these with activated PKB in the presence of P ATP.
Initial experiments were performed using an N-terminally His(6) tagged 
Cayp2a and Cavp2aS574A purified from sf9 insect cells infected with a recombinant 
baculovirus. However, as has been reported previously (Puri et al., 1997) the CavP2 
protein copurified with an unknown protein kinase which caused substantial 
phosphorylation of CavP2a and CavP2aS574A without exogenously added PKB (not 
shown). To try to circumvent this problem, the C-termini (the last 80 amino acid
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Figure 5.5
Purified C-terminus
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Figure 5.5. A. Coomassie blue stained SDS-PAGE on NuPage 4-12% Bis-Tris gel showing purified Cavp2a 
wild-type and S574A C-termini used as  substrate for in vitro kinase assays. Lane 1, whole lysate; lane 2, flow through; 
lanes 3,4,5, eluate. B. (upper panel) Coom assie blue stained SDS-PAGE on NuPage 4-12% Bis-Tris gel showing 
loadings of substrate proteins after phosphorylation reactions. Lane 1, Bad + PKB. Lane 2, Cavp2a C-terminus only. 
Lane 3, Cavp2a C-terminus + PKB. Lane 4, CavP2aS574A C-terminus only. Lane 5 Cavp2aS574A C-terminus 
+ PKB. Autoradiogram of the sam e gel showing Incorporation of 32P into substrate proteins (Lower panel), S574A 
mutation causes 14.6 ± 5.6 % (n=3) reduction in phosphorylation.
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residues) of CavP2a and CavP2S574A were amplified by PCR as described in 
Chapter 2 and subcloned into expression vector pET28 for expression in E.coli. The 
pET28 vector encodes a C-terminal His(6) tag which is fused to the Cavp subunit C- 
termini so that the resulting proteins can be efficiently purified by Ni-NTA 
chromatography.
The CavP2a C-termini constructs were expressed in E.coli BL21 (DE3) RIL 
bacteria and could be efficiently purified from the soluble fraction by Ni-NTA 
chromatography. Samples of the purified proteins are shown in Figure 5.5 after 
analysis by SDS-PAGE and coomassie blue staining. The proteins migrated at the 
expected molecular weight (18 kDa) and were stable after purification for several 
weeks.
The purified C-termini were used as substrates in in vitro phosphorylation 
experiments. In these experiments, the purified CavP2a C-termini were incubated 
with purified PKB in the presence of magnesium and [y-32P] ATP, the resulting 32'P 
incorporation was measured by autoradiography after separation by SDS-PAGE. 
Purified, activated PKB was obtained from Upstate Biotechnology. As a positive 
control substrate, the proapoptotic protein Bad was used. This protein has previously 
been shown to be directly phosphorylated on serine 136 by PKB (Datta et al., 1997; 
del Peso et al., 1997). Figure 5.5 shows the incorporation of 32P into the CavP2a C- 
termini and Bad after incubation with activated PKB. Absence of phosphorylation in 
the conditions lacking exogenous PKB suggests that no other kinases copurify with 
CavP2a C-terminus from this bacterial source. The positive control substrate Bad is 
efficiently phosphorylated by PKB whereas the wild-type CavP2a C-terminus is 
phosphorylated to a lesser extent. There was not any substantial reduction in 
phosphorylation in the S574A mutant, the amount of P incorporation was measured 
using ImageQuant 5.2 software (Molecular dynamics, GE healthcare) and 
incorporation into the S574A mutant C-terminus was found to reduced by 14.6 ± 5.6 
% (n=3) compared to wildtype CavP2a C-terminus. These results suggest that the 
Cayp2 C-terminus is a poor substrate for PKB in vitro, the small reduction in 
incorporation seen in the S574A mutant may be due simply to a reduction in the 
number of serine residues available for phosphorylation in the substrate from 9 to 8, a 
reduction of 12 %. This would mean however that all available serine residues were 
substrates for PBK and thus that the all phosphorylation was completely non-specific.
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5.3 Discussion
In addition to modulation by the CayP subunit, calcium influx through 
voltage dependent calcium channels can be modulated by other regulatory pathways 
which are linked to G-protein coupled receptors or receptor tyrosine kinases (Dolphin, 
2003; Viard et al., 2004; Viard et al., 1999; Blair et al., 1997). Such modulation can 
be a direct physical interaction as is the case for G-protein Py subunits binding to the 
I-II linkers of the Cay 2 class of channel (De Waard et al., 1997; Zamponi et al.,
1997) or via signaling intermediates which result in phosphorylation of the channel 
protein.
Experiments performed by Viard et al. (2004) in our laboratory showed that 
coexpresssion of PI3 kinase y promotes voltage dependent calcium channel trafficking 
to the plasma membrane. The increase in trafficking is dependent upon the presence 
of the CavP2a subunit. The CavP2a subunit contains a putative PKB phosphorylation 
motif in its C-terminus which would result in phosphorylation of serine 574. Viard et 
al. (2004) found that mutation of serine 574 to alanine or glutamate which should 
abolish or mimic phosphorylation on this residue abolished or mimicked the effects of 
PI3 kinase or PKB on trafficking Cay calcium channel complexes to the plasma 
membrane.
Antibodies to the phosphorylated forms of threonine 308 and serine 473 of 
PKB were used to measure its activation. In COS-7 cells, expression of PI3 kinase y 
resulted in activation of endogenous PKB and when Cay|32a was coexpressed caused 
an 83 ± 35 % increase in phosphorylation on CayP2a compared to CayP2a expressed 
in the absence of PI3 kinase. The increase in CayP2a phosphorylation caused by 
coexpression of PI3 kinase was blocked by mutation of serine 574 on CayP2a to 
alanine suggesting that this residue is involved in the phosphorylation. These results 
correlate well with the results of electrophysiological and fluorescence confocal 
microscopy experiments preformed by Viard et al. (2004) and suggest that PKB may 
act directly on serine 574 of CayP2a. Further evidence for a direct phosphorylation of 
CayP2a by PKB came from coimmunoprecipitation experiments which showed that 
PKB can be pulled down with CavP2a when both proteins were over expressed in 
COS-7 cells. However PKB also coprecipitated with CayP2aS574A (not shown) a 
possible explanation for this could be that although the target serine is mutated, the 
surrounding consensus sequence remains intact and so this serves as the site of
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association. In addition, when pull down experiments were performed in reverse 
using an N-terminally HA tagged PKB construct, no interaction could be detected 
(not shown). This could be because the N-terminus is involved in the interaction with 
the Cavp subunit or because the addition of the epitope tag disrupted the structure of 
the protein. Neither of these possibilities were investigated further. Experiments 
performed in vitro using the purified C-terminus of CavP2a and Cavp2aS574A also 
failed to show that PKB can directly phosphorylate serine 574. The results show that 
the CavP2a C-terminus is not a good substrate for PKB in vitro as it was 
phosphorylated substantially less than the positive control substrate.
The PI3 kinase/ PKB pathway has previously been shown to be involved in 
trafficking and membrane insertion of ion channels and membrane proteins (Kanzaki 
et al., 1999; Lhullier et al., 2002; Wang et al., 1999; Blair et al., 1997; Viard et al., 
2004) although the molecular mechanism remains unclear. In this case, it appears that 
the PI3 kinase induced trafficking is dependent upon phosphorylation of CavP2a on 
serine 574 and that PKB is involved as the effect can be reproduced by transfection of 
a constitutively active PKB and abolished by the dominant negative mutant. It 
remains possible however that other kinases downstream from PKB are involved in 
phosphorylation of CavP2a on serine 574 and further work is necessary to either 
confirm that serine 574 as a substrate for PKB or to establish their molecular identity 
of the kinase responsible.
Recent work has revealed that the 14-3-3 family of proteins plays an important 
role in the function, translocation and membrane insertion of some ion channels 
(Bunney et al., 2002). The 14-3-3 proteins are phospho-serine / phospho-threonine 
binding proteins which have been shown to play important roles in many cellular 
processes such as apoptosis and transcriptional regulation, in addition, they can 
control subcellular localisation of proteins and modulate protein-protein interactions 
(Yaffe, 2002; Tzivion et al., 2001; Van Hemert., 2001). Rajan et al. (2002) reported 
that 14-3-3 proteins were essential for plasma membrane expression of TASK (two- 
pore-domain, acid-sensitive potassium channel) and only channels which were able to 
associate with 14-3-3 were localised at the plasma membrane. In addition, the brain 
chloride intracellular channel protein (Clic4) was shown to bind directly to 14-3-3^ 
(Suginta et al., 2001). As 14-3-3 proteins have been shown to bind to phosphorylated 
serine or threonine residues including those phosphorylated by PKB (Datta et al.,
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1997; Del Peso et al., 1997) it is tempting to speculate that 14-3-3 binding to the site 
around the phosphorylated serine 574 of Cav(32a may represent the trafficking 
mechanism for Caval/CavP2a calcium channels. However, most 14-3-3 protein 
binding partners contain one of two binding motifs (Muslin et al., 1996; Yaffe et al., 
1997; Petosa et al., 1998), either R S X p S X P o r R X  Y/F pS X P where X is any 
amino acid residue and pS is phospho-serine. These motifs are absent in the C- 
terminus of CavP2a and it is therefore unlikely that CavP2a interacts directly with 14- 
3-3 proteins although the possibility of interactions occurring via other proteins 
cannot be ruled out.
In conclusion, experiments described here show that in COS-7 cells CavP2a is 
phosphorylated on serine 574 in response to PI3 kinase activation. CavP2a will 
associate with PKB in COS-7 cells and although it is likely that PKB is responsible 
for phosphorylation of serine 574, further experiments are necessary to both confirm 
the identity of the serine 574 kinase and shed more light on the molecular mechanism 
by which PI3 kinase activation leads increased plasma membrane expression of 
voltage dependent calcium channels.
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Chapter 6:
Identification of protein binding partners of Cay|3
subunits
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6.1 Introduction
The CavP subunit is an essential component of the HVA calcium channel 
complex controlling both trafficking and modulation of the pore forming a l  subunit. 
Until recently the only function of the auxiliary p subunit was thought to be to 
modulate the expression, targeting and gating of the a l  subunit. A number of recent 
studies have provided evidence to suggest that CavP subunits can interact with 
proteins other than the Caval and that CavP could even act as an independent 
regulatory protein. The first such report was from Beguin et al. (2001). These 
workers found that the small Guanosine triphosphatase (GTPase) Gem, a member of 
the RGK family of G proteins which includes Rem, Rem2 and Rad interacted with 
CavP3 in a yeast two-hybrid assay, immunoprecipitation subsequently confirmed a 
direct interaction between these two proteins. The GTP-bound form of Gem in the 
presence of calcium and calmodulin was found to reduce calcium channel activity by 
preventing the p subunit from trafficking the Caval to the plasma membrane. This 
reduction was in calcium channel activity was found for CavPl, 2 and 3 subunits and 
both L-type and non L-type a l  subunits suggesting, that it is a general mechanism of 
HVA calcium channel regulation.
Subsequent studies found that two other members of this family Rem and Rad 
could also associate with CavP subunits (Finlin et al., 2003). Coexpression of Rem 
with cells expressing Cavl.2 and CavP2a resulted in the abolition of HVA calcium 
currents, also there was no effect on low voltage activated calcium channels. The site 
of interaction on the RGK protein family was mapped to a highly conserved polybasic 
region in the last 32 residues of the C-terminus.
Another novel binding partner for the CavP subunit was reported recently by 
Viard et al., (2004). This work showed that the CavP2a subunit interacts with and can 
be phosphorylated in its C-terminus by Akt/PKB kinase. Akt is activated by 
activation of PI3 kinase which recruits it to the plasma membrane. Phosphorylation 
of CavP2a resulted in increased HVA channel trafficking to the plasma membrane. 
This mechanism was shown to be specific for the Cavp2a subunit and may represent a 
more specialised mechanism of HVA calcium channel regulation.
Whilst these new interactions appear to be specific for the CavP subunit, the 
functional outcome of the above interactions is still associated with the Caval
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subunit, the result being an increase or decrease in calcium channel activity. Two 
novel functions of the CavP subunit have been reported which seem to be independent 
of their ability to modulate calcium channel function. Firstly, work by Berggren et al. 
(2004) showed that in the pancreatic p cells of a Cavp3 mouse, the modulation of 
L type calcium channels was not affected compared to wild-type, nor was the 
decrease in Cayp3 compensated for by an increase in expression of other CavP 
subunits. The mutant mice displayed enhanced intracellular calcium oscillation 
frequency leading to increased glucose induced insulin release and therefore a more 
efficient glucose homeostasis. The CavP3 subunit appears to modulate the formation 
of inositol 1,4,5-trisphosphate (InsPs) and thus modulate the release of calcium from 
intracellular stores completely independently from modulating Caval subunits. 
Secondly, a short isoform of the CavP4 subunit known as P4c was isolated from 
cochlea, (Hibino et al., 2003) this variant is truncated between the SH3 and GK like 
domains. Although the authors suggest that it retains the sequence known as BID and 
so can interact with the AID of a HVA a l  subunit, more recent structural data has 
shown that most of the GK module is required for binding to the AID. In addition to 
this the authors report that P4c has little effect on the current density again suggesting 
that it may not interact with AID. The short CavP4c subunit did however modulate 
some HVA calcium channel properties as has been described for other short CavP 
subunit isoforms (Cohen et al., 2005). Yeast two-hybrid assays with this short 
isoform revealed that it could interact with a nuclear protein involved in gene 
silencing known as chromobox protein 2 (CHCB2), this was confirmed by co- 
immunoprecipitation. Analysis of CavP4c subcellular location revealed that it is 
targeted to the nucleus of transfected tsA201 cells and can regulate gene silencing 
activity of CHCB2 although no mechanism was proposed as the short CavP subunit 
did not interact with the methyltansferase enzyme SUV39H1 or transcription factor 
1 p both of which are involved in gene silencing. The question of whether these 
functions are primary or secondary to the modulation of HVA calcium channels is 
still an open one although there is evidence to suggest that under physiological 
conditions Cavp subunits can unbind from the a l  (Canti et al., 2001; Restituto et al., 
2001; Bichet et al., 2000), leaving them free to perform other roles.
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In the light of the results of work from other groups and work in our 
laboratory which identified Akt/PKB kinase as a binding partner for the CavP2a 
subunit (Viard et al., 2004), experiments were designed to try to identify other 
proteins which may interact with Cavp subunits. A conventional approach would 
have been to use CavP subunits as bait in a yeast two-hybrid assay to screen cDNA 
libraries of brain or other tissue for potential binding partners. However, this 
approach, although sensitive, is time consuming and requires substantial amounts of 
screening, subcloning, cloning and DNA sequencing. As procedures for 
immunoprecipitation and purification of epitope tagged CayPl and 2 subunits were 
already in place, these techniques were used to “fish” for p subunit binding partners 
from a neuronal cell line and from a mouse brain lysate.
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6.2 Results
6.2.1 Expression of HA tagged Cay(3 subunits in the NG108-15 cell line.
Attempts were made to overexpress Cavp subunits in NG108-15 cells. 
NG108-15 is a neuronal cell line formed from the fusion of a mouse neuroblastoma 
and a rat glioma cell line (Klee et al., 1973). These cells have been widely studied 
and display electrophysiological and pharmacological properties similar to 
sympathetic neurons (Tsunoo et al., 1986; Docherty et al., 1989; Filippov et al., 1996 
Buisson et al., 1995). The NG108-15 cell line expresses LVA calcium channels when 
undifferentiated, expression of Cay3.2 and Cay3.3 but not Cay3.1 channels have been 
detected (Chemin et al., 2002), the expression of LVA channels appears to change 
after differentiation. Differentiation of NG108-15 cells can be achieved by treatment 
with isobutylmethylxanthine (50pM) and prostaglandin El (10pM). Three to six days 
after treatment the cells change from being spherical and clustered and begin to 
express neurite like projections, accompanied by a slowed rate of growth. Many 
electrophysiological studies have shown that differentiation of NG 108-15 cells leads 
to an increase in the expression of HVA calcium channels (Brown et al., 1989; 
Caulfield et al., 1992; Docherty et al., 1992; Schmitt et al.,1995). Pharmacological 
blockers of HVA calcium channels have been used to confirm the presence of N, P/Q 
L and R type current (Lukyanetz, 1998). Gottschalk et al. (1999) performed RT-PCR 
analysis on total RNA from undifferentiated NG108-15 cells and showed that all four 
Cavp subunits were expressed as were Cay2.2 and Cavl.2 a l  subunits. These 
findings make the NG108-15 cell line a reasonable model for searching for Cavp 
subunit binding partner proteins as they express all four CavP subunits endogenously 
and are likely therefore to express proteins with which they associate.
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6.2.2 Immunoprecipitation of HA tagged proteins
Previous experiments (see chapter 5) used haemaglutinin (HA) tagged CavP2a 
constructs which could be efficiently precipitated from transfected Cos-7 cells using 
anti HA monoclonal antibodies. These constructs were modified so that they were no 
longer able to be palmitoylated, this was done by changing cystine 3 and 4 to serine. 
The same construct was expressed in NG105-15 cells. In addition to this, an HA tag 
was introduced into the N-terminus of CavPlb. It was necessary to subclone both HA 
tagged constructs from expression vector pMT2 into pRK5 as preliminary 
experiments showed that the fluorescent marker protein GFP did not express in 
NG108-15 cells when it was in pMT2 (not shown). NG108-15 cells in 75cm dishes 
were transfected 2-4 hours after the start of the differentiation process as described in 
chapter 2 with 15pg Cavp subunit DNA or 15pg empty pRK5 vector as a control. 
Four days after transfection, cells were harvested and HA tagged CavP subunits were 
immunoprcipitated using 4pg anti HA antibody (clone 3F10, Roche diagnostics).
Western blot analysis of whole cell lysates (lOpg) from transfected NG108-15 
cells was performed using anti CavP and anti HA antibodies. Figure 6.1 shows good 
expression of both CavP2a and Cavp lb when lysates were probed with antibodies 
against the respective subunits, a weak signal at 75 kDa in the negative control lane 
may represent some endogenous CavP subunit. Attempts were made to express the 
wild-type, Cayp2a subunit which could be palmitoylated. As palmitoylation directs 
CavP2a to the plasma membrane in the absence of a Caval (Leroy et al., 2005) it 
may be able to interact with membrane associated protein partners. However, 
although this construct induced slowed inactivation kinetics typical of CavP2a when 
expressed in Xenopus laevis oocytes with Cay2.2 and a252, no HA tag could be 
detected by western blotting and subsequent immunoprecipitation experiments 
showed that HA tagged wild-type CavP2a could not be captured by anti HA 
antibodies, suggesting that either the lipid modification hinders antibody binding or 
the HA motif is modified or removed during the palmitoylation process.
The Cavp subunits were immunoprecipitated from whole lysates of 
transfected, differentiated NG108-15 cells with anti HA monoclonal antibodies.
Figure 6.2 shows a Coomassie stained SDS PAGE gel of HA tagged CavPlb and p2a
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Figure 6.1 Expression of HA tagged Cayp2a and Cavp ib  in differentiated NG108-15 cells. W estern blot analysis 
of whole cell lysates probed with A. Anti Cavp2a or B. Anti C a ^ lfa  or C. Anti HA antibodies. Cells were transfected 
with empty vector (Lane 1), HAp2a (lane 2), empty vector (Lane 3), HAplb (Lane 4). Position of HA tagged Cavp 
subunit is indicated.
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Figure 6.2 Coomassie blue stained SDS-PAGE on NuPage 4-12% Bis-Tris gel showing immunoprecipitated
Cavp subunits and co-precipitated proteins. NG108-15 cells were transfected with empty vector (Lane 1), 
HAp2a (Lane 2), HApib (Lane 3). Positions of the Cayp subunits, the heavy and light chain antibody fragments 
and the position of the proteins selected for further analysis are shown.
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subunits after immunoprecipitation. After extensive washing, only the heavy and 
light chain proteins from the HA antibody can be seen in the negative control lane 
while many proteins appear to be co-precipitated with both CavP subunits. Of the co­
precipitated proteins, four were chosen as candidates for identification, the size and 
abundance of these is marked on Figure 6.2. These proteins were chosen in 
preference to others as there was no trace of a corresponding protein in the negative 
control, they were sufficiently resolved so as not to be contaminated by nearby 
proteins and there was sufficient material for further analysis.
6.2.3 Identification of unknown proteins by Peptide Mass Fingerprinting
Peptide mass fingerprinting (PMF) was used to identify the unknown proteins 
in this study. Proteins are subjected to proteolytic digestion followed by Matrix 
Assisted Laser Desorption Ionisation Time of Flight (MALDI-TOF) mass 
spectroscopy. PMF works because each individual protein yields a unique set of 
peptides after digestion with a proteolytic enzyme. Trypsin is used to completely 
digest the proteins, it cleaves between lysine (K) and arginine (R) residues and 
generates peptides of suitable size for further analysis. After digestion, the peptides 
are mixed with a matrix which readily absorbs energy from the laser and aids 
desorption and ionisation of the sample. Once ionised, the sample is accelerated 
through an electric field into a vacuum where an analyser measures the time of flight, 
as small peptides fly slower than large ones, the mass of the peptide can be calculated 
from the time of flight. Once a spectrum has been collected from an unknown 
protein, databases containing fully sequenced genomes can be interrogated and 
software can be used which will assign the peptide fragments to a particular protein.
In these experiments, Peptide Mass Fingerprinting analysis was carried out by 
Dr Dinah Rahman (Section of Proteomics, MRC Clinicial Sciences Centre, Imperial 
College London). The resulting spectra were analysed using Mascot software (Matrix 
Science, www.matrixscience.com).
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Figure 6.3
35 kDa protein. Glyceraldehyde-3-phosphate dehydrogenase -  Accession number P09328
1 VKVGVNGFGR IGRLVTRAAF SCDKVDIVAI NDPFIDLNYM VYMFQYDSTH 
51 GKFNGTVKAE NGKLVINGKP ITIFQERDPV KIKWGDAGAE YWESTGVFT 
101 TMEKAGAHLK GGAKRVIISA PSADAPMFVM GVNHEKYDNS LKIVSNASCT 
151 TNCLAPLAKV IHDNFGIVEG LMTTVHAITA TQKTVDGPSG KLWRDGRGAA 
201 QNHPASTGA AKAVGKVIPE LNGKLTGMAF RVPTPNVSW  DLTCRLEKPA 
251 KYDDIKKW K QAAEGPLKGI LGYTEDQWS CDFNSNSHSS TFDAGAGIAL 
301 NDNIVKLISW YDNEYGYSNR WDLMAYMAS KE
45 kDa protein. Cardiac actin - Accession number Q9DFH5
B
1 MCDDEEVTAL VCDNGSGLVK AGFAGDDAPR AVFPSIVGRPRHQGVMVGMG 
51 QKDSYVGPEA QSKRGILTLK YPIEHGIITN WDDMEKIWHH TFYNELRVAP 
101 EEHPTLFTEA PLNPKVNREK MTQIMCETFN VPAMYWIQA VLSLYASGRT 
151 TGIVLDSGDG VTHIVPIYEG YALPHAIQRL DLAGRDLTDY LMKILTERGY 
201 SFVTTAEREI VRDIKEKLCY VALDFENEMA TAASSSSLEK SYELPDGQVI 
251 TIGNERFRCP ETLFQPSFIG MESAGIHETT YNSIMKCDID IRKDLYANNV 
301 LSGGTTMYPG IADRMQKEIT ALAPSTMKIK HVPPERKYS VWIGGSILAS 
351 LSTFQQMWIS KQEYDEAGPS IVHRKCF
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70kDa protein. Bos taurus serum albumin -  Accession number AF542068
C 1 MKWVTFISLL LLFSSAYSRG VFRRDTHKSE IAHRFKDLGE EHFKGLVLIA 
51 FSQYLQQCPF DEHVKLVNEL TEFAKTCVAD ESHAGCEKSL HTLFGDELCK 
101 VASLRETYGD MADCCEKQEP ERNECFLSHK DDSPDLPKLK PDPNTLCDEF 
151 KADEKKFWGK YLYEtARRHP YFYAPELLYY ANKYNGVFQE CCQAEDKGAC 
201 LLPKIETMRE KVLTSSARQR LRCASIQKFG ERALKAWSVA RLSQKFPKAE 
251 FVEVTKLVTD LTKVHKECCH GDLLECADDR ADLAKYICDN QDTISSKLKE 
301 CCDKPLLEKS HCIAEVEKDA IPENLPPLTA DFAEDKDVCK NYQEAKDAFL 
351 GSFLYEYSRR HPEYAVSVLL RLAKEYEATL EECCAKDDPH ACYSTVFDKL 
401 KHLVDEPQNL IKQNCDQFEK LGEYGFQNAL IVRYTRKVPQ VSTPTLVEVS 
451 RSLGKVGTRC CTKPESERMP CTEDYLSLIL NRLCVLHEKT PVSEKVTKCC 
501 TESLVNRRPC FSALTPDETY VPKAFDEKLF TFHADICTLP DTEKQIKKQT 
551 ALVELLKHKP KATEEQLKTV MENFVAFVDK CCAADDKEAC FAVEGPKL W  
601 STQTALA
100kDa protein. Heterogeneous nuclear ribonucleoprotein U - Accession number Q6IMY8
1 MSSSPVNVKK LKVSELKEEL KKRRLSDKGL KADLMDRLQA ALDNEAGGRP 
51 AMEPGNGSLD LGGDAAGRSG AGLEQEAAAG AEDDEEEEGI AALDGDQMEL 
101 GEENGAAGAA DAGAMEEEEA ASEDENGDDQ GFQEGEDELG DEEEGAGDEN 
151 GHGEQQSQPP AAAQQASQQR GPGKEAAGKS SGPTSLFAVT VAPPGARQGQ 
201 QQAGGDGKTE QKAGDKKRGV KRPREDHGRG YFEYIEENKY SRAKSPQPPV 
251 EEEDEHFDDT WCLDTYNCD LHFKISRDRL SASSLTMESF AFLWAGGRAS 
301 YGVSKGKVCF EMKVTEKIPV RHLYTKPIPI HEVRIGWSLT TSGMLLGEEE 
351 FSYGYSLKGI KTCNCETEDY GEKFDENDVI TCFANFETDE VELSYAKNGQ 
401 DLGVAFKISK EVLADRPLFP HVLCHNCAVE FNFGQKEKPY FPIPEDCTFI 
451 QNVPLEDRVR GPKGPEEKKD CEWMMIGLP GAGKTTWVTK HAAENPGKYN 
501 ILGTNTIMDK MMVAGFKKQM ADTGKLNTLL QRAPQCLGKF IEIAARKKRN 
551 FILDQTNVSA AAQRRKMCLF AGFQRKAVW CPKDEDYKQR TQKKAEVEGK 
601 DLPEHAVLKM KGNFTLPEVA ECFDEITYVE LQKEEAQKLL EQYKEESKKA 
651 LPPEKKQNTG SKKSNKNKSG KNQFNRGGGH RGRGGFNMRGGNFRGGAPGN 
701 RGGYNRRGNM PQRGGGGGSGGIGYPYPRGPVFPGRGGYSNRGNYNRGGMP 
751 NRGNYNQNFR GRGNNRGYKN QSQGYNQWQQ GQFWGQKPWS QHYHQGYY
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Figure 6.3 Numbers and positions of peptides identified by peptide mass fingerprinting analysis on proteins 
co-precipitating with CayP2a. A positions of the 7 peptides generated from the 35kDa protein. Protein identified 
as Glyceraldehyde-3-phosphate dehydrogenase (P09328). B Positions of the 8 peptides generated from the 
40 kDa protein. Protein identified as Cardiac actin (Q9DFH5). C Positions of the 10 peptides generated from
the 70 kDa protein. Protein identified as Bovine Serum Albumin (AF542068). D Positions of the 10 peptides
generated from the 100 kDa protein. Protein identified as Heterogeneous nuclear ribonucleoprotein U (Q6IMY8).
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Spectra were obtained from all four of the unknown proteins submitted for 
identification. The abundance and positions of the peptides relative to the proteins 
from which they originate is shown in Figure 6.3. The 35 kilodalton protein was 
identified as Glyceraldehyde-3-phosphate dehydrogenase, 7 different peptides were 
identified which represents a coverage of 29%. The 40 kilodalton protein was 
identified as Actin, 8 peptides were identified representing 23% coverage. The 70 
kilodalton protein was identified as Bovine Serum Albumin (BSA), 10 peptides were 
identified representing 19% coverage. The 100 kilodalton protein was identified as 
Heterogeneous nuclear ribonucleoprotein U, 10 peptides were identified representing 
15% coverage.
In all cases, many peptides were identified, representing significant portions of 
the proteins from which they originated, it is therefore highly likely that the 
identifications are correct. However, the presence of BSA and actin in the samples 
suggests that the samples may have been contaminated during the precipitation or the 
SDS-PAGE procedure, the relevance of the other two proteins identified is therefore 
called into question. No further work was carried out on these samples.
6.2.4 Co-precipitation of Cay(31b binding partners from mouse brain extract
Co-precipitation of binding partners for CavPlb from the neuronal cell line 
proved to be unsuccessful. Attempts were made to use already purified CavPlb and 
fragments of CavPlb to capture potential binding partners from native tissue, in this 
case mouse brain.
Full length CavPlb was expressed in E.coli and purified by Ni-NTA 
chromatography as has been described previously (Bell et al., 2001). Two further 
constructs were generated by removing the C-terminus of CavPlb by restriction 
enzyme digestion of CavPlb cDNA. These constructs are CavPlb C-terminus and 
CavPlb without C-terminus (CavPlbAC-terminus). The two new constructs were 
expressed in E.coli and purified using NI-NTA chromatography. Figure 6.4 (Left 
panel) shows an SDS PAGE gel containing samples of the purified CavPlb 
fragments.
154
Figure 6.4 B
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a  and p subunits
Figure 6.4. A. Coomassie blue stained SDS PAGE gel showing purified proteins used in pull down experiments 
CayP1b (lane 1) Cavp ib  A C-terminus (lane 2) Cayplb C-terminus (lane 3). B. Coomassie blue stained 
SDS PAGE gel showing protein eluted from CayP1b coupled to sepharose beads after incubation with mouse 
brain extract. Control (lane 1), CaVpib (lane 2) CaVpib A C-terminus (lane 3). Band representing CaM kinase II 
a  and p subunits is indicated.
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Figure 6.5
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Figure 6.5 Alignment of primary sequences of mouse CaM kinase II a (P11789) and p (CAA45160) 
subunits, differences in sequence are shown in red.
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Figure 6.6 CaM kinase II a  subunit (P11789)
MATITCTRFTEEYQLFEELGKGAFSWRRCVKVLAGQEYPAKHNTKKLSARDHQ
KLER EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD
ASHCIQQIL EAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEG
EQQRWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH
RLYQQIKARAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR
STVASCMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSGGKSGGNKKNDGV
KESSESTNTTIEDEDTKVRKQEIIKVTEQLIEAISNGDFESYTKMCDPGMTAFEPEA
LGNLVEGLDFHRFYFENLWSRNSKPVHTHLNPHIHLMGDESACIAYIRiTQYLDA
GGIPRTAQSEETRVWHRRDGKWQIVHFHRSGAPSVLPH
Figure 6.6 Sequence and position of peptides derived from CaM kinase ii a  subunit by Peptide Mass 
Fingerprinting. Peptides specific for the a  subunit shown in red, peptides common to both a  and (3 subunits 
shown in blue
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Figure 6.7 CaM kinase II B subunit (CAA45160)
MATTVTCTRFTDEYQLYEEfGKGAFSWRRCVKLCTGHEYAAKllNTKKLSARD
HQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE
YYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEV
QGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDED
QHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWV
CQRSTVASMMHRQETVECLKKFNARRKLKGAILTTMLATRNFSVGRQTTAPAT
MSTAASGTTMGLVEQAKSLLNKKADGVKPQTNSTKNSSAITSPKGSLPPAALEP
QTTVIHNPVDGIKESSDSTNTTIEDEDAKARKQEIIKTTEQUEAVNNGDFEAYAKI
CDPGLTSFEPEALGNLVEGMDFHRFYFENLLAKNSKPIHTTILNPHVHVIGEDAA
CIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWQNVHFHCSGAPVAPLQ
Figure 6.7 Sequence and position of peptides derived from CaM kinase II p subunit by Peptide Mass 
Fingerprinting. Peptides specific for the p subunit shown in red, peptides common to both a  and p subunits 
shown in blue
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Equal amounts of the purified proteins (5mg) were chemically immobilised 
onto 1 ml HiTrap NHS activated sepharose columns (Amersham biosciences, Little 
Chalfont, UK) according to manufacturers instructions, as a control one column was 
activated and blocked but no protein was immobilised. The brains of 10 adult mice 
were homogenised and prepared as described in chapter 2.2.12. Mouse brain was 
used for several reasons, firstly CavPlb is expressed highly in brain and this material 
is likely to contain proteins with which it associates, secondly a full mouse genome 
sequence is available, this greatly facilitates identification of unknown proteins after 
MALDI-TOF spectroscopy. Equal amounts of the cleared brain extract were applied 
to each column. After extensive washing, bound proteins were eluted with 5 volumes 
of Glycine pH 2.2. Eluted proteins were analysed by SDS PAGE and Coomassie 
staining.
6.2.5 CaM kinase II interacts with the C-terminus of Cavp lb
Figure 6.4 (Right panel) shows an SDS PAGE gel containing samples of 
eluates from beads coupled to CavPlb and CavplbAC-terminus compared to control 
beads. Some proteins were retained by the column containing no Cayp subunit, 
proteins of similar size in the other lanes were considered to be bound non- 
specifically and were ignored. One band of approximately 60 kDa was of particular 
interest as it appeared in the eluate from full length CavPlb and in the C-terminus 
only but not the CavPlbAC-terminus. Peptide mass fingerprinting analysis of this 
protein revealed its identity to be a mixture of CaM kinase II a  and p subunits.
Figure 6.5 shows an alignment of the primary sequences of mouse CaM kinase II a  
and p subunits. Both subunits are similar in size and as the CaM kinase II enzyme is 
a complex of both a  and P subunits, it is likely that both subunits could be present 
together. A total of 13 different peptides were identified, 9 of which were specific to 
the p subunit, 2 were specific for the a  subunit and 2 could be assigned to either a  or 
p. The sequence and positions of the peptides is shown in Figure 6.6 and 6.7, these 
represent 31% of the CaM kinase II p subunit protein and 10.5% of the a  subunit, it is
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Figure 6.8
MW
KDa
50 —
W estern blot: Anti CaM Kinase II Ab
Figure 6.8 W estern blot analysis of proteins eluted from beads coupled to purified Cavp ib  subunit 
domains shown in Figure 6.4.A. Control (lane 1), CayPlb (lane 2), CayPlb A c-terminus (lane 3), Cavp ib  
C-terminus (lane 4).
Figure 6 .9  Ca„B1b C-terminus
MATALAASPAPVSNLQGPYLVSGDQPLDRATGEHASVHEYPGELGQPPLYPS
NHPPGRAGTLWALSRQDTFDADTPGSRNSVYTEPGDSCVDMETDSEGPGPG
DPAGGGTPPARQGSWEEEEDYEEEMTDNRNRGRNKARYCAEGGPVLGRNK
NELEGWGQGVYIR
Figure 6.8 Primary sequence of the C-terminus of Cavp1b subunit, the positions of putative CaM kinase 
II phosphorylation sites are marked in red.
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therefore highly likely that this identification is correct. To further confirm the 
presence of CaM Kinase II a  subunit, western blotting was performed on the eluates 
from the pull down experiment using an antibody specific for the CaM kinase II a  
subunit (Chemicon monoclonal antibody, clone 6G9). CaM kinase II a  subunit was 
not found to be associated with the control beads or the beads containing Cayplb 
lacking a C-terminus but was it was associated with both the full length Cayplb and 
the CavPlb C-terminus (Figure 6.8).
Since the Interaction between CaM kinase II and CavPlb appears to be 
specific to the C-terminus of Cayplb, the primary sequence of CavPlb was analysed 
for the presence of putative CaM kinase II phosphorylation motifs. CaM kinase II can 
phosphorylate serine or thereonine residues which occur in the consensus sequence 
(p X R nb X S/T where cp represents a hydrophobic residue, X can be any amino acid 
and nb is a non-basic residue (Hudmon and Schulman, 2002). Three putative sites 
were identified, Figure 6.9 shows the primary amino acid sequence of the C-terminus 
of Cayplb and the position of the three putative CaM kinase II phosphorylation sites.
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6.3 Discussion
Recent work has revealed that the CayP subunit may have secondary roles 
within the cell other than enhancing the functional expression and modulating the 
biophysical properties of HVA calcium channel a l  subunits (Hibino et a l, 2003; 
Viard et al., 2004; Finlin et al., 2003; Beguin et al., 2001).
Purified full length CavPlb, CavPlbAC-terminus and C-terminus alone were 
used to pull down potential binding partners from mouse brain lysate. Proteins which 
appeared to interact specifically with the C-terminus of CavPlb were identified as the 
a  and p subunits of Ca2+/Calmodulin dependent protein kinase II. Western blotting 
using an antibody against the a  subunit confirmed that no a  subunit was associated 
with the Cavp subunit lacking a C-terminus. A search of the primary sequence of the 
CavPlb C-terminus revealed three putative CaM kinase II phosphorylation sites.
The Ca /Calmodulin dependent kinase II is a multi-subunit serine/threonine 
kinase which is composed of homo or hetero multimers of a,p,y or 8 subunits. 
Structural studies have shown each enzyme to be composed of twelve subunits 
(Kolodziej et al., 2000) although more recent X-ray crystallographic structure showed 
a tetradecameric arrangement (Hoelz et al., 2003). The holoenzyme is activated by
ty,
Ca /Calmodulin binding which prevents inhibition by the autoregulatory domain, 
making the ATP binding and substrate binding sites available (Hudmon and 
Schulman, 2002). CaM kinase II is highly expressed in some parts of the brain, the 
neuronal a  and p subunits can constitute up to 1% of the total protein of the forebrain 
(Erondu et al, 1985). The enzyme is described as multifunctional and has roles in 
long term potentiation (LTP) and long term depression (LTD). In addition to this, 
CaM kinase II is reported to be involved in the regulation of L-type calcium channels 
in cardiomyocytes (Wu et al., 2003). Activation of CaM kinase II causes an increase 
in calcium current through L-type channels by increasing the open probability of the 
channel, this occurs through a phosphorylation dependent mechanism (Dzhura et al, 
2000). Recent work by Hudmon et al. (2005) demonstrated that CaM Kinase II can 
interact with the C-terminus of Cay 1.2 and that the C-terminus of Cay 1.2 is a 
substrate for CaM kinase II in vivo and suggested that this interaction is essential for 
the calcium dependent facilitation reported previously by other studies.
Results shown here suggest that the neuronal CaM kinase II can interact with 
the C-terminus of Cayplb. Although putative CaM kinase II phosphorylation sites
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are present in the C-terminus, it is not known whether it is a substrate for this enzyme. 
As the CavP subunit itself is responsible for modulating the open probability the 
Cayal subunit (Meir et al., 2000;Wakamori et al., 1999) it is possible if not likely that 
the modulation of Cayal subunit open probability by CaM kinase II occurs via the 
CayP subunit.
Further experiments are necessary to establish the nature of the interaction 
between neuronal CaM kinase II and Cayplb. Mutation of the putative CaM kinase II 
phosphorylation sites in the C-terminus of CavPlb would enable phosphorylation 
experiments to be carried out in vitro. The purified mutated Cayp subunits could be 
incubated with active CaM kinase II in the presence of radio labelled ATP, decreases 
in the amounts of phosphate incorporated into the mutants compared to the wildtype 
CayP subunit would show if the C-terminus really is a substrate for this enzyme. In 
addition, functional experiments could be carried out to investigate the effect of CaM 
kinase II on HVA Cayal/Cayplb subunit combination and to investigate what effects 
if any mutation of the putative CaM kinase II phosphorylation sites in Cayplb may 
have on HVA calcium channel function. It would also be of interest to know if all 
CayP subunits can interact in this way or if it is limited to Cayplb. Recent work by 
Abiria et al. (2005) showed that in tsA-201 cells, CaM kinase II mediated increase in 
open probability of Cayl .2 required coexpression of Cayp2a and furthermore that a 
fragment of Cayp2 containing a putative CaM kinase II phosphorylation site will 
complex with CaM kinase II in vitro. In addition, CaM kinase II co-precipitated with 
the Cayp2a subunit from a transfected cell line suggesting that this enzyme might 
interact with other CayP subunits.
Surface plasmon resonance experiments were performed using purified 
Cayplb and purified CaM kinase II however no interaction was observed (not 
shown). This may have been due to the very small amounts of CaM kinase II 
available, such that only low concentrations could be tested or because the Kd for this 
interaction is so low that it cannot be measured by this method.
Immunoprecipitation of HA tagged CavPlb and Cavp2a subunits from 
transfected, differentiated NG108-15 cells with anti HA monoclonal antibodies was a 
highly effective way of capturing the proteins. Analysis of the precipitated proteins 
by SDS PAGE showed several different proteins associating with the P subunits
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which were not pulled down by the beads alone. These proteins were identified 
successfully by MALDI-TOF spectroscopy however, their identities lead to the 
conclusion that the samples had been contaminated at some stage during the 
procedure and no further experiments were carried out. It is possible that the analysis 
of the immunoprecipitates could have been more successful if two dimensional SDS 
PAGE had been used, this procedure separates the proteins firstly by charge and then 
by size (Gorg et al, 2000). This may have given rise to cleaner, better resolved 
samples which may have produced better results.
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Chapter 7 
General discussion
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7.1 General discussion
In this study, an SPR assay was developed to measure the interaction between 
the cytoplasmic I-II linker of L-type and non L-type Ca2+channels and Cavp subunits. 
Interaction between the I-II linker of Cavl.3, Cay2.1 and Cay2.2 and CavPl, 2a and 3 
subunits were tested and the results show that the dissociation constants for these 
interactions is in the low nanomolar range, between 12.1 and 20nM. This is in 
agreement with other studies (De Waard et al., 1995; Scott et al., 1996; Geib et al., 
2002). However, these authors used only short fragments of the I-II linker containing 
the AID motif. The results shown here suggest that other residues within the I-II 
linker do not significantly contribute to the high affinity interaction between the I-II 
linker and CavP- The study was then extended to measure the interaction of G protein 
Py subunits with the I-II linker of L-type and non L-type channels. G protein Py 
subunits bound specifically to the Cay2.2 I-II linker and the Kd for this interaction 
was calculated to be 62.2 nM, this again is in agreement with previous studies (De 
Waard et al., 1997). In agreement with Bell et al., (2001) who found that Cayl .3 was 
resistant to modulation by G protein py subunits, no interaction between Cay 1.3 I-II 
linker and G protein Py subunits was detected.
It has been shown that both G protein Py subunits and CayP subunits can bind 
to residues within the AID motif and there is some controversy over whether both 
subunits can bind at the same time (Canti et al., 1999; Sandoz et al., 2004; Hummer ct 
al., 2003). Attempts were made to adapt the SPR assay to determine whether one 
subunit can be displaced from its binding site on the I-II linker by the other subunit or 
if both subunits can occupy the I-II linker at the same time. However due to the 
relatively fast dissociation rates of both G protein Py and Cayp subunits it was 
impossible to arrive at a situation where sites on the I-II linker were fully occupied by 
one protein or the other. Although the competition experiments were attempted, the 
results were impossible to interpret and it seems that this assay is not robust enough to 
address this complicated problem.
The SPR assay was then extended further to examine the effects of mutating 
the conserved tryptophan and tyrosine residues in the I-II linker on CayP subunit 
binding. These residues have previously been shown to disrupt CayP subunit binding 
(Pragnell et al., 1994; Witcher et al., 1995; De Waard et al., 1995). The results 
showed that the conserved tryptophan but not the tyrosine is critical for Cayp subunit
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binding although mutation of the tyrosine to phenylalanine or serine reduced the 
affinity of CavP by 5.6 and 24 fold respectively (Leroy et al., 2005; Butcher et al., 
2006). Biochemical and functional assays showed that expression of Cay2.2W391 A 
with Cayplb resulted in a substantial reduction in the number of Cay2.2 channels at 
the plasma membrane, substantial reduction in whole cell current and altered 
biophysical properties similar to those of a Cay2.2 channel expressed without a Cayp 
subunit. These findings suggest that Cayp binding to AID regulates both channel 
trafficking and the biophysical properties of the channel. However whilst 
coexpression of Cayp2a with the Cay2.2 W391A mutant channel resulted in fewer 
channels at the plasma membrane, the biophysical properties of the channel appeared 
to be modulated by Cayp2a including restoration of voltage dependent G protein 
inhibition. Mutation of cysteines 3 and 4 serine prevents Cayp2a from becoming 
palmitoylated (Chien et al., 1996), this also prevented CayP2a from modulating 
Cay2.2W391 A (Leroy et al., 2005). As palmitoylation directs CayP2a to the plasma 
membrane (Bogdanov et al., 2000), it seems that although the high affinity interaction 
with AID is lost and the channels can no longer be efficiently trafficked to the plasma 
membrane, CayP2a can still interact with channels in the plasma membrane possibly 
through low affinity interactions at sites other than AID.
The tyrosine to serine mutant was studied in preference to the phenylalanine 
mutant as the effects of the serine mutation on CayP subunit binding were much 
greater. Although this mutation reduced Cayp subunit binding 24 fold, no functional 
effects were observed when Cay2.2Y388S was expressed in tsA201 cells with 
Cayplb and the mutated channels were efficiently trafficked to the plasma membrane. 
However, in a Xenopus laevis oocyte expression system where the amounts of DNA 
introduced into each oocyte can be more tightly controlled, experiments performed by 
Professor Annette Dolphin (Department of Pharmacology, University College 
London) showed that a 50 fold reduction in the amount of Cayplb DNA injected into 
the oocytes abolished the influence of CavPlb on Cay2.2Y388S whilst the same 
dilution had no effect on the wildtype channel (Butcher et al., 2006). These findings 
suggest that a high affinity interaction between AID and CayP is not required for any 
of the modulatory effects of Cayp but that Cayp subunit occupancy of the AID site is 
important. In overexpression systems such as the one used in this study, it is possible
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due to its size and cytoplasmic localisation that CayP subunits are produced at 
substantially higher levels relative to Cayal subunits. These results also show the 
limitations of using overexpression systems to study the function of protein 
complexes in which there are large differences in the size and nature of the protein 
components and where the stoichiometry of interaction is important to the function of 
the complex.
The second part of this work focused specifically on the CayP2a subunit. It 
was recently reported that activation of phosphoinositide 3-kinase (PI3 kinase) 
promotes translocation of VDCC’s to the plasma membrane (Viard et al., 2004). This 
mechanism was shown to involve protein kinase B and be specific for channels 
containing the CavP2a subunit. The experiments described here show that PKB will 
co-precipitate with Cayp2a from transfected COS-7 cells and that transfection of PI3 
kinase causes an increase in Cayp2a phosphorylation, an increase which is blocked by 
mutation of serine 574 in CavP2a to alanine. It was not possible to demonstrate direct 
phosphorylation of serine 574 in Cayp2a using an in vitro assay, the purified C- 
terminal region of CavP2a appeared to be a poor substrate for PKB and thus, whether 
PKB is the kinase responsible for the increased phosphorylation observed in vivo is 
still an open question.
Finally, taking advantage of epitope tagged constructs, purified proteins and 
immunoprecipitation assays which had been developed previously, a proteomic 
approach was used to try to identify proteins which coprecipitated with Cayp 
subunits. Peptide mass fingerprinting was used to identify proteins which bound to 
CavPlb from a mouse brain lysate. Ca2+/calmodulin dependent kinase II was found 
interact with the C-terminus of CavPlb and inspection of the primary sequence of 
Cayplb revealed three putative CaM kinase II phosphorylation sites. It is known that 
CaM kinase II can regulate L-type Ca2+ channels in cardiomyocytes by increasing the 
open probability of the channels and that it can interact with the C-terminus of Cay 1.2 
(Wu et al., 2003; Dzhura et al, 2000; Hudmon et al., 2005) but further experiments 
are necessary to determine whether the interaction of CaM kinase II with CavPlb is 
relevant to Ca2+ channel function.
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7.2 Future work
Mutation of tryptophan to alanine in AID of HVA channels abolishes CayP 
subunit binding (De Waard et al., 1995) and also prevents Cayp subunit modulation 
of Cay2.2 channels containing this mutation (Leroy et al., 2005). However, when the 
CayP subunit is directed to the plasma membrane as is the case for palmitoylated 
CayP2a, modulation of the mutated channels can occur, possibly via low affinity 
interactions at sites other than AID (Leroy et al., 2005). In future, it would be of 
interest to identify the regions of CayP responsible for these lower affinity 
interactions as well as the sites on the pore forming a l  subunit with which they 
interact. Using a combination of mutagenesis and functional experiments, further 
mutations could be introduced into Cay2.2W391A to try to remove modulation by 
palmitoylated CayP2. As additional Cayp subunit binding sites have already been 
reported on the N- and C-termini and elsewhere within the I-II linker (Walker et al., 
1999; Stephens et al., 2000; Maltez et al., 2005), these regions would be of particular 
interest. In addition, constructs containing isolated domains such as SH3 alone, GK 
alone or C-terminus alone could be used in combination with wild type a l  subunits to 
look for any modulatory effects which these domains or combinations of domains 
may impart upon the channel. The confirmation of the CayP subunit structure has 
made this approach more reliable as the boundaries between the CayP subunit 
domains are now well-defined.
In the final part of this work, a protein from a mouse brain lysate which 
interacted specifically with the C-terminus of CayPlb was identified by Peptide mass 
fingerprinting as CaM kinase II. The presence of CaM kinase II was further 
confirmed by western blotting using antibodies to the CaM kinase II a  subunit.
Further experiments should be performed to determine whether CaM kinase II can 
phosphorylate any of the three putative CaM kinase II phosphorylation sites present in 
the C-terminus of CavPlb. This could be done by mutating the putative sites in the C- 
terminus and performing in vitro phosphorylation experiments. The investigation 
could then be extended so that these sites within the full length Cayplb are mutated 
and metabolic labelling experiments could be performed which would show whether 
the C-terminus of Cayp is a substrate for CaM kinase II under more physiological 
conditions.
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Recent work by Abiria et al. (2005) showed that in tsA-201 cells, CaM kinase 
II mediated increase in open probability of Cavl.2 required coexpression of CavP2a 
and furthermore that a fragment of CavP2 containing a putative CaM kinase II 
phosphorylation site will complex with CaM kinase II in vitro. Further experiments 
should be performed to determine whether all Cavp subunits can interact with CaM 
kinase II in this way or whether this interaction is specific for Cavpib.
Finally, it would be important to know the functional outcome of CavPlb 
interaction with or phosphorylation by CaM kinase II. Electrophysiological 
experiments could be performed using a cell line transfected with CaM kinase II, an 
HVA calcium channel a l  subunit and CavPlb and these recordings compared to 
those made under the same conditions using Cavpib containing the appropriate 
mutations in its C-terminus.
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